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Abstract  
  
  
  
The importance of extracellular ATP for cell-to-cell communication in the nervous and vascular 
systems has been deeply studied for years, while less characterized is its role in regulating 
immune responses. Extracellular ATP is sensed by a class of ubiquitously expressed plasma 
membrane receptors termed P2 purinergic receptors (P2Rs), whose activation elicits different 
responses. Furthermore, extracellular ATP is rapidly degraded by ectonucleotidases such as 
CD39 and CD73 into adenosine, which in turn exerts additional regulatory effects through its 
own P1 receptors. In the first part of my PhD I addressed the role of ATP-gated ion channel 
P2X7 receptor in regulating T follicular helper (Tfh) cells functions. Tfh cells support affinity 
maturation of B cells in germinal centers (GCs) and differentiation to IgA-secreting plasma cells 
in gut-associated lymphoid tissues (GALTs). This function is critical in maintaining intestinal 
homeostasis and efficient mucosal defense. We have shown that P2X7 receptor is selectively and 
robustly upregulated in Tfh cells isolated from chronically stimulated secondary lymphoid 
organs, such as Peyer’s patches (PPs) and mesenteric lymph nodes. Deletion of P2rx7 in Tfh 
cells resulted in resistance to cell death, enhanced GC reaction in PPs, increased IgA binding to 
commensals, and reduction of mucosal bacteria. Our results unravel P2X7 as a regulator of the 
adaptive IgA response in the small intestine to allow commensalism and systemic stimulation of 
the immune system.  
In the second part of my PhD I addressed the role of the ectonucleotidases CD73 in the human 
B cell memory generation. It was previously shown from my host lab that peripheral human B 
cells co-expressing CD73 and CD39 have a more prompt capacity to expand and differentiate 
into antibody secreting cells in vitro. This property has been linked to the hydrolyzing enzymatic 
function of CD39 and CD73, which in tandem generates adenosine starting from extracellular 
ATP. We developed a method to functionally dissect antibody repertoire in different human B 
cell subsets differentiated according to CD73 expression and identified a novel subset of antigen-
experienced B cells. We have shown for the first time that human peripheral IgM+IgD+CD27− B 
cells lacking expression of CD73 carry somatically mutated variable region genes, in contrast to 
CD73+ counterpart. Furthermore, IgM+IgD+CD27−CD73− B cells were less prone to perform 
class switch recombination in vitro and showed comparable functional properties with GC-
independent memory B cells. Collectively, these results reveal CD73 as a novel human B cell 
marker that identifies functional distinct populations with different genetic hallmarks and a 
distinct differentiation fate.  
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1. Introduction  
  
  
1.1 Overview of innate and adaptive immune systems and their interplay  
  
The immune system is composed of a complex network of cells and molecules that are 
responsible for generating a response against any type of foreign substances. Historically 
immunity meant protection from infectious diseases, but research over the last several years has 
shed light on the additional roles of the immune system in patrolling cancer cells and, in some 
cases, generating a detrimental response against self-antigens which could finally lead to 
emergency of autoimmune diseases. To exploit this complex function the immune system has 
evolved two main cellular and molecular components: the innate and adaptive immunity (Figure 
1). The innate immune system, which is in place before infection and is poised to respond rapidly, 
relies on cells expressing a limited number of germline-encoded receptors to recognize the 
molecular patterns of common pathogens. The basic protective strategy of the innate immune 
system is to constitutively produce generic receptors that recognize conserved patterns on 
different classes of pathogens in order to trigger an inflammatory response that limits pathogen 
invasion (Janeway and Medzhitov 2002, Hoffmann 2003, Akira et al. 2006). Twenty years ago, 
Janeway proposed a simple and revolutionary hypothesis that the innate immune system senses 
microbial infection using receptors that are predominantly expressed on sentinel cells referred to 
as ‘pattern recognition receptors’ (PRRs) that recognize the molecular signature known as 
‘pathogen-associated molecular patterns’ (PAMPs) (Janeway 1989). Despite the fast and specific 
pathogen response, the early innate systems of defense do not lead to immunological memory 
making crucial the contribution of the adaptive immunity (Ausubel 2005). There are two types 
of adaptive immune responses, called humoral immunity, mediated by B lymphocytes and cell-
mediated immunity, which is mainly regulated by T lymphocytes. These cellular subsets display 
on the surface an antigen receptor, which is clonally restricted and generated through the somatic 
diversification of antigen-receptor genes to generate a vast repertoire of cells, each of which 
expresses a different antigen receptor (Cooper and Alder 2006). The adaptive immune response 
is initiated when the innate immune system fails to eliminate the infection; therefore, activated 
antigen-presenting cells and the antigen are delivered to the draining lymphoid tissues. When a 
recirculating lymphocyte encounters its specific foreign antigen in peripheral lymphoid tissues, 
it is induced to proliferate and its progeny then differentiate into effector cells that can eliminate 
the infectious agent. A subset of these proliferating lymphocytes differentiates into memory  
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cells, ready to respond rapidly to a second exposure to the same pathogen. The effective 
development of the overall immune response depends on careful interplay and regulation 
between innate and adaptive immunity (Abbas et al. 2012, Murphy and Weaver 2016).  
  
  
  
  
  
  
  
  
  
  
 
    
Figure 1. Overview of innate and adaptive immune system. The innate immune response functions as 
the first line of defense against infection. It consists of soluble factors, such as complement proteins, and 
diverse cellular components including granulocytes (basophils, eosinophils and neutrophils), mast cells, 
macrophages, dendritic cells and natural killer cells. The adaptive immune response is slower to develop, 
but manifests as increased antigenic specificity and memory. It consists of antibodies, B cells, and CD4+ 
and CD8+ T lymphocytes. Natural killer T cells and γδ T cells are cytotoxic lymphocytes that straddle the 
interface of innate and adaptive immunity (Dranoff 2004).  
  
12  
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The clonal selection of lymphocytes provides a theoretical framework for understanding all the 
key features of adaptive immunity, like the ability to recognize all pathogens specifically and to 
provide enhanced protection against reinfection. Each lymphocyte carries cell-surface receptors of 
a single specificity, generated by the random recombination of variable receptor gene segments 
and the pairing of different variable chains. This molecular process ensures that the total repertoire 
of receptors can recognize virtually any antigen. T and B lymphocytes use their cell surface 
receptor to recognize antigenic configurations of specific pathogens and respond to antigen 
triggering by clonal amplification, cellular differentiation and production of antibodies with the 
same antigen binding specificity (Burnet 1959).  
Despite the division of labor existing between innate and adaptive immune system, the tight 
interplay between the two systems is now emerging. Specifically, PRRs have been shown to be 
expressed by B and T lymphocytes and intriguingly generate complementary responses 
(Bernasconi et al. 2003, Imanishi et al. 2007).  
  
  
1.2 T lymphocytes  
  
Generation of T lymphocytes  
  
T lymphocyte development is a process occurring early in life in the thymus, a mediastinal organ 
that enlarges during childhood and undergoes atrophy at puberty. The thymus has a bi- lobar 
structure, each lobe being composed by multiple lobules organized in an outer cortical and an inner 
medullary region (Abbas et al. 2012, Murphy and Weaver 2016). Multipotent lymphoid 
progenitors are generated from hematopoietic stem cell precursors in the bone marrow (BM) from 
which they continuously emigrate to reach the thymus. Within the thymus a complex sequence of 
events occurs that leads to the generation of a large pool of mature T lymphocytes each expressing 
a unique T cell receptor (TCR) that can recognize a specific peptide bound to major 
histocompatibility complex (MHC) molecules displayed on the surface of antigen presenting cells 
(APCs) (Takahama 2006). The stages of development of the major lineages of T cells are 
delineated by the surface expression of the co-receptor molecules CD4 and CD8. The earliest 
precursors, CD4-CD8- double negative (DN) cells proliferate extensively and become  
CD4+CD8+ double positive (DP) cells, which are still immature and are the targets for TCRbased 
selection events. The positive selection process takes place in the cortex of the thymus and is 
mediated by specialized cortical thymic epithelial cells (cTECs) which express high amounts of 
MHC class II molecules on their surface and are endowed with distinguishing antigen processing 
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machinery (Jameson et al. 1995). In fact, they possess a unique catalytic subunit of the proteasome, 
called β5t, and lysosomal proteases (cathepsin L and thymus-specific serine protease, TSSP) that 
determine their unique array of MHC-displayed peptides. Moreover, cTECs display an high rate 
of constitutive macroautophagy, through which self-proteins from endogenous cell compartments 
can be presented on MHC class II molecules (Klein et al. 2014). Positively selected T cells then 
migrate to the medulla, where approximately 5% die by apoptosis because of a very strong 
interaction between the TCR and self-peptide-MHC complexes. This process, known as negative 
selection, is essential to purge the T cell repertoire from potentially autoreactive clonotypes 
(Baldwin et al. 1999). Negative selection is primarily carried out by medullary thymic epithelial 
cells (mTECs); through the autoimmune regulator gene (AIRE) mTECs can ectopically express a 
broad set of tissue restricted antigens (TRAs), and therefore present self-antigens which would not 
otherwise be available for screening of auto-reactive T cells (Anderson et al. 2002, Liston et al. 
2003). Low-affinity interactions between the newly expressed TCRs and self–peptide–MHC 
molecules select a broad repertoire that will be refined to react strongly to pathogen-derived 
peptides bound to the same MHC in the periphery. Thymocytes at the single positive (SP) stage 
are finally ready to leave the medulla and reach the peripheral lymphoid sites. CD8+ T cells 
recognize peptides bound to MHC class I molecules which are expressed by virtually all nucleated 
cells in the body and generally present peptides derived from intracellular proteins. CD4+ T cells 
express TCRs that instead bind peptides bound on MHC class II molecules, which are expressed 
on the surface of professional APCs, such as dendritic cells (DCs), B cells, macrophages, and 
monocytes and generally present peptides derived from extracellular antigens (Figure 2) (Germain 
2002, Abbas et al. 2012, Murphy and Weaver 2016).  
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Figure 2. Overall scheme of T-cell development in the thymus. Committed lymphoid progenitors arise in 
the BM and migrate to the thymus. Early committed T cells lack expression of T-cell receptor (TCR), CD4 
and CD8, and are termed double-negative (DN) thymocytes. DN thymocytes can be further subdivided into 
four stages of differentiation (DN1, CD44+CD25−; DN2, CD44+CD25+; DN3, CD44−CD25+ and DN4, 
CD44−CD25−). As cells progress through the DN2 to DN4 stages, they express the pre-TCR, which is 
composed of the non-rearranging pre-Tα chain and a rearranged TCR β-chain. Successful pre-TCR 
expression leads to substantial cell proliferation during the DN4 to double positive (DP) transition and 
replacement of the pre-TCR α-chain with a newly rearranged TCR α-chain, which yields a complete αβ TCR. 
The DP thymocytes then interact with cortical epithelial cells that express a high density of MHC class I and 
class II molecules associated with self-peptides. The fate of the DP thymocytes depends on signaling that is 
mediated by interaction of the TCR with these selfpeptide–MHC ligands. The appropriate, intermediate level 
of TCR signaling initiates effective maturation (positive selection). Thymocytes that express TCRs that bind 
self-peptide–MHC-class-I complexes become CD8+ T cells, whereas those that express TCRs that bindself-
peptide–MHC-class-II ligands become CD4+ T cells; these cells are then ready for export from the medulla 
to peripheral lymphoid sites (Germain 2002).  
 17  
  
Early events of CD4 T cell activation  
  
TCR activation promotes a number of signaling cascades that ultimately determine cell fate 
through regulating cytokine production, cell survival, proliferation, and differentiation. The αβ 
TCR has no intrinsic enzymatic activity and transduction of the extracellular event into a 
cytosolic cascade is mediated by a complex composed of two CD3 molecules, each consisting 
of two chains, εδ and εγ respectively, and a homodimer of ζ chains. These invariant components 
are associated with the TCR through electrostatic interactions between oppositely charged 
residues in the transmembrane region (Call et al. 2002). All these invariant dimers possess 
immunoreceptor tyrosine-based activation motifs (ITAMs) in their intracellular portion, which 
contain two tyrosine residues that upon phosphorylation provide a site for recruitment of Src-
homology 2 (SH2) domain-bearing enzymes (Irving and Weiss 1991, Letourneur and Klausner 
1992). The first event upon antigen recognition and TCR triggering is the activation of the Src-
family kinases (SFKs), particularly Lck and Fyn are the first molecules initiating the signaling 
cascade (Brownlie and Zamoyska 2013). Lck is regulated like other SFKs, via its C-terminal 
negative regulatory tyrosine, which is normally not phosphorylated, rendering Lck in a so-called 
‘primed’ state ready to be activated. During TCR-MHC/peptide interactions, Lck is recruited to 
the complex via its noncovalent association with CD4 co-receptor; the interaction with this co-
receptor facilitates its participation in the initiation of TCR signal transduction (Turner et al. 
1990). Active Lck phosphorylates the CD3 and ζ chain ITAMs, resulting in the recruitment of 
the ζ chain associated protein of 70 kDa (ZAP-70) kinase (Palacios and Weiss 2004). 
Subsequently, ZAP- 70 phosphorylates T-cell-specific adapters, such as LAT and SLP-76, 
leading to the recruitment and activation of other enzymes (Brownlie and Zamoyska 2013). The 
γ1 isoform of the enzyme phospholipase C (PLCγ1) for instance is recruited to the plasma 
membrane by the adaptor LAT and catalyzes the hydrolysis of phosphatidylinositol 4,5-
bisphosphate (PIP2), which results in the production of inositol trisphosphate (IP3) and 
diacylglycerol (DAG). These second messengers are responsible for rapid and sustained increase 
in cytoplasmic free calcium and activation of protein kinase C (PKC), respectively (Weiss and 
Littman 1994). The rapid increase in cytosolic free calcium is thought to influence 
calcium/calmodulin-dependent events, like the activation of a serine/threonine phosphatase 
called calcineurin, which in turn activates the nuclear factor of activated T cells (NFAT) 
transcription factor (Macian 2005). Furthermore, the PKC is involved in the activation and 
nuclear translocation of the nuclear factor kB (NFkB) transcription factor (Vallabhapurapu and 
Karin 2009). As a result of this activation process, the T cells proliferate, produce effector 
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molecules, such as cytokines, and express membrane receptors critical for adhesion to target 
cells.  
  
  
  
 
    
Figure 3. Overview of TCR signaling. TCR signal transduction is initiated by the recognition of cognate 
peptide–MHC molecules. The first molecule to be recruited to the TCR–CD3 complex is the SRC family 
kinase (SFK) member LCK, which phosphorylates ITAMs of the CD3γ chain, CD3δ chain,  
CD3εchains and the ζ‑chains. Phosphorylation of the ITAMs enables the recruitment of ZAP70, its 
phosphorylation by LCK and its activation. Activated ZAP70 phosphorylates four key tyrosine residues on 
linker for activation of T cells (LAT), which recruits numerous signaling molecules to form a multiprotein 
complex, termed the LAT signalosome. Important molecules that constitute this complex include 
phospholipase Cγ1 (PLCγ1), growth factor receptor-bound protein 2 (GRB2), GRB2‑related adaptor 
protein GADS, SLP76 (SH2 domain-containing leukocyte protein of 76 kDa), adhesion- and 
degranulation-promoting adaptor protein (ADAP), interleukin-2‑inducible T cell kinase (ITK), NCK1 and 
VAV. The LAT signalosome propagates signal branching to three major signaling pathways, the  
Ca2+, the mitogen activated protein kinase (MAPK) kinase and the nuclear factor-κB (NF‑κB) signaling 
pathways, leading to the mobilization of transcription factors that are critical for gene expression and 
essential for T cell growth and differentiation. Signals initiated from the TCR also result in actin 
reorganization and the activation of integrins by inside-out signaling (Brownlie and Zamoyska 2013).  
  
  
Immune responses are initiated in the T cell area of secondary lymphoid organs where DCs 
present antigens, taken up locally or in peripheral tissues, to naïve T cells. For the antigen 
recognition, the establishment of highly regulated contact between T cells and APCs is crucial. 
This is accomplished through the formation of the immunological synapse, a cellular structure 
that forms at the interface between a T cell and an APC cell that expresses the appropriate 
peptide–MHCII complexes. Within the synapse, a ring of adhesion molecules surrounds TCRs 
and costimulatory molecules (Dustin and Cooper 2000). During this interaction, DCs deliver 
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three different types of signals to the T cells: they present the antigen displaying peptides loaded 
on their surface MHC molecules (1st signal), provide co-stimulation through surface receptors 
(2nd signal), and produce cytokines (3rd signal). The strength and type of such signals, together 
with other environmental cues, instruct proliferating T cells toward specific effector and memory 
fates, acquiring functions that are believed to be optimal for the clearance of the eliciting 
pathogen (Lanzavecchia 1999). The first signal is delivered through the TCR when it engages an 
appropriate peptide–MHC complex. Upon TCR-peptide– MHC complexes ligation naïve T cells 
leave the quiescent G0 phase and enter the G1 phase, start producing IL-2 and synthesizing 
CD25, the α subunit of the IL-2 receptor, which greatly increases their sensitivity to the cytokine 
(Acuto and Michel 2003). The second signal is generally referred to as co-stimuli and is 
conferred by counter-receptors expressed by APCs or by soluble factors such as cytokines and 
chemokines. This signal is necessary for the functional expansion of naïve T cell clones: antigen 
presentation in the absence of costimulation leads either to an unresponsive state, defined as 
anergy, in which the T cell is refractory to any further stimulation, or to switch to a regulatory 
(tolerogenic) phenotype (Schwartz 2003). It is now accepted that a major T cell co-stimulatory 
pathway involves the CD28 molecule, which is constitutively expressed on naïve T cells, and its 
ligands B7.1 (CD80) and B7.2 (CD86) expressed at high levels by activated professional APCs. 
Other crucial pathways are regulated by co-stimulator ligand (ICOSL), whose receptor on T cells 
is ICOS and CD40 on B cells and DCs whose receptor on T cells is CD40 ligand (CD40L)  
(Figure 4). Both ICOS and CD40L are not expressed by naïve T cells and are upregulated upon 
TCR stimulation. CD28 triggering by B7.1 and B7.2 molecules increases the production of IL-2 
which binds to the IL-2 receptor, promoting survival and expansion of T cells through the 
induction of anti-apoptotic factors, such as Bcl-xL (Boise et al. 1995). ICOS enhances 
proliferation and effector functions on T cells in an IL-2-independent fashion (Greenwald et al. 
2005). The CD40-CD40L interaction is important for enhancing the antigen presentation 
properties of B cells and DCs and therefore indirectly promoting T cell proliferation (Grewal et 
al. 1997).  
One important feature of the immune system is that each time an immune reaction is initiated 
regulatory mechanisms are in place to switch off and avoid a chronic inflammation. For this 
purpose, after activation T cells start to express inhibitory molecules, which dictate the 
termination of the immune response. One of the first inhibitory molecules discovered is cytotoxic 
T-lymphocyte-associated protein 4 (CTLA4), also known as CD152, it is expressed on activated 
T cells, especially regulatory T cells (Tregs), displaying high sequence similarity to CD28 
(Walker 2013). This molecule functions as an immune checkpoint, down-regulating T cell 
 20  
  
activation, possibly through competition with CD28 for binding to B7 molecules (of note, 
CTLA-4 affinity for those receptors is about 20 times higher). The CD28/CTLA-4 pathway is 
considered an internal mechanism, which controls the balance between T cell activation and self-
tolerance, in a process that is influenced by the expression of two shared ligands (Lenschow et 
al. 1996, Greenwald et al.2005, Gardner et al. 2014).  
  
  
  
Figure 4. Ligand–receptor interactions between T cells and APCs that regulate the T cell response 
to antigen. These responses can occur at the initiation of T cell responses in lymph nodes (where the major 
APCs are dendritic cells) or in peripheral tissues or tumors (where effector responses are regulated). In 
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general, T cells do not respond to these ligand–receptor interactions unless they first recognize their 
cognate antigen through the TCR. Many of the ligands bind to multiple receptors, some of which deliver 
co-stimulatory signals and others deliver inhibitory signals. In general, pairs of co- stimulatory–inhibitory 
receptors that bind the same ligand or ligands — such as CD28 and CTLA4— display distinct kinetics of 
expression with the co-stimulatory receptor expressed on naive and resting T cells, but the inhibitory 
receptor is commonly upregulated after T cell activation. One important family of membrane-bound 
ligands that bind both co-stimulatory and inhibitory receptors is the B7 family. All of the B7 family 
members and their known ligands belong to the immunoglobulin superfamily. Many of the receptors for 
more recently identified B7 family members have not yet been identified. Tumor necrosis factor (TNF) 
family members that bind to cognate TNF receptor family molecules represent a second family of 
regulatory ligand–receptor pairs. These receptors predominantly deliver co- stimulatory signals when 
engaged by their cognate ligands. Another major category of signals that regulate the activation of T cells 
comes from soluble cytokines in the microenvironment. Communication between T cells and APCs is 
bidirectional. In some cases, this occurs when ligands themselves signal to the APC. In other cases, 
activated T cells upregulate ligands, such as CD40L, that engage cognate receptors on APCs (Pardoll 
2012).  
  
  
Dynamics of Naïve CD4 T cell priming  
 Once being released from primary lymphoid organs in the bloodstream, the majority of lymphocytes 
continuously recirculate through almost all compartments of the body to bring the entire range 
of antigen-specific immune cells into close contact with potential invading pathogens. In this 
context, the principal function of secondary lymphoid organs is to facilitate the physical contact 
between APCs and rare antigen-specific lymphocytes. Lymph nodes are encapsulated bean-
shaped lymphoid organs located along the lymphatic system. Structurally they are subdivided 
into three main regions: the cortex, the paracortex and the medulla (Abbas et al. 2012, Murphy 
and Weaver 2016). The cortex contains densely packed B cells and follicular dendritic cells 
(FDCs) arranged into discrete B cell follicles. FDCs cluster in the centre of the follicle and form 
a dense network in which B cells search for antigens. By contrast, T cells accumulate in the T 
cell zone of the paracortex and continuously recirculate through lymphoid organs thanks to the 
expression of surface molecules such as CCR7 and CD62L, among others, which mediate 
extravasation upon binding of their ligands expressed on specialized afferent vessels, called high 
endothelial venules (HEVs) (Cyster 1999, Girard et al. 2012). The recognition of the appropriate 
antigen by incoming T cells leads to their expansion and differentiation into effector cells. Once 
inside the lymph node, in fact, naïve T cells are driven and kept in the T cell zone by a gradient 
of CCL18-CCL19-CCL21, produced by stromal cells as well as by DCs. If not activated, T cells 
leave the lymph node following upregulation of sphingosine 1-phosphate receptor-1 (S1P1), re-
enter the circulation and resume their screening activity elsewhere (Rot and von Andrian 2004). 
By continuously moving, every single naïve T cell can screen in a few hours thousands of 
antigens, thus greatly increasing the chance to encounter its cognate one.  
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The main APCs involved in the T cell activation process are DCs and a critical event in the 
initiation of most immune responses is their migration from the infected peripheral tissue to the 
draining lymphoid organ, bearing antigens derived from the infecting agent. Discovered in 1973 by 
Steinman and Cohn, DCs are usually defined as cells with stellate morphology characterized by 
numerous dendrites, which allow efficient antigen sampling and phagocytosis from the 
extracellular space (Steinman and Cohn 1973). In the peripheral tissues, resident DCs can sense 
and take up pathogens as well as soluble antigens, as they can efficiently exert phagocytosis (Reis e 
Sousa et al. 1993), fluid phase and receptor mediated pinocytosis and macropinocytosis (Sallusto 
and Lanzavecchia 1994, Sallusto et al. 1995). The sensing and uptake are made possible by the 
impressive variety of phagocytic and pathogen-sensing receptors these cells are endowed with, 
such as C-type lectin receptors (CLRs), toll-like receptors (TLRs), NOD-like receptors (NLR) and 
scavenger receptors (Osorio and Reis e Sousa 2011). Following antigen recognition and uptake, 
DCs undergo a process known as activation or maturation, which fully enables them for stimulation 
of naïve T cells, as they undergo major changes in their biological activities (Reis e Sousa 2006). 
To ensure the stimulation of naive T cells, DCs require efficient directional migration toward T cell 
zones either within their respective lymphoid organ of residence or toward remote tissue-draining 
lymph nodes. Peripheral DCs migration via afferent lymphatics is CCR7 dependent (Förster et al. 
1999) and the upregulation of this chemokine receptor selectively drives DCs through a gradient of 
chemo-attractant factor produced in the T cell area, mainly CCL19 and CCL21 (Sallusto et al. 
1998). In this way, tissue resident DCs transport antigen to the draining lymph nodes and while 
migrating, they also upregulate costimulatory molecules such as CD80 and CD86, and initiate 
production of cytokines. T cell encounter of MHC-peptide on DCs that lack costimulatory 
molecules contributes to peripheral tolerance (Hawiger et al. 2001, Probst et al. 2003). 
Alternatively, the antigen can be delivered to the lymph node directly via the lymph, where it is 
taken up by resident DCs that become activated in situ. Lymph node-resident DCs can also present 
antigens handed over by tissue-derived migratory DCs (Allan et al. 2006). The process through 
which naive CD4+ T cells are firstly stimulated in the lymph node by their cognate antigen is 
known as “priming” (Mempel et al. 2004). During this process firstly, DCs and T cells display high 
motility, and perform a great number of interactions in search for a high affinity peptide-MHC 
complex recognition. As a second step, when the naïve T cell TCR matches its cognate peptide-
MHC complex on a DC, both cells arrest and stably interact for 12-24h, during which the T cell 
starts producing IL-2. Finally, the T cell dissociates from the DC, the latter moving away in search 
of other potential interaction candidates, the former launching an intensive proliferative activity 
(Mempel et al. 2004). The clonal expansion phase that follows the initial priming can bring a single 
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naïve T cell through more than 15 cell divisions, generating a population of more than 50,000 
daughter cells (Zehn et al. 2012).While proliferating, these cells differentiate and acquire specific 
functional properties. This process generates both effector T cells, that are short lived and readily 
deal with the invading agent, and memory T cells that confer efficient protection in case of 
pathogen reattack. The effector phase of a T cell response is followed by a 1-2 weeks long 
contraction during which most of the clonally expanded cells undergo apoptosis. Only about 5% of 
the progeny enter the memory compartment and remain in a quiescent state to confer protection to 
a second encounter with the same pathogen (Seder and Ahmed 2003, Pepper and Jenkins 2011).  
  
  
Memory CD4 T cell generation  
  
One evolutionary step of the adaptive immune system over the innate arm is the ability to 
remember the past and generate a more prompt and robust response after a second exposure to 
antigen. Immunological memory is purely determined by a change in frequency and properties 
of antigen specific B and T lymphocytes, which persist also after the antigen is eliminated. 
Memory T cells exhibit considerable heterogeneity in particular in their surface-receptor 
expression, effector function and trafficking properties and they can be classified in three main 
subsets: central memory T cells (TCM cells), effector memory T cells (TEM cells), tissueresident 
memory T cells (TRM cells) and follicular helper memory T cells (Tfh) (Figure 5) (Hamann et 
al. 1997, Sallusto et al. 2004, Jaigirdar and MacLeod 2015).  
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Figure 5. Heterogeneity in memory CD4 T cells. Memory CD4 T cells can be found in lymphoid organs, 
blood, and at tissue sites. Stem cell memory T cells (Tscm) and central memory T (Tcm) cells are found in 
lymphoid organs and in the blood. Both populations are relatively undifferentiated compared to other 
memory CD4 T cell subsets, and are long lived. Follicular helper memory T (Tfh) cells can also be found 
in the blood and lymphoid organs. They express the B cell follicle homing receptor, CXCR5, which can 
position them near B cell follicles to provide rapid B cell help upon reactivation. Effector memory (Tem) 
and tissue resident memory T (Trm) cells can both be found in peripheral tissues and are more 
differentiated than Tcm and Tscm. Tem are migratory, passing through tissues and the blood, while Trm 
are restricted to tissues. Both populations can respond rapidly to tissue invading pathogens (Jaigirdar and 
MacLeod 2015).  
  
  
Nearly 15 years ago, Lanzavecchia and colleagues first identified heterogeneity in human 
peripheral blood based on the expression of the lymph node homing CC-chemokine receptor  
CCR7. TEM cells are CCR7− and express homing receptors that facilitate migration to 
nonlymphoid sites of inflammation and produce a variety of microbicidal cytokines, including 
IFN-γ, IL-4, and IL-5, within several hours of TCR stimulation. TCM constitutively express 
CD62L and CCR7, which are involved in migration through lymph nodes and mucosal lymphoid 
organs and positioned in the T cell areas of these organs. Following TCR triggering, TCM 
produce mainly IL-2, but after proliferation, they efficiently differentiate to effector cells and 
produce large amounts of IFN-γ, or IL-4 (Sallusto and Lanzavecchia 1994). Much of the 
understanding about the gene expression programs that govern the formation and function of 
memory populations has been achieved studying recirculating populations of TEM cells and 
TCM cells. However, subsequent studies have highlighted the presence of tissue-resident 
memory T cells (TRM cells) at sites of potential reinfection, such as the intestinal, genital and 
respiratory mucosa and skin. The unique location of these memory cells allow them to coordinate 
the initial response to pathogen by directly recognizing antigen, recruiting circulating memory 
cells and diminishing pathogen load in the earliest phase of infection (Gebhardt et al. 2009, 
Schenkel et al. 2014).  
An important aspect in the definition of immunological memory is the self-renewal capacity of 
the cells. According to the stem cell model of immunologic memory a single memory 
lymphocyte re-encountering antigen gives rise to one set of progeny capable of terminal 
differentiation and another with self-renewing capability. If so, then the memory lymphocyte not 
only protects against future reinfection, but also maintains the long-term production of effector 
lymphocytes in chronic, persistent infections (Fearon et al. 2001, Turtle et al. 2009).  
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CD4 T helper cells plasticity and subset  
  
It is well appreciated that in addition to the heterogeneity of memory T cells, diversity of cell fate 
among the progeny of activated T lymphocytes also exists in the effector T cell population.  
CD4+ T cells play central roles in shaping the immune response by regulating the function of 
many other immune and non-immune cell types (Abbas et al. 2012, Murphy and Weaver 2016). 
They help B cells to produce antibody, regulate the activity of phagocytes and APCs, sustain and 
enhance CD8+ T cell response and memory formation, induce a responsive state in peripheral 
tissues. Importantly, they also regulate the magnitude and persistence of such responses to 
prevent tissue damage. To achieve such a multiplicity of functions, CD4+ T cells are endowed 
with a surprising capacity of differentiation toward phenotypically and functionally distinct 
effector lineages. The functional specialization of the distinct lineages is coordinated by genetic 
programs controlled by lineage-specifying transcription factors, whose activation induces 
expression of distinct soluble mediators and surface molecules that support interactions with 
other immune cells (Sallusto and Lanzavecchia 2009). Many different factors influence the 
outcome of the priming process; however, the main driver of T cell differentiation is considered 
to be the cytokine milieu produced during activation, which is mostly determined by DCs 
(Pulendran 2005). Cytokines, acting on T cell cytokine receptors, modulate activation of 
intracellular cascades that eventually lead to the phosphorylation of a given signaling transducer 
and activator of transcription (STAT) protein. Once phosphorylated, STAT proteins dimerize 
and translocate into the nucleus, where they promote transcription of a series of lineage-
specifying molecules, among which are “master” regulator transcription factors. STATs and 
master regulators together orchestrate the coordinate expression of a variety of molecules, 
including effector cytokines and tissue homing chemokine receptors, which define the fate of the 
proliferating T cells. The principal subsets for CD4+ T cells are Th1, Th2, Th17, Th22, Th9, Tfh, 
and Tregs (Figure 6) (O’Shea and Paul 2010, Zhu and Paul  
2010, Zhu et al. 2010). DC-derived IL-12 acts on the IL-12R to activate expression of STAT4, 
determining acquisition of a Th1 phenotype (Hsieh et al. 1993) concomitant with upregulation 
of T-bet as transcriptional factor. Th1 cells are characterized by production of IFN-γ (together 
with TNF-α and other inflammatory cytokines) and expression of inflamed tissue homing 
receptors, such as CXCR3 and CCR5. On a functional level Th1 are the main players in response 
to viruses and intracellular bacteria, as they efficiently activate macrophages and cytotoxic CD8+ 
T cells, and act on non-immune cells by inducing an anti- viral state and upregulation of MHC 
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molecules (Abbas et al. 2012, Murphy and Weaver 2016). IL-4 induces instead activation of 
STAT-6 and consequently of GATA3. GATA3 is the master regulator of Th2 cells, characterized 
by expression of chemokine receptors such as CCR4 and CCR3 and by production of IL-4, IL-
5, and IL-13. All these cytokines act synergistically with IL-4 in the induction of STAT5 
activation (Le Gros et al. 1990, Yamane and Paul 2012). Th2 cells are endowed with effector 
mechanisms required to counteract invasion from multicellular parasites, such as helminths, 
protect from venom, but also provoke onset of allergic diseases. Th2 effector responses are 
characterized by eosinophils and basophils infiltration, mucus production, smooth muscle 
contraction, and production of mastcell-activating IgE (Allen and Sutherland 2014). TGF-β, IL-
6 and IL-1β induce STAT-3 (Bettelli et al. 2006, Acosta-Rodriguez et al. 2007a, Chung et al. 
2009) and ultimately RORγt (Ivanov et al. 2006), a transcription factor that specifies for the 
Th17 lineage (Park et al. 2005). Th17 produce cytokines like IL-17A/IL-17F, IL-22 which 
promote the activation of neutrophils on the one hand, and act on epithelial cells to induce anti-
microbial peptides, on the other (Acosta-Rodriguez et al. 2007b, Annunziato et al. 2007). 
Moreover Th17 are required in case of infection from fungi or extracellular bacteria (Hernández-
Santos and Gaffen 2012). A population characterized by the capacity to produce IL-22, but not 
IL-17, has been identified and defined as Th22 subset (Duhen et al. 2009, Trifari et al. 2009). 
Recently Th9 cells, producing exclusively IL-9, have also been identified and associated to 
several functions, mainly helminth clearance (Goswami et al. 2012, Schlapbach et al. 2014). 
Regulatory T cells (Tregs) have a critical role in protecting from excessive tissue damage during 
inflammation, as well as from autoimmunity (Sakaguchi et al. 2008, Wing and Sakaguchi 2010). 
These cells can be originated through two distinct pathways. Natural Tregs (nTregs) originate in 
the thymus, where the driving element is thought to be the strength of selfpeptide recognition 
upon antigen presentation by TECs. In particular such interaction has been postulated to happen 
with a strength that is below threshold for negative selection, but higher than that for non-self-
specific T lymphocytes. This would induce tolerization in potentially autoreactive cells and 
prevent autoimmunity (Klein et al. 2014). Alternatively, Treg phenotype can be induced in the 
periphery, (iTregs), by antigen-presentation in the absence of costimulatory molecules and 
inflammatory cytokines (Lan et al. 2012). Cytokines such as TGF-β and IL-2 have been shown 
to play an important role in driving this fate decision by inducing the specific transcription factor 
Foxp3 (Fontenot et al. 2003, Hori et al. 2003). Tregs can dampen the immune response acting 
through both release of soluble factors such as TGF-β, and expression of surface immune-
inhibitory receptors such as CTLA4 (Tang et al. 2004, Sakaguchi et al. 2009).  
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Last, but not least, follicular helper CD4 T (Tfh) cells are the specialized providers of B cell help 
and are instrumental for mounting an efficient and high affinity antibody response, as they direct 
the germinal center reaction (Crotty 2011). Tfh cells differentiation is a multi-stage process 
which depends on the expression of the master regulator transcription factor B cell lymphoma 6 
(Bcl6) (Johnston et al. 2009, Nurieva et al. 2009). Distinguishing features of Tfh cells are the 
expression of CXCR5, PD-1 and ICOS, among other molecules, and the production of IL-21 
which is crucial in the germinal center formation and Tfh polarization (Crotty 2011). Tfh cell 
differentiation requires input from several surface receptors (CD28, ICOS and CD40L) and 
signaling lymphocytic activation molecule (SLAM) family members, as well as from cytokines 
and their associated signaling pathways (for example STAT3 or SLAM associated protein (SAP; 
also known as SH2D1A), which all culminate in the induction of Bcl6 (Yu et al. 2009). Tfh cell 
differentiation begins at the priming stage when naïve CD4+ T-helper cells interact with antigen 
presenting DCs in the T-zone of a secondary lymphoid organ. Activated CD4+   T cells undergo 
rapid changes in their expression of costimulatory molecules and chemokine receptors. 
Downregulation of CCR7 expression and concomitant upregulation of the chemokine receptor 
CXCR5 subsequently allow these activated T cells to migrate to the T-B zone border of 
secondary lymphoid organs, where they interact with antigen-specific B cells. Some of these 
early Tfh cells, together with a few antigen-specific B cells enter the follicle to establish a 
germinal center (GC) reaction in which somatic hypermutation and selection of high-affinity B 
cells result in the generation of memory B cells and plasma cells (Okada and Cyster 2006, Allen 
et al. 2007, Haynes et al. 2007). The major help signals provided by Tfh cells are CD40L, IL-21 
and IL-4 which are crucial to keep GC B cells alive and induce their proliferation (Crotty 2011). 
Furthermore, Tfh cells regulate GC size (Johnston et al. 2009, Rolf et al. 2010, Hams et al. 
2011), restrict lowaffinity B cell entry into the GC, support high affinity B cell occupancy of the 
GC (Schwickert et al. 2011), and select high affinity B cells during affinity maturation (Victora 
et al., Good- Jacobson and Shlomchik 2010). A role of Tfh in driving the differentiation of high 
affinity germinal center B cells into plasma cells has been proposed (Kräutler et al. 2017). 
Studies of Tfh cells in human remained relatively limited until recently, mainly due to difficulties 
in assessing the dynamics of this cell population in human lymphoid organs. However, our 
knowledge on the biology of Tfh cells and their contribution to disease has significantly 
increased in the past decade, especially since the identification of circulating memory Tfh cells  
(cTfh). In fact emerging evidences show that blood CXCR5+CD4+ T cells contain long-lived 
memory cells which share functional properties with Tfh cells. Accordingly, blood cTfh cells 
are recognized and defined as CXCR5+ CD45RA− CD4+ T cells (Morita et al. 2011, Schmitt et 
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al. 2014). Due to the essential role of Tfh cells in regulating high-affinity antibody production 
and B-cell memory formation, deficiency of those cells can lead to immunodeficiency, while 
excessive Tfh cells might contribute to the development of autoimmunity and lymphoid 
malignancy (King et al. 2008, Tangye et al. 2012, Tangye et al. 2013a). Many mouse models 
have demonstrated that aberrant generation and/or activation of Tfh cells contributes to the 
pathogenesis of autoimmune diseases (Luzina et al. 2001, Vinuesa et al. 2005, Linterman et al. 
2009, Hua and Hou 2013). These observations also appear applicable to human diseases.  
For instance the detection of CD4+CXCR5+ T cells in organs that are affected by autoimmune 
disorders, such as the salivary glands in Sjögren’s syndrome, suggested that aberrant Tfh cell 
development can drive human autoimmunity (Salomonsson et al. 2002). Increased frequency of 
Tfh cells has also been shown in the peripheral blood of patients with systemic lupus 
erythematosus (SLE) (Hutloff et al. 2004) and myasthenia gravis (Tackenberg et al. 2007). 
Furthermore, memory T cells from type-1 diabetes (T1D) patients showed high expression of 
Tfh cell markers, including CXCR5, ICOS, BCL6, and IL-21. This observed expansion has been 
linked with the altered IL2 sensitivity in T1D patients (Kenefeck et al. 2015). Several primary 
immunodeficiencies have also been associated with genetic defects that might affect Tfh cells 
differentiation and function. For instance Hyper-IgM syndrome (HIGM) is a rare human 
immunodeficiency characterized by normal or elevated serum IgM levels with absence of IgG, 
IgA and IgE, resulting in a profound susceptibility to bacterial infections (Notarangelo et al. 
1992). The molecular basis of the X-linked form (HIGM1) is due to mutations in the gene coding 
for CD40L (Aruffo et al. 1993, Korthauer et al. 1993). Besides the Ig switch defect and 
remarkable paucity in germinal center formation (Facchetti et al. 1995) these patients show a 
considerably decrease in the number of cTFH (Bossaller et al 2006, Tangye et al. 2013b).   
Recently, follicular regulatory T (Tfr) cells were identified as a Treg cell subset that localizes in 
the germinal center to suppress B-cell response. Sharing certain key features of Tfh cells, like 
Bcl6 and CXCR5 expression, Tfr cells also express Treg-associated molecules including Foxp3, 
CD25, GITR, and CD103. Unlike Tfh cells, Tfr cells express Blimp-1, which is required to 
control the GC. It has been shown that Tfr cells can limit the number of Tfh cells and furthermore 
the production of antibodies specific for an immunizing self-antigen (Chung et al. 2011, 
Linterman et al. 2011).  
Using a multidimensional cytometry, transcriptomics and functional assays, Rao et al have 
recently described a subset of human CD4+PD-1highCXCR4- T cells, characterized by a strong 
ability to support B cell differentiation. This subset, which they named peripheral helper T cells 
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(Tph), is expanded in the synovial fluid and peripheral blood of rheumatoid arthritis patients 
participating in the autoimmune response (Rao et al. 2017).  
  
    
Figure 6. Polarized CD4+ T cell subsets. Each CD4+ T cell subset can be defined by their distinct abilities 
to sense (red), programme (orange) and function (blue) in the control of specific pathogens or immune 
pathologies. The inductive cytokines, polarizing transcription factors and cytokines or chemokine 
receptors that are characteristic of each subset are shown, along with their association with specific forms 
of immune defense. AHR, aryl hydrocarbon receptor; BATF, B cell-activating transcription factor; BCL-
6, B cell lymphoma 6; CCR, CC-chemokine receptor; CD40L, CD40 ligand; CTLA4, cytotoxic T 
lymphocyte antigen 4; CXCR, CXC-chemokine receptor; EOMES, eomesodermin; FOXO, forkhead box 
O; FOXP3, forkhead box P3; GATA3, GATA-binding protein 3; GFI1, growth- factor independent 1; 
HIF1α, hypoxia-inducible factor 1α; ICOS, inducible T cell co-stimulator; IFNγ, interferon-γ; IL, 
interleukin; IRF4, interferon-regulatory factor 4; MAF, macrophage-activating factor; NR4A,  nuclear  
receptor  4A;  PD1,  programmed  cell  death  1;  pTReg  cell,  peripherally  derived regulatory T cell; 
RAR, retinoic acid receptor; ROR, retinoic acid receptor-related orphan receptor; RUNX3, runt-related 
transcription factor 3; SHM, somatic hypermutation; STAT, signal transducer and activator of 
transcription; TCF1, T cell factor 1; TCR, T cell receptor; TFH, T follicular helper; TGFβ, transforming 
growth factor-β; TH, T helper; Treg cell, regulatory T cell; tTreg cell, thymus-derived regulatory T cell 
(DuPage and Bluestone 2016).   
 30  
  
1.3 B lymphocytes  
  
Central and peripheral B cell development  
  
B cell generation occurs throughout life and proceeds through distinct stages that begin in the 
fetal liver and adult bone marrow (BM) where hematopoietic stem cells (HSC) develop via 
various B lineage-restricted precursors into immature B cells, which then enter the periphery. 
The BM, located in the medullary cavities of the bones, contains a dense network of medullary 
vascular sinuses and it is in the extravascular spaces between the sinuses that blood cells and 
their precursors are packed (Lichtman 1981). The BM microenvironment is responsible for a 
proper B cell development, which requires the presence and complex interplay of particular 
growth factors and cytokines such as stem cell factor (SCF), fms-like tyrosine kinase ligand 
(FLT3-L), or IL-7, all of which are provided by BM stromal cells (Nagasawa 2006). In addition 
to these exogenous factors, developing B cells depend on intrinsic signals which promote 
proliferation and differentiation (Herzog and Jumaa 2012). The different stages in the B cell 
differentiation process can be identified by the expression of CD antigens and the rearrangement 
status of immunoglobulin heavy (IgH) and light (IgL) chains. The current consensus is that B 
lineage-committed cells pass through a CD34+CD10+CD45RA+ common lymphoid progenitors 
(CLPs) stage which mature via CD34+CD19+CD10+  pro-B and CD34-  
CD19+CD10+  pre-B into CD34-CD19+sIgM+ immature B cells (Galy et al. 1995). The pro-B cell 
stage represents the earliest BM cell committed to the B cell lineage, which is characterized by 
the expression of lineage-restricted surface molecules like CD19 and CD10 and by the 
expression of Rag-1 and Rag-2 proteins which are responsible for the first recombination event 
at the heavy chain locus (Mombaerts et al. 1992, Shinkai et al. 1992). The D-J recombination 
brings together one D and one J gene segment, with the deletion of the  
DNA segments located in between. Subsequently one of the many 5’V genes is joined to the DJ 
unit resulting in a rearranged VDJ exon (Jung et al. 2006). At the pro-B cell stage no surface 
expression of heavy chain is detected. At this stage the expression of terminal deoxynucleotidyl 
transferase (TdT) enzyme is essential since it catalyzes the non-templated addition of junctional 
nucleotides. Pro-B cell differentiation into pre-B cells is characterized by loss of CD34 and TdT 
and based on cell-cycle analysis human pre-B cells can be generally subdivided into large 
proliferating pre-BI cells, large proliferating pre-BII cells, and small resting pre-BII cells. The 
pre-BI cells, which express CD19, complete IgH DJ rearrangement and continue to rearrange its 
V gene segments until productive VH–DJH alleles are generated in large pre-BII cells. These cells 
cease to express Rag1 and Rag2 and display the product of the rearranged IgH gene at the cell 
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surface; there, it assembles with the surrogate IgLs VpreB and λ5, together with the signaling 
molecules Igα and Igβ to form the pre-B-cell receptor (pre- BCR) (Reth 1992, Ghia et al. 1996, 
Blom and Spits 2006). Signals from the pre-BCR are responsible for the largest proliferation 
expansion of the B lineage cells in the BM and its expression is a crucial step in early B-cell 
development, at which the functionality of the heavy chain is monitored. In fact the phenomenon 
of allelic exclusion in the IgH locus ensures that in any B cell clone one heavy chain allele is 
productively rearranged and expressed whereas the other is either retained in the germline 
configuration or nonproductively rearranged. In case of unproductive rearrangement the gene on 
the second chromosome will undergo recombination (Vettermann and Schlissel 2010). Lastly 
signaling pathways induced by the pre-BCR leads to the generation of a conventional light chain 
that replaces the surrogate immunoglobulin light chains of the pre-BCR to form a mature BCR 
(Löffert et al., Herzog et al. 2009). In addition, similar to the heavy chain recombination the 
kappa and lambda light chain rearrangement is tightly controlled, ensuring that only one chain 
(either kappa or lambda) is associated with the heavy chain to make a functional B cell receptor. 
Indeed during the light chain isotype exclusion process, the kappa locus rearranges first and only 
if this event generates a non-functional or a self-reactive protein, the lambda locus will undergo 
recombination (Perfetti et al. 2004). Newly formed immature B cells exit the BM to migrate into 
the spleen to complete their maturation process. Cells that are developmentally intermediate 
between immature BM B cells and fully mature naive B cells in the peripheral blood and 
secondary lymphoid organs are termed “transitional B cells”. This term was first used for mouse 
B cells (Carsetti et al. 1995) and three stages of murine transitional cells, namely T1, T2 and T3, 
have been identified (Allman et al. 2001). More recently, transitional B cells have been identified 
in humans and defined as new emigrant B cells, which have been selected for self-tolerance in 
the BM and have been exported to the periphery (Sims et al. 2005). During BM development, 
the Ig gene segment encoding V, D and J regions are rearranged in a unique stochastic process. 
While the random nature of this process ensures an unlimited variability of BCR, it includes the 
obvious risk to generate B cells able to recognize self-antigens. Thus, it has been suggested that 
negative selection should take place starting from the early phases of B cell development in the 
BM. Elegant mouse models have led to the characterization of three main mechanisms of 
negative selection taking place in early B cell development: clonal deletion, anergy and receptor 
editing, the latter one consisting in starting a new rearrangement of the light chain (Tiegs et al. 
1993, Pelanda et al. 1997). Recently, the development of strategies to clone and express a BCR 
isolated from a single human B cell has allowed the analysis and quantification of the negative 
selection process. Wardemann et al demonstrated that while 76% of pre-B cells or early 
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immature B cells from BM are potentially self-reactive, this number drops to 40% in immature 
BM B cells and a 20% in mature, peripheral B cells, suggesting that most of the discrepancy 
between B-cell production in the BM and B-cell immigrants in the periphery is due to negative 
selection of autoreactive cells. Hence two distinct B cell development check points are delineated 
(Figure 7): a central tolerance check point in the BM which ensures a selection process between 
the early immature B cells and immature B cells stage and a peripheral checkpoint which 
removes autoantibodies from the transitional B cells before they enter the naive pool 
(Wardemann et al. 2003). It has been estimated that 20-50% of all peripheral naive B cells have 
undergone receptor editing (Meffre and Wardemann 2008). Furthermore, two additional check 
points have been suggested during the B cell development. Specifically one which ensures the 
exclusion of remaining autoantibodies from IgM memory pool (Tsuiji et al. 2006) and one which 
controls the differentiation towards IgG memory B cells (Tiller et al. 2007). Whether a positive 
selection of B cells exist is still not completely clear. Remarkably, it has been shown that 
selfrecognition is indeed crucial for the generation of B cells and the pre-BCR could function as 
an auto-reactive component (Köhler et al. 2008).  
  
 
    
Figure 7. The role of B cell-intrinsic MYD88 signaling in B cell tolerance and autoimmunity.  
B cell development frequently results in the generation of autoreactive B cells. Such cells are removed at 
distinct checkpoints in the bone marrow (central tolerance) and periphery (peripheral tolerance) via a 
combination of mechanisms, including B cell clonal deletion, receptor editing and functional anergy. 
Although the mechanisms remain to be determined, signaling through myeloid differentiation primary- 
response protein 88 (MYD88) may have an impact on tolerance mechanisms, as greater autoreactivity is 
noted in both new emigrant and mature naive B cell populations in patients with inborn errors in MYD88, 
IL-1R-associated kinase 4 (IRAK4) or UNC93B. Despite intact tolerance mechanisms, autoreactive B 
cells also enter the mature compartment in healthy individuals. Mouse models have demonstrated the 
crucial importance of dual B cell receptor (BCR) and Toll-like receptor (TLR) signaling in the activation 
of autoreactive B cells. Antigen receptors on DNA- or RNA-reactive B cells can be engaged either directly 
by self-antigens on the surface of apoptotic cells and apoptotic debris or indirectly by self-antigens on 
APCs in the context of MHC class II molecules (not shown). Following engagement, BCR internalization 
shuttles DNA- or RNA-associated antigens to TLR7- and TLR9- containing intracellular compartments, 
resulting in MYD88-dependent B cell activation. The potential requirement for additional TLRs in 
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activating autoreactive B cells with different specificities has not yet been addressed. Activated 
autoreactive B  cells either undergo T-independent class-switch recombination (CSR) and produce 
autoantibodies (processes that are enhanced by B cell-activating factor (BAFF)), or recruit autoreactive 
T cells to germinal centres, where the autoreactive B cells undergo T-dependent CSR and affinity 
maturation and produce pathogenic autoantibodies (Rawlings et al. 2012).   
  
Early events of B cell activation  
  
The B cell antigen receptor, BCR complex is an hetero-oligomeric structure composed of 
immunoglobulin heavy (IgH) and light (IgL) chains, involved in the antigen recognition process, 
associated with two signaling components Igα and Igβ (CD79α and CD79β) which are 
characterized by a single ITAM. The unique binding specificity is determined by the 
combination of variable domains (VH and VL) in the heavy chain and the light chain (LC) while 
the Igα/Igβ heterodimer functions as the signaling subunit of the complex. Engagement of the 
BCR initiates signaling mechanisms that can lead to cell proliferation and differentiation (Reth 
1989). Igα and Igβ share similar structural features, since they both carry an extracellular Ig 
domain, an evolutionarily conserved transmembrane domain and a cytoplasmic tail with an 
ITAM motif. Phosphorylation of ITAM-associated tyrosine residues creates docking sites for the 
recruitment and activation of Src family kinases, such as Lyn and Syk, which phosphorylate 
multiple downstream targets and adaptors like the SLP-65 and Nck proteins (Burkhardt et al. 
1991, Hutchcroft et al. 1991). Such adaptors can bring together several effector proteins and 
promote multiple signaling pathways, for instance calcium signaling pathway, initiating the gene 
transcription process required for B cell functions (Ohhora and rao 2009). Following the 
activation phase, B lymphocytes can undertake a large number of distinct fates important for 
immune regulation (Duffy et al. 2012). The classical activation of naïve B cells to T-dependent 
antigens requires four types of signals. The first signal is given by the crosslinking of the BCR 
by multivalent antigens and is facilitated by complement receptors (CRs). The second signal is 
orchestrated by the help of CD4+ T cells. The third signal is given by engaged toll like receptors 
(TLRs), which are expressed on the plasma membrane (TLR4) or in intracellular compartments 
(TLR3, TLR7 and TLR9) (Takeda et al. 2003, Hua and Hou 2013, Pihlgren et al. 2013). The 
fourth signal is given by soluble cytokines and membrane-bound ligands expressed by T helper 
cells, DCs or other myeloid cells (Traggiai et al. 2003). After antigen recognition, the BCR 
triggers a signaling cascade that leads to up-regulation of costimulatory molecules and efficient 
antigen internalization, followed by processing and presentation of antigenic peptides on MHC 
class II molecules for recognition by specific T cells (Chatterjee et al. 2012). This mechanism of 
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BCR-mediated antigen internalization allows specific B cells to present antigen to T cells with 
very high efficiency (Lanzavecchia 1985).  
  
  
 
    
FIGURE 8. Signal transduction by the BCR complex. Antigen-induced cross-linking of membrane Ig 
on B cells leads to clustering and activation of Src family tyrosine kinases and tyrosine phosphorylation 
of the ITAMs in the cytoplasmic tails of the Igα and Igβ molecules. This leads to docking of Syk and 
subsequent tyrosine phosphorylation events as depicted. Several signaling cascades follow these events, 
as shown, leading to the activation of several transcription factors. These signal transduction pathways 
are similar to those described in T cells (Abbas et al. 2012).  
  
  
Antigen modular responses of B lymphocytes  
  
The features of B cells activation and the subsequent generated antibody response depend on the 
availability of different possible cellular help and on the type of activating antigens. Studies of 
athymic (nude) mice or mice that had undergone removal of the thymus provided early insights 
into the cellular factors needed to elicit antibody responses to immunizing antigens. Thymus 
dependent (TD) responses are absent in those mice because of the essential requirement for 
thymus-derived T cells for the full activation and subsequent proliferation of the B cells (Gershon 
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and Kondo 1970). TD antigens are generally monomeric soluble proteins that display single or 
few epitopes to antigen-specific B cells and require cognate T cell help for induction of highly 
specific antibody responses through GC reaction. After receiving a signal through the BCR, 
mature B cells migrate to the interface of the T cell zone (T zone) and the B cell follicle and 
present antigen-derived peptides on MHCII molecules for recognition by newly primed Tfh cells 
(Cyster 2010). As already discussed the key function of Tfh cells is to provide help to B cells 
and to support their activation, expansion and differentiation and the formation of the GC. 
Several features of Tfh cells enable them to carry out these functions (Crotty 2011). Possibly the 
best-characterized B cell helper signal provided by Tfh cells is CD40L, which is highly expressed 
on these cells. CD40L is a potent activator of the B cells, it is able to induce proliferation and, in 
combination with cytokines, isotype switching and cell differentiation (Noelle et al. 1992, 
Elgueta et al. 2009). Mutation of CD40L gene results in a disease called X-linked hyper-IgM 
syndrome which is characterized by defect in the TD antibody response, isotype switching, 
affinity maturation and memory B cell generation (Notarangelo and Hayward 2000).  
The experimental results with the mutant mice showed that the in vivo TD-immunoglobulin class 
switching but not the thymus independent (TI) antibody responses is affected; indeed it is well 
know that TI antigens can induce IgG antibody responses in athymic nude mice (Mongini et al. 
1981). Antigens that are expressed on the surface of pathogens in an organized, highly repetitive 
form can activate specific B cells in the absence of T-help by crosslinking of antigen receptors 
in a multivalent fashion, by a mechanism that depends on the expression of a functional Bruton’s 
tyrosine kinase (Btk) (Bajpai et al. 2000). TI antigens are further classified in two main groups: 
type I (TI-1) and type 2 (TI-2). TI-1 antigens are mitogens that stimulate all B cells in a 
polyclonal manner and irrespective of antigen specificity. Physiological TI-1 antigens include 
Toll-like receptor (TLR) ligands, such as LPS which is expressed by gram negative bacteria 
(Coutinho et al. 1974), or certain viral coat proteins (Berberian et al. 1993, Blutt et al. 2004). TI-
2 antigens are instead composed of repetitive epitopes that simultaneously engage multiple 
antigen receptors on the surface of antigen specific B cells. TI-2 antigens include polysaccharides 
found on encapsulated bacteria and viral capsid proteins and elicit robust IgM and IgG3 antibody 
production (Mongini et al. 1984, Bachmann et al. 1995, Bachmann et al. 1997). Furthermore, a 
third recent type of TI B cell activation (TI-3) pathway has been described that is based on blood-
borne or gut bacteria and requires help of myeloid cells, such as neutrophils (with B help activity, 
NBH) (Puga et al. 2012), basophils, mast cells (Merluzzi et al. 2010), eosinophils (Wang and 
Weller 2008, Chu et al. 2011) or DCs (Gatto et al. 2013, Vinuesa and Chang 2013) (Figure 9).   
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Figure 9. TI antibody responses. (a) In TI-1 responses, B cells receive second signals through their TLRs. 
(b) In TI-2 antibody responses, extensive crosslinking of the BCR provides essential signals through Btk. 
(c) TI-3 antibody responses are elicited when B cells receive help from bone marrow– derived myeloid 
cells (neutrophils (NBH cells), monocytes, mast cells and basophils). Ag, antigen; PS, polysaccharide; B1-
b mem, B-1b memory B cell; B1-b mem PC, B-1b memory plasma cell; MZ, marginal zone; AID, 
activation-induced cytidine deaminase; SHM, somatic hypermutation; FcεR, receptor for IgE (Vinuesa 
and Chang 2013).  
  
  
Peripheral B cell subsets  
  
The mature peripheral B cells pool includes three distinct subsets according to their ability to 
migrate, their location and their propensity to generate a T-dependent or a T-independent 
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response: follicular B cells (FO B cells), marginal zone B cells (MZ B cells) and B-1 cells (Figure 
10). Most mature naive B lymphocytes are FO B cells that constantly recirculate in the blood 
and migrate to the B cell areas of secondary lymph nodes where they might mediate TD immune 
responses to protein antigens. FO B cells enter secondary lymphoid organs (spleen, lymph nodes, 
mucosal lymphoid tissue) through blood vessels located in the T cell areas and then migrate into 
the follicle, precisely into the B cell zones and primarily make antibody response to protein 
antigens that require T cell help (Batista and Harwood 2009). The movement into the lymphoid 
follicle is mainly driven by the chemokine CXCL13 secreted by the stromal component of the 
follicle, above all follicular dendritic cells. Recirculating B cells express CXCR5, the chemokine 
receptor for CXCL13, and the specific interaction between the two partners attract the B cell into 
the follicle (Cyster 2010). The antigen can be delivered to naive B cells in lymphoid organs by 
multiple routes, for example the small antigens can be transported by afferent lymphatic vessels 
that drain into the subcapsular sinus of the nodes; large antigens instead can be captured by the 
subcapsular sinus macrophages or by the dendritic cells resident in the medullary region. In any 
cases the antigen is presented to B cells in a naive conformation and is not processed by antigen-
presenting cells (Batista and Harwood 2009). This is one of the aspects that differ between the 
forms of antigens recognized by B and T lymphocytes.  
FO B cells mainly mediate immune responses to TD protein antigens whereas MZ and B-1 
subsets are primary responders to TI antigens. Early studies of MZ B cells in rodents showed 
that they are non-recirculating and restricted to the spleen with limited motility (MacLennan et 
al. 1982, Lu and Cyster 2002). Yet recent studies provided indirect evidence that this B cells 
population continuously exchanges between the marginal zone and follicle (Ferguson et al. 2004, 
Cinamon et al. 2008, Arnon et al. 2013). In rodents a small proportion of memory B cells may 
also populate the marginal zone, whereas in humans most MZ B cells are thought to represent a 
memory population. MZ B cells have long been considered critical determinants of host defense 
directed against encapsulated blood-borne bacterial TI antigens. There is, however, a growing 
appreciation of a broader role for MZ B cells in both T-independent and T-dependent immune 
responses (Weill et al. 2009).  
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Figure 10. Distinct B cell subsets mediate different types of antibody response. Follicular B cells 
respond to protein antigens and thus initiate T-dependent antibody responses. T-independent responses to 
multivalent antigens are mediated mainly by marginal zone B cells in the spleen and B-1 cells in mucosal 
sites. These functional distinctions between subsets are not absolute (Abbas et al. 2012).  
  
  
Dynamic of mature B lymphocytes fates: extra-follicular and germinal center responses  
  
As already mentioned B cells responding to a TD antigen are considered to develop along two 
pathways; one leads to the rapid differentiation to extrafollicular plasma cells and the second to 
GC formation (MacLennan et al. 2003). After interaction with CD4+ T helper cells in the T and 
B zones, activated B cells can migrate to the bridging channels the and red pulp of the spleen to 
form extrafollicular foci. Here they differentiate into plasma cells, many of which are short lived 
(Jacob and Kelsoe 1992) and secrete antibodies that may be either switched or un- switched 
(IgM) (Phan et al. 2005). During the extrafollicular response B cells do not undergo SHM and 
therefore the resultant antibodies are comprised almost exclusively of specificities encoded 
within the primary repertoire. Thus, the early extrafollicular response provides an immediate, 
germline encoded antibody response that can be crucial to fight the invading pathogen. The 
decision between extrafollicular differentiation and GC migration represents the main branch 
point during a TD B cell response and the mechanisms which direct B cells down one pathway 
versus the other are currently unknown (MacLennan et al. 2003). One theory counts on a 
stochastic process where the activated B cells can follow either pathway such that the original 
specificities are represented equally in both the extrafollicular and early GC populations (Dal 
Porto et al. 1998, Blink et al. 2005). Alternatively, according to the nonstochastic theory the 
nature of the interaction between antigen and BCR may influence the subsequent responses 
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causing different specificities in the extrafollicular and in the early GC populations (Paus et al. 
2006). Therefore, what is really driving this process is still controversial (Newman et al. 1992, 
Roost et al. 1995).  
Upon plasma cell differentiation there is an increase in the steady-state amount of Ig heavy and 
light chains mRNA and also an increased cytoplasmic to nuclear ratio. Because they are 
terminally differentiated, end-stage cells, plasma cells do not divide, however at a transient stage 
of plasmablast they can both secrete antibody and proliferate (McHeyzer-Williams and 
McHeyzer-Williams 2005). Differentiated plasma cells are endowed with prominent amounts of 
secretory vacuoles and rough endoplasmic reticulum and increased expression of syndecan1 
(CD138) a membrane proteoglycan which is often used as a plasma cells surface marker 
(Sanderson et al. 1989). Others B cell specific surface proteins are instead downregulated, 
including MHCII, B220, CD19, CD21, and CD22 (Calame 2001). Furthermore differentiated 
plasma cells show increased chemotactic sensitivity to the CXCR4 ligand CXCL12 and in the 
meanwhile decreased responsiveness to the B and T zone chemokines CXCL13, CCL19, and 
CCL21 thanks to the downregulation of CXCR5 and CCR7 (Hargreaves et al. 2001). Several 
transcriptional factors required for early steps in B cell development are decreased or absent in 
plasma cells, for instance PAX5 which is involved in a B cell commitment and B cell 
lymphopoiesis in BM and spleen (Nutt et al. 1999, Nutt and Tarlinton 2011). Furthermore, the 
differentiation of mature B cells into antibody-secreting plasma cells is controlled by the 
presence of B lymphocyte-induced maturation protein 1 (BLIMP1) and the absence B cell 
lymphoma 6 (BCL6). BLIMP1 promotes B cell terminal differentiation by turning off the 
expression of genes that are associated with cell-cycle progression, DNA synthesis and repair, 
as well as those that are involved in mature B cell function (Turner et al. 1994, Piskurich et al. 
2000, Shaffer et al. 2002). These include many transcriptional factors, such as  
Bcl6 which is required for the GC-B cell formation (Chang et al. 1996, Dent et al. 1997, Fukuda 
et al. 1997). Of the genes that are turned on, particularly interesting is the transcriptional activator 
XBP1, which is a crucial regulator of plasma cells differentiation (Todd et al. 2009, Nutt et al. 
2015). The second wave of TD responses is characterized by B cells migrating into specialized 
area called primary follicle where they give rise to the GC.   
The GC was first described in 1884 by Walther Flemming, who observed a site of large 
lymphocytes undergoing mitosis in the follicles of many secondary lymphoid organs and 
proposed this site to be the major source of lymphocytes in the body (reviewed in (Nieuwenhuis 
and Opstelten 1984). Nowadays the association between the GC and the TD antibody response 
is well established, in which B cells undergo extensive round of proliferation, somatic 
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hypermutation, and antigen-affinity driven selection resulting in the generation of high-affinity 
antibody- secreting plasma cells and memory B cells (Liu et al. 1989, Honjo et al. 2002).  
In secondary lymphoid organs, lymphocytes are segregated on the basis of chemokine sensitivity 
into discrete B cell zones (follicles) and T cell zones. TD antibody responses are initiated when 
rare B and T cells specific for an incoming antigen cluster at the boundary between B cell 
follicles and T cell zones and engage in cognate interactions (Garside et al. 1998, Okada et al. 
2005). Localization to the B cell zones and the T cells zones depends on the chemokine receptors 
CXCR5 and CCR7, respectively. After being activated by antigen, B cells increase their 
expression of CCR7 and migrate to the interface between the zones, where they encounter 
cognate T cells (Cyster 2005). This results in a burst of proliferation in the outer follicle. The 
activated B cells can then adopt one of three potential fates: they can migrate   in   the   
extrafollicular   areas   where   they   undergo   proliferation   and   terminal differentiation into 
short-lived plasma cells that produce a transient wave of relatively low affinity, antigen specific 
antibodies (Gatto et al. 2009, Pereira et al. 2009); they can return to the B cell follicle and 
proliferate further to establish a GC (Allen et al. 2007). Or finally, some of these expanding 
clones can assume a memory phenotype, forming the early memory B cells that enter the 
circulation (Blink et al. 2005).The precise kinetics of GC development vary depending on the 
system examined and are influenced by several factors like the species studied, the availability 
of T cell help, the immunizing antigen and the tissue in which the response occurs (Liu et al. 
1991a, Liu et al. 1991b, Pape et al. 2003, Wang and Carter 2005). Despite these variables, some 
common principles of GC formation have emerged and decades of anatomical and functional 
studies have led to an overall model of how the GC reaction operates. Few days after the 
initiation of an immune response, activated B cells move to the center of B cell follicle in 
secondary lymphoid organs and start to proliferate within the follicular dendritic cells (FDCs) 
network (Liu et al. 1991b). FDCs are specialized stromal cells capable of capturing large 
amounts of antigen in the form of immune complexes and thought to be an important source of 
chemokines such as CXCL13 which is crucial for the localization of CXCR5 positive B and T 
cells within the GC (Allen and Cyster 2008, Vinuesa et al. 2010). From the very beginning, the 
GC was viewed primarily as an anatomical entity and conventional histology techniques allowed 
the identification of two main compartments termed “light” and “dark” zone (LZ and DZ, 
respectively) (Rohlich, 1930). The DZ consists almost entirely of B cells with a high nucleus-to-
cytoplasm ratio, thus appearing “dark” by light microscopy. By contrast, B cells in the LZ are 
interspersed among a network of FDCs which give this zone its “lighter-appearance 
(Nieuwenhuis and Opstelten 1984, Cyster et al. 2000).  
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GC B cells in DZ and LZ were historically defined as centroblasts and centrocytes respectively, 
with centroblasts named on the basis of their mitotic activity and suggested to exit the cell cycle, 
re-express surface Ig and become smaller centrocytes that traveled to the LZ (MacLennan 1994). 
However recent works have demonstrated that cells progress through the cell cycle in both zones 
(Rahman et al. 2003, Wang and Carter 2005, Allen et al. 2007). The mechanism promoting cell 
movement from DZ to LZ seems likely to be regulated by the chemokine receptor CXCR4, 
which is needed for GC B cells positioning in the DZ and its ligand SDF-1 (CXCL12) which is 
more abundant in this zone than it is in the LZ (Allen et al. 2004). Therefore, based on expression 
levels of ‘‘signature’’ surface proteins centroblasts are defined by higher expression of CXCR4 
but lower level of CD83 and CD86, whereas centrocytes are identified as being CXCR4lo, 
CD83hi, and CD86hi (Allen et al. 2004, Victora et al. 2010, Victora et al. 2012). The functional 
importance of the DZ became apparent when it was shown that these cells undergo somatic 
hypermutation (SHM) of their immunoglobulin variable region (IgV) genes which is the basis 
for the affinity maturation of antibodydependent immune responses (Jacob et al. 1991). The 
SHM process modifies the IgV of the rearranged antibody genes in B cells during an immune 
response. The mutations (mostly nucleotide substitutions) are introduced in the rearranged 
variable (V) region that encodes for the antigen binding sites of the antibody, allowing the 
generation of high-affinity BCR (Li et al. 2004). SHM is associated with DNA strand breaks and 
requires the activity of activationinduced cytidine deaminase (AID), an enzyme that catalyses 
the deamination of cytidines directly on DNA. The rate of mutation in the IgV regions during 
SHM in the GC is estimated to be as high as 103 per base pair per generation (Berek and Milstein 
1987). A centroblast that expresses a newly generated antibody mutation needs to be tested for 
improved antigen binding and this process is thought to take place in the light zone and to be 
mediated by specific cell types located in this area, like antigen-presenting FDCs and TFH cells 
(MacLennan 1994). In fact the centrocytes within the LZ are selected according to their ability 
to bind antigen complexes on FDCs and to elicit help from cognate TFH cells (Tew et al. 1993, 
Fazilleau et al. 2009). Positively selected B cells have the 'choice' of recycling to the  
DZ for further mutation or exiting the GC reaction as memory cells or PCs (Allen et al. 2007, 
Victora et al. 2010). Another important process occurring in the LZ is the class-switch 
recombination (CSR) through which the heavy chain class of the antibody produced by an 
activated B cell changes from IgM and IgD to IgG, IgA or IgE. The process requires the 
enzymatic activity of AID and occurs not only within GCs, but also extensively outside of GCs 
in both T‑cell-dependent and T‑cell-independent responses (MacLennan 1994).  
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Isotype switching alters the effector functions of an antibody that can be specifically required to 
clear an antigen by leaving the antibody specificity defined by the rearranged V(D)J region of 
the heavy chain unchanged. CSR is AID driven and occurs by DNA recombination involving 
non-homologous end-joining processes between specific repetitive regions of several hundred 
base pairs (known as switch regions) that precede the immunoglobulin constant region genes 
(Muramatsu et al. 2000). The discovery of AID and the demonstration that it is required for SHM 
and CSR triggered many of the recent advances in this field (Muramatsu et al. 1999). Even 
though SHM and CSR occur in B cells at the same stage of differentiation, they appear to be 
very different biochemical processes. There are IgM antibodies expressing V regions that have 
undergone SHM, as well as IgG and IgA antibodies with no somatic mutations, suggesting that 
SHM and CSR are independent processes mediated by completely different sets of enzymes 
(Bemark et al. 2000, Manis et al. 2002, Reina-San- Martin et al. 2003). Recent study suggests 
that different AID domains recruit factors that differentially mediate the outcomes of SHM and 
CSR (Ta et al. 2003).   
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Figure 11. A T cell-dependent B cell response proceeds in three spatiotemporal phases in lymphoid 
tissues. a | Upon initial activation by antigen, antigen-specific T cells and B cells interact in the border 
region between the T cell area and the B cell area, forming long-lived mobile conjugates. With T cell help, 
some of the clonally expanding B cells differentiate into plasma cells in extrafollicular foci. Some of the 
activated T cells and B cells move back into the follicle, interacting with each other in an increasingly 
short-lived manner and supporting continued expansion of the B cell populations. Germinal centres (GCs) 
develop as B cell clusters coalesce on the follicular dendritic cell network at the follicular centre (not 
depicted). GCs are divided into the light zone (LZ; light green) and dark zone (DZ; dark green); T 
follicular helper (TFH) cells are located primarily in the light zone. b | The GC reaction proceeds in a 
cyclic manner. A B cell in the light zone that receives sufficient T cell help becomes positively selected 
(red circled) for re-entering the dark zone for multiple rounds of cell division and somatic hypermutation 
(cyan circled); the resulting progenies transition back into the light zone, acquiring antigen and competing 
for access to TFH cell-derived help primarily through levels of antigen presentation. Some B cells die 
(black circled) while some are positively selected and give rise to cells that exit GCs eventually to become 
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long-lived plasma cells and memory B cells. BCL-6, B cell lymphoma 6; CD40L, CD40 ligand; ICOS, 
inducible T cell costimulator; SAP, SLAM-associated protein (Qi 2016).  
Memory B cells and long-lived plasma cells  
  
Hallmark of adaptive immune responses is the generation of long-lived protection after primary 
exposure to a pathogen. In humoral responses, this protection stems from a combination of 
sustained antibody titers, deriving from long-lived plasma cells (PCs) and long-lived memory B 
cells. Both types of cells are thought to primarily derive from the germinal center (GC). Memory 
lymphocytes confer immediate protection in peripheral tissues and mount recall responses to 
antigens in secondary lymphoid organs (Blanchard-Rohner et al. 2009). The contribution of B 
cells to immunological memory involves two distinct populations of cells that are generated 
during primary immune responses: long-lived plasma cells (LLPCs), which continue to secrete 
high levels of functional antibodies for protracted periods of time after antigen clearance, and 
memory B cells, which can rapidly proliferate and differentiate into PCs following recurrent 
exposure to the initial immunizing antigen. The maintenance of serological memory by LLPCs 
was first shown in mice by the groups of Radbruch and Ahmed in the late 1990s. Manz et al. 
used bromodeoxyuridine (BrdU) incorporation to discriminate long-lived from short-lived PCs 
in defined murine immune responses. They found that 70% of the specific PCs entered the BM 
within the first month after immunization, followed by the 30% within the second month. These 
cells were found to persist for at least another 2 months without proliferation; furthermore despite 
the antigen clearance they were constantly secreting their antibodies (Manz et al. 1997). Slifka 
et al. investigated the role of PCs in maintaining long-term antibody production using the mouse 
model of infection with lymphocytic choriomeningitis virus (LCMV). They observed that 
infected mice continued to produce specific antibodies for 250 days despite being irradiated to 
inhibit the differentiation of new PCs (Slifka et al. 1998). A strong argument for LLPCs in 
humans comes from the analysis of patients with autoimmune diseases treated with the 
therapeutic anti-CD20 antibody (rituximab). CD20 is a B-cell restricted antigen expressed on B 
lymphocytes precursors and mature B cells, thereafter lost during differentiation to plasma cells. 
In human subjects depleted of CD20+ B cells, total serum IgG and IgA antibody titers decline 
only initially to remain stable thereafter and still being within the normal range (Cambridge et 
al. 2003, Edwards et al. 2004). The long-term persistence of PCs is dependent on continued 
expression of the prosurvival molecule of the Bcl-2 family, Mcl1 (Peperzak et al. 2013). This in 
turn depends on survival signals derived from the BM microenvironment which contain 
monocytes, eosinophils, megakaryocytes, CXCL12+ reticular stromal cells, basophils, 
osteoclasts and osteoblasts. Collectively, these cells provide survival factors that recruit, retain 
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and sustain BM PCs, like BAFF and APRIL (members of the tumor-necrosis factor superfamily), 
the cytokine IL-6, and the co-receptor CD28 ligands CD80 and CD86 (Tangye 2011). LLPCs 
appear an homogenous population whose preferential niche is the BM, whereas memory B cell 
compartment include different subpopulations harboring different effector functions and can 
either be tissue resident or recirculate through secondary lymphoid organs. Nevertheless, like 
LLPCs, memory B cells can persist in the absence of BCR signaling and T cell help (Vieira and 
Rajewsky 1990, Maruyama et al. 2000, Bernasconi et al. 2002). As already mentioned a vast 
majority of memory B cells are generated in GCs and are distinguished from naive B cells by an 
increased lifespan, faster and stronger response to stimulation and expression of somatically 
mutated and affinity matured immunoglobulin (Ig) genes (Rajewsky 1996, Klein et al. 1998). 
Memory B cells can be identified by higher expression of costimulatory molecules (SLAM, 
tumor necrosis factor, TLR7/9, CD27, CD80, CD86 and IL-21 receptor), antiapoptotic molecules 
(BCL2 family members) and signal transducers (STAT3) (Bernasconi et al. 2003, Good and 
Tangye 2007, Avery et al. 2010). Upon reactivation, memory B cells proliferate and either 
reenter GC reactions or differentiate into PCs which quickly produce large amount of high-
affinity antibodies. This is essential to maintain the antibody serum pool as LLPCs lack 
proliferative potential and cannot supply an additional boost of high-affinity antibodies (Yoshida 
et al. 2010). If reactivated memory B cells reenter GC reactions, they may improve immunity to 
modified pathogens or infection conditions by downstream CSR and new rounds of affinity 
maturation (Dogan et al. 2009).  
The study of long-term memory has generally focused on class switched IgG B cells, which 
represent approximately 15–20% of peripheral B cells in adults (Fecteau et al. 2006). Hence 
IgM+IgD+ B cells were generally assumed to represent antigen-inexperienced expressing variable 
region genes without somatic mutations. However somatically mutated IgM+IgD− B cells have 
been identified and further classified as IgM-expressing counterpart of classical class-switched 
memory B cells (Klein et al. 1993, 1997). It’s now well established that in human two distinct 
populations of IgM memory can be identified: IgM only, with a GC derivation (Weill et al. 2009) 
and IgM+IgD+ memory B cells with a doubtful origin. Reynauld and Weill proposed that at least 
a fraction of IgM+IgD+CD27+ B cells undergo somatic hypermutation in an antigen-independent 
pre-diversification process, rather than during antigen-driven B-cell responses (Weller et al. 
2004, Weller et al. 2008). An historically method to discriminate memory B cells has been to 
use CD27 as a marker considering that its expression correlates with SHM in IgM+IgD+ cells 
(Klein et al. 1998). CD27 is a member of TNF-receptor family and the interaction with the ligand 
CD70, expressed on activated T cells, contributes to B cell expansion, differentiation, and 
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antibody production (Hintzen et al. 1994, Kobata et al. 1995, Lens et al. 1996, Arens et al. 2001). 
Nowadays is widely accepted to use CD27 and IgD as markers to distinguish four main 
populations: CD27−IgD+ antigeninexperienced cells, two subsets of CD27+ memory cells (IgD+ 
and IgD−) and CD27−IgD− memory cells. The latter population shares similar morphology with 
CD27+ and includes class switched B cells with mutated Ig genes. Furthermore this population 
lacks ABCB1 transporter, which discriminates human resting naive B cells from cycling 
transitional and memory B cells (Wirths and Lanzavecchia 2005, Fecteau et al. 2006, Wu et al. 
2011). CD27− memory cells are present at birth (van Gent et al. 2009), and in healthy adult 
subjects they account for approximately 5% of the peripheral B cell population (Sanz et al. 2008). 
The increase of this subpopulation in the elderly has led to the idea that these cells are aged or 
exhausted memory B cells (Colonna-Romano et al. 2009). It is important to gain a better 
understanding of the CD27− cell population because it occurs at a greater frequency not only in 
elderly but also in pathologic situation like systemic lupus erythematosus (SLE), rotavirus 
infection, and human immunodeficiency virus (HIV) infection (Wei et al. 2007, Moir et al. 
2008). Overall it is emerging that CD27 is not an appropriate marker and this highlight the need 
to have a precise method to define memory B cells. Despite the importance of memory B cells 
for vaccine and infection-induced protection (Bevan 2011) there is limited understanding of the 
nature of these cells, with most information coming from human studies. Presumably because of 
the constant exposure to antigens, humans have an abundance of memory-like cells. Using a 
transgenic mouse model in which relative numbers of antigen-specific memory B cells are 
elevated, several cell surface markers were investigated enabling the definition of memory B 
cells, which were confirmed in non-transgenic mice. In this mouse system, the costimulatory 
molecule CD80 has been identified as a memory B cell marker (Anderson et al. 2007). In later 
studies CD80 was combined with CD73 and PD-L2, which resulted in the identification of at 
least five different subsets of memory B cells in response to immunization (Tomayko et al. 
2010). The authors suggested that there exists a spectrum of memory B cells consisting of naive-
like memory B cells with few mutations and infrequently isotype-switched BCRs, and other 
more memory-like cells, expressing multiple memory-specific markers, with more frequently 
isotype-switched BCRs and containing high mutational content. These data demonstrate that 
there is significantly more heterogeneity within the memory B cell compartment than has been 
previously appreciated (Tomayko et al. 2010).  
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Figure 12. Pathways leading to memory B cell formation. Two pathways are illustrated of which both 
are T-dependent, whereas one is germinal centre (GC)-dependent and the other is GC- independent. 
Depicted is a follicle (FO) with a GC that consists of a dark zone (DZ) and a light zone (LZ). (1) At the B 
and T cell border, an antigen-activated B cell interacts with its cognate CD4+ helper T cell, here shown 
as interactions between MHC/antigen and CD40/CD40L, resulting in cytokine production; (2) This would 
lead to B cell proliferation and adaptation of one of three fates; (3) extrafollicular short-lived antibody-
secreting plasma cells (PCs); (4) memory B cell formation independently of a GC reaction; or (5) GC 
formation in which the B cells can undergo somatic hypermutation (SHM) and/or class switch 
recombination(CSR); (6) In the DZ of the GC, B cells proliferate. In the LZ, GC B cells either; (7) undergo 
apoptosis; or (8) become positively selected by follicular dendritic cells (FDC) based on their affinity for 
antigen; and can then (10) receive further signals from TFH cells to either; (11) re-enter the DZ to initiate 
another GC cycle, or exit from the GC, to; (12) become a high-affinity memory B cell; or (13) a PC 
secreting high-affinity antibodies (Bergmann et al. 2013).  
1.4 Purinergic signaling  
  
Purinergic pathway in the immune system regulation  
  
Cellular ATP serves as an energy carrier implicated in virtually all metabolic processes. Its potent 
extracellular actions acting as a messenger were first recognized in 1929 by Drury and Szent-
Gyorgy who reported the activities of adenine compounds on the mammalian heart (Drury and 
Szent-Györgyi 1929). It’s now well established that these mediators act as signaling molecules, 
operating in virtually all tissues through the activation of G-protein–coupled or ligand-gated ion-
channel receptors (Burnstock 1997). In addition, several families of ectonucleotidases that 
hydrolyse ATP to ADP, and AMP to adenosine have been found expressed on the surface of 
different mammalian cell types (Corriden and Insel 2010). The term purinergic receptor was first 
introduced to describe classes of membrane receptors that, when activated by either e-ATP (P2 
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receptors, P2R) or its breakdown product adenosine (P1 receptors, P1R), mediated relaxation of 
gut smooth muscle (Burnstock 1972, Burnstock et al. 1978). Controlled ATP release from intact 
cells was first discovered in neurons, which release it into neuronal synapses. Since then, many 
aspects of purinergic signaling in neurons have been elucidated (Abbracchio et al. 2009). 
Additional work revealed that purinergic mechanisms regulate key aspects of many other 
physiological processes, including activation of the different cell types of the immune system 
(Bours et al. 2006).  
The P2R family is subdivided into the P2Y (eight members, P2Y1, P2Y2, P2Y4, P2Y6 and  
P2Y11- P2Y14) and P2X (seven members, P2X1-7) subfamilies. P2Y receptors (P2YRs) are 7-
membrane-spanning proteins, with aminoterminal domain in the extracellular environment and 
the carboxyterminal on the cytoplasmic side of the plasma membrane. P2YRs are coupled via 
G-proteins to Ca2+ mobilization and cyclic AMP generation/inhibition, as well as to stimulation 
of the ERK/MAPK pathway (Abbracchio et al. 2006). Signal transduction occurs via the 
classical pathways triggered by the most 7-membrane-spanning receptors: activation of 
phospholipase C and/or stimulation/inhibition of adenylate cyclase. All the P2Y receptors are 
activated by ATP, but there is some selectivity, and for instance UTP preferentially triggers P2Y4 
and P2Y6 while ATP and UTP are equipotent on P2Y2 (Lustig et al. 1993, Communi et al. 
1996a, Communi et al. 1996b). P2X receptors (P2XRs) are homo-heterotrimeric ATPgated ion 
channels, characterized by two transmembrane hydrophobic domains and both the N-and C-
termini on the cytoplasmic side (Stojilkovic and Koshimizu 2001). Signal transduction occurs 
via fast Na+ and Ca++ influx and K+ efflux, leading to depolarization of the plasma membrane and 
an increase in the concentration of cytosolic Ca++ (North 1996, Surprenant and North 2009). It is 
likely that the altered intracellular ion homeostasis caused by  
P2X receptor opening activates additional intracellular messengers and enzyme pathways  
(Virgilio et al. 2001). Seven genes in vertebrates encode P2X receptor subunits, which are 40– 
50% identical in amino acid sequence. Each subunit has two transmembrane domains, separated 
by an extracellular domain. Channels form as multimers of several subunits and homomeric 
P2X1, P2X2, P2X3, P2X4, P2X5, and P2X7 channels and six functional P2XR heteromeric 
receptors have been characterized: P2X1/2R, P2X1/4R, P2X1/5R, P2X2/3R (North 2002, Spelta 
et al. 2002, Jiang et al. 2003, Aschrafi et al. 2004, Nicke et al. 2005). All homomeric and 
heteromeric receptors are activated by ATP but in a receptor-specific manner with EC50 values 
ranging from nanomolar to submillimolar concentrations. The gating of P2XRs usually consists 
of three phases: activation phase, triggered by the stimulation with the agonist and characterized 
by a rapid rising of inward current, desensitization phase with a slowly developing decay phase 
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in the presence of the agonist and a deactivation phase as a result of ATP removal with a rapid 
decay of current. The main difference among receptors is in their sensitivity for agonists and 
their activation and desensitization rates (North 2002).  
  
  
  
  
 
    
Figure 13. Purinergic receptors and their natural ligands. Purinergic receptors are divided into P2 
receptors which are activated by a variety of nucleotides and can be further subdivided into ionotropic 
P2X receptors activated by ATP and the metabotropic G-protein-coupled receptors (P2Y) which are 
stimulated by nucleotides, di- or triphosphates, purines or pyrimidines. In contrast, metabotropic P1 
receptors are preferentially activated by adenosine. Recently, evidences for the functional expression of 
adenine receptors, designated as P0 receptors, have been found. 1: ecto-nucleoside triphosphate 
diphosphohydrolases (E-NTPDases) e.g. CD39, 2: ecto-5’-nucleotidase (CD73), 3: purine nucleoside 
phosphorylase (PNP) (Kaebisch et al. 2015).  
Autocrine and paracrine actions of extracellular ATP  
  
Immune cells have developed highly sensitive receptor systems that allow them to execute their 
many roles in immune surveillance and host defense. In this context extracellular ATP represents 
an ideal harbinger of cell stress. Indeed in their physiologic state mammalian cells contain high 
concentrations of ATP (5 to 8 mM) inside the cells, whereas in the extracellular environment the 
concentration is ~10 nM. The high nucleotide concentration inside the cells and its virtual 
absence extracellularly in healthy tissues renders ATP also an ideal harbinger of cell death; in 
fact, pathologic conditions cause the release of ATP from necrotic and apoptotic cells, which can 
serve as a “find-me” signal that, together with other mediators, attracts monocytes to 
phagocytose and remove dead or dying cells (Ravichandran 2010, Eltzschig and Eckle 2011). 
Interestingly it has been shown that inflammasomes activation involves ATP release through 
pannexin-1 and purinergic signaling through P2X7 receptors. Inflammasomes activation triggers 
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innate immune by inducing the maturation of pro-inflammatory cytokines, such as IL-1β 
(Trautmann 2009).  
Concomitant to a necrosis dependent ATP release, autocrine/paracrine mechanisms regulating 
the function of healthy immune system by regulated ATP release, has been shown and three 
different mechanisms have been proposed so far:  
1. Transmembrane diffusion via ATP permeable channels  
2. Active transports  
3. Exocytosis from vesicles  
 All these mechanisms of ATP release in the extracellular space contribute to regulate different 
function of the immune system. For instance, the directed migration of neutrophils, referred to 
as chemotaxis, requires the temporal and spatial regulation of intracellular signaling pathways 
allowing the neutrophil to detect a gradient of attractant, polarize, and migrate rapidly toward 
the highest concentration of the chemoattractant (Li Jeon et al. 2002). Interestingly autocrine 
purinergic feedback mechanisms control several aspects of this process and the stimulation of 
chemotaxis receptors induce a rapid release of ATP resulting in the accumulation of extracellular 
ATP near the cell surface closest to the source of chemoattractants. The released ATP can 
activate multiple adjacent P2Y2 receptors to provide autocrine signal amplification, which 
greatly increases the intracellular signals generated by chemotactic stimuli. Modifications in the 
extracellular ATP concentration, caused for example by blocking ATP release or P2Y2 receptors 
impairs chemotaxis by interfering with the autocrine signaling systems of neutrophils (Chen et 
al. 2006). Similar autocrine signaling systems were recently identified in macrophages (Kronlage 
et al. 2010). Furthermore a number of studies have shown that T cells can release ATP in 
response to various extracellular stimuli, suggesting that purinergic signaling may indeed play 
an active role in T cell activation (Filippini et al. 1990, Canaday et al. 2002). As already 
mentioned autocrine regulation mechanisms similar to those identified in neutrophils, also 
regulate T cell activation (Schenk et al. 2008, Woehrle et al. 2010). However, although 
neutrophils seem to amplify stimulatory signals using P2Y2 receptors, purinergic signal 
amplification in T cells occurs through P2X1, P2X4 and P2X7 receptors. Besides the ATP-
permeable release channels the ATP-filled vesicles depict another important mechanism which 
allows the nucleotide release in the extracellular space (Schwiebert and Zsembery 2003). Indeed 
in human B cells ATP is stored in secretory vesicles released upon BCR triggering in a Ca2+-
sensitive fashion. Specifically, Schena et al in 2013 showed that in B cells ATP accumulates in 
late endosomal/vesicular compartments and pointed out the role of TI-VAMP vesicular protein 
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in the regulated ATP release. This role has been confirmed by the analysis of TI-VAMP-deficient 
B lymphocytes, which displayed reduced level of extracellular ATP upon stimulation (Schena et 
al. 2013). Extracellular ATP and P2 receptors play a direct role in the modulation of DCs 
response; expression of P2X7 on mouse DCs, for instance, correlates with antigen-presenting 
activity (Mutini et al. 1999, Ferrari et al. 2000). Chronic stimulation with low doses of 
extracellular ATP has been reported to affect the maturation and antigen presenting functions of 
DCs. Moreover mature DCs exposed to ATP showed an impaired ability to initiate Th1 response 
(la Sala et al. 2001).  
  
  
P2X7 receptor  
  
Among the P2RX family, the P2X7 receptor encoded by the P2rx7 gene is the most abundant 
and prominent in the immune system (Coddou et al. 2011). Of the P2X family, the P2X7 
monomeric subunit is the largest, with a length of 595 amino acids for the human, rat, mouse, 
dog, and Rhesus macaque receptors (Surprenant et al. 1996, Rassendren et al. 1997, Chessell et 
al. 1998, Roman et al. 2009, Bradley et al. 2011). Each subunit is characterized by relatively 
short and long intracellular amino and carboxyl termini respectively, as well as two hydrophobic 
membrane-spanning segments (transmembrane domains) separated by a long glycosylated 
extracellular ATP-binding domain. P2X7 receptor is distinguished structurally from other 
members of P2XRs by its long intracellular C terminus tail containing multiple protein, lipid 
interaction motifs and a cysteine-rich 18 amino acid segment. This receptor is widely expressed 
in cells of the immune system, such as macrophages/monocytes, dendritic cells, lymphocytes, 
and mast cells, as well as in glia cells, including microglia, astrocytes, oligodendrocytes and 
Schwann cells (Collo et al. 1997, Rassendren et al. 1997, Chessell et al. 1998, Di Virgilio et al. 
2001, Franke et al. 2001, Di Virgilio et al. 2009, Skaper et al. 2010). Epithelial cells, fibroblasts, 
osteoblasts, pituitary cells, and some neuronal populations also express P2X7Rs (Groschel-
Stewart et al. 1999, Koshimizu et al. 2000, Sim et al. 2004). Stimulation of the receptor with 
low ATP doses reversibly opens a membrane channel permeable to small cations (Na+, Ca2+, 
K+). Upon sustained stimulation with higher ATP doses or repeated stimulation with sequential 
ATP pulses, the P2X7 receptor channel undergoes a large increase in conductance and a shift in 
selectivity, from cation-selective to nonselective. Under these conditions, the plasma membrane 
becomes permeable to solutes of molecular weight up to 900 Da. Up until now unequivocal 
demonstrations for the opening of such a peculiar pore are available only for the P2X7R subtype, 
where extensive studies have documented uptake of various low-molecular weight hydrophilic 
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fluorescent markers (Steinberg et al. 1987, Di Virgilio et al. 1989, Di Virgilio 1995). Pore 
formation has been functionally linked to the long intracellular C-terminus region of P2X7 
(Becker et al. 2008). However, whether P2X7 it-self directly mediates pore formation by channel 
dilation or whether other P2X7-associated proteins such as pannexin1 form the pores is still a 
matter of debate. Activation of P2X7 by ATP results in a number of downstream signaling events 
which depend on cell type, extracellular conditions and the concentration of extracellular ATP, 
(Burnstock 2007). The activation requires cell surface ATP levels >100 μM sustained over some 
minutes. For this reason P2X7 receptors are possibly only activated after injury, infection, or in 
tumor microenvironments when the concentration of ATP increases locally or when 
ectonucleotidases are downregulated (Lenertz et al. 2011). P2X7 activation acts as a costimulus 
for the formation of the NALP3 inflammasome and t h e secretion of the proinflammatory 
cytokines IL-1β and IL-18 and nitric-oxide release (Sperlagh et al. 1998, Mariathasan et al. 2006, 
Piccinni et al. 2008). Ligation of the P2X7 receptor leads to the activation of NF-kB which 
controls cytokine expression and apoptosis (Ferrari et al. 1997). Furthermore it is well 
documented that prolonged stimulation of cells using high concentrations of ATP causes cell 
death via P2X7-induced apoptosis characterized by phosphatidylserine externalization and 
membrane blebbing (MacKenzie et al. 2001). Contrary to the aforementioned role in apoptotic 
cell death, P2X7 has also been proposed to have a role in cell proliferation. For example T cell 
activation induces the release of ATP through pannexin-1 channels that translocate with P2X7 
receptor to the immune synapse, where they promote calcium influx and cell activation through 
autocrine purinergic signaling (Figure 14) (Schenk et al. 2008, Yip et al. 2009). Schenk et al in 
2011 showed that P2X7 activity regulates the immunosuppressive function of Treg cells. 
Particularly they showed that the activation of P2X7 by ATP inhibits the suppressive potential 
of Tregs and that the pharmacological antagonism of P2X receptors promoted the cell-
autonomous conversion of naïve CD4+ T cells into Tregs after TCR stimulation (Schenk et al. 
2011). Further, Proietti et al identified a novel role of the P2X7 receptor as an important regulator 
of the adaptive IgA response in the small intestine. Deletion of P2rx7 resulted in the expansion 
of TFH with consequent enhanced germinal center reaction which in turn resulted in higher 
affinity IgA production and depletion of mucosal bacteria in P2rx7-/- mice (Proietti et al. 2014).  
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Figure 14. Purinergic control of T cell activation. Schematic representation of a T cell (red) interacting 
with a professional APC (gray). The early phase of T cell activation, which is triggered by the interaction 
of the TCR with the MHC–peptide complex, is characterized by CCE (step 1), which is accompanied by 
mitochondrial uptake of Ca2+ (step 2) and Ca2+-dependent stimulation of ATP synthesis (step 3). ATP is 
released from activated T cells through pannexin hemichannels, which open when the cytosolic [Ca2+] is 
elevated. This mechanism guarantees a high concentration of pericellular ATP, which by binding to 
P2XRs, serves as an indispensable autocrine costimulus for productive T cell activation (step 4). Finally, 
ATP released from activated T cells might also modulate APC function, such as secretion of IL-1β (step 
5) (Schenk et al. 2008).  
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Extracellular ATP metabolism: role of CD39 and CD73  
  
Following its release into the extracellular space, ATP is rapidly hydrolysed by ectonucleotidases 
in a two-step enzymatic process which is important for calibrating the duration, magnitude and 
composition of the “purinergic halo” surrounding the immune cells. The first step provides for 
ATP and ADP conversion to AMP through the ectonucleoside triphosphate diphosphohydrolase 
1 (CD39) and it is followed by a second step mediated by ecto-5’-nucleotidase (CD73) which 
converts extracellular AMP to adenosine (Yegutkin 2008). Besides CD39 and CD73, which are 
the major ectonucleotidases that regulate immunity and inflammation, there are other less 
understood enzymes involved in the catabolism of extracellular nucleotides, which include 
alkaline phosphatases, pyrophosphatases, and phosphodiesterases as well as the counteracting 
ATP-regenerating ectoenzymes adenylate kinase and nucleoside-diphosphate kinase (Yegutkin 
2008). The expression and activity of both CD39 and CD73 undergo dynamic changes in 
accordance with environment context, contributing to the outcome of several pathophysiological 
conditions, such as infections, autoimmune diseases and cancer (Deaglio and Robson 2011, 
Zhang 2012, Bastid et al. 2013). Ectonucleoside triphosphate diphosphohydrolases 
(ENTPDases) hydrolyze nucleotide diphosphates and triphosphates to generate nucleotide 
monophosphates, and they are the largest family of ectonucleotidases, consisting of ENTPDase1 
to 8, including E-NTPDase1 (CD39), E-NTPDase2 (CD39L1), E-NTPDase3 (CD39L3), E-
NTPDase5 (CD39L4), and ENTPDase6 (CD39L2) (Zimmermann 2000). CD39 is a 510-amino 
acid membrane protein which hydrolyzes ATP, and less efficiently ADP, in a Ca2+- and Mg2+-
dependent manner (Heine et al. 2001). Structurally it is characterized by two transmembrane 
domains, a small cytoplasmic domain and a large extracellular domain consisting of five regions, 
known as apyrase conserved regions (ACR) 1-5, important for the enzymatic activity. The 
localization on the cell surface is essential for the catalytic activity and post translational 
glycosylation is crucial for correct protein folding, membrane targeting and enzyme activity 
(Smith and Kirley 1998). CD39 expression is regulated by several pro-inflammatory cytokines, 
oxidative stress and hypoxia and is primarily associated with endothelial cells and immune cell 
populations, specifically B cells, natural killer (NK) cells, dendritic cells, Langerhans cells, 
monocytes, macrophages, neutrophils and Treg cells (Dwyer et al. 2007). In addition, the 
expression of CD39 is increased in several solid tumors (colorectal cancer, head and neck cancer, 
pancreatic cancer) as well as in chronic lymphocytic leukemia, suggesting this enzyme is also 
involved in the development and progression of malignancies (Bastid et al. 2013). The second 
step in the metabolism of purine nucleotides is catalyzed by ecto-5'-nucleotidase CD73, which 
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is considered as the rate limiting enzyme responsible for the irreversible dephosphorylation of 
AMP into adenosine (Hunsucker et al. 2005). Notably the hydrolysis of ATP to AMP by CD39 
is reversible thanks to the action of membrane-bound ATP regenerating enzymes (Yegutkin 
2008); CD73-mediated conversion of AMP to adenosine is instead virtually irreversible but is 
actually possible after the uptake of extracellular adenosine and the conversion into AMP by 
intracellular adenosine kinase (AK) (Beavis et al. 2012). In this context, CD73 can be considered 
as a crucial regulator of the extracellular ATP/adenosine balance.  
  
  
CD39 and CD73 in the immune system  
  
The generation of adenosine by CD39 and CD73 can be viewed as “immunological switches” 
that shift ATP-driven pro-inflammatory activity toward an anti-inflammatory state mediated by 
adenosine. This system has to be tightly regulated in order to preserve and restore homeostasis. 
Several regulatory mechanisms are used to maintain immune equilibrium and in this regard Treg 
cells are considered the primary mediators of peripheral tolerance (Sakaguchi et al. 2008). It has 
been shown that CD39 and CD73 expression in Foxp3+ Tregs synchronized with the activation 
status of these cells. Indeed murine Treg display increased ATPmetabolizing activity and this 
feature appears to be crucial for the immunosuppressive activity of these cells (Mandapathil et 
al. 2009, Ernst et al. 2010). Deaglio et al showed that the inhibitory control by Treg-derived 
adenosine is mediated by the engagement of adenosine A2A receptors on effector T cells 
(Deaglio et al. 2007). In humans, it has been reported that the expression of CD39 on peripheral 
CD4+ T cells is associated with regulatory Foxp3+ signatures and the acquisition of a memory 
phenotype. In contrast to murine Treg phenotype, CD73 is not substantially co-expressed but it 
accumulates in the cytoplasmic compartment (Mandapathil et al. 2010). It has been suggested 
that human Treg cells secrete CD73 which may in turn convert AMP to adenosine. Alternatively 
other AMP-metabolizing enzymes may contribute to the adenosine generation (Antonioli et al. 
2013). In addition to Treg other T cell subsets express the CD39 and CD73 ectonucleotidases. 
For instance in Th17 cells the expression of both enzymes is tightly regulated by cytokines like 
IL6 and TGFβ which control the immunosuppressive function of these cells (Chalmin et al. 
2012).  
As already mentioned, ATP can be released by neutrophils and act in an autocrine fashion 
modulating the migration capacity of these cells (Chen et al. 2006). Additionally it has been 
reported that neutrophils widely express CD39 and to some extent CD73 and that adenosine also 
plays a critical role in the polarization and migration of these cells (Pulte et al. 2007, Flogel et 
 56  
  
al. 2012). Hence inadequate enzymatic activity has been associated with uncontrolled cell 
activation and amplified chemotactic functions (Corriden et al. 2008). The purine concentration 
in the extracellular space is also important for the regulation of macrophages activity and 
differentiation. In particular pro-inflammatory M1 macrophages decrease the expression and the 
activity of both CD39 and CD73 resulting in reduced level of ATP degradation. By contrast, 
anti-inflammatory M2 macrophages showed increased expression and activity of both catalytic 
enzymes, resulting in the generation of adenosine-rich environment (Csoka et al. 2012). 
Ectonucleotidases are involved in the modulation of dendritic cells functions. For instance CD39 
has been proposed to prevent the desensitization of P2 receptors, which are required for the 
optimal T cells stimulation by dendritic cells (Mizumoto et al. 2002).  
CD73 is a human orthologue of bacterial monomeric 5’-nucleotidases, indicating a common 
evolutionary origin of these enzymes (Zimmermann 1992). The catalytic properties are instead 
different, since the human enzyme catalysis the hydrolysis of AMP into adenosine and in contrast 
the bacterial ecto-nucleotidases are able to hydrolyze AMP, ADP and ATP and other 5-ribo- and 
5-deoxyribonucleotides (Neu 1967). Structurally CD73 is a dimer of two identical 70 kD 
subunits, anchored to the plasma membrane via a C-terminal serine residue, linked to glycosyl-
phosphatidylinositol (GPI). Each subunit of the dimer consists of two structural domains: the N-
terminal, which contains the metal ion binding site and the C-terminal domain which contains 
the substrate binding site and dimerization interface. The two domains are linked by a small 
hinge region, which enables the enzyme to undergo large domain movements and thereby switch 
between the open and closed conformations (Knapp et al. 2012). Switching movements from 
one conformation to another are responsible for substrate selectivity and catalytic reaction 
(Knapp et al. 2012). A soluble form of CD73 can be shed from the membrane through proteolytic 
cleavage or hydrolysis of the GPI anchor by phosphatidylinositol-specific phospholipase (Strater 
2006, Heuts et al. 2012). Those soluble forms have been described in several tissues, including 
serum (Chuang et al. 1984) as well as seminal and synovial fluids (Johnson et al. 1999, Fini et 
al. 2003).  
CD73 can be detected in several mammalian tissues including colon, brain, kidney, liver, lung 
and heart, spleen, lymph nodes, thymus and BM. The expression and the function of the enzyme 
are both up-regulated under hypoxic conditions and by pro-inflammatory mediators like TGF-β, 
INFs, TNF-α and IL-1β (Thompson et al. 2004, Regateiro et al. 2011). Plasma membrane-bound 
CD73 has been shown to be involved in lymphocytes-endothelial cells interaction, cell-matrix 
interactions and a signal transducing molecule in the immune system. A subpopulation of 
peripheral blood lymphocytes expresses CD73, and specifically the majority of B cells and CD8+ 
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T cells and only about 10% of CD4+ T cells (Thompson et al. 1987, Airas et al. 1995). Owing to 
its ubiquitous expression and to its pivotal role in adenosine homeostasis, CD73 has been 
implicated in many physiological functions and disorders (Colgan et al. 2006). In particular, its 
role as a costimulatory molecule in T cell activation has been well established (Resta et al. 1994, 
Gutensohn et al. 1995). Furthermore, recently CD73 has been described as functional enzymatic 
marker expressed on peripheral B cell subsets (Schena et al. 2013). Peripheral human B cells co-
expressing CD73 and CD39 have a more prompt capacity to expand and differentiate into 
antibody secreting cells in vitro. This property has been linked to the hydrolyzing enzymatic 
function of CD39 and CD73, which generate in coordination adenosine starting from 
extracellular ATP, pointing out for the first time a role of adenosine in activating instead of 
inhibiting the immune system (Figure 15). Remarkably common variable immunodeficiency 
patients displaying low levels of IgG and IgA showed a reduced CD73 surface expression 
(Schena et al. 2013). In addition, it has been observed that the expression of CD73 on follicular 
dendritic cells is crucial for the adhesive interaction between these cells and the germinal center 
B cells (Airas and Jalkanen 1996, Airas 1998). Recently, more studies have been focused in 
understanding the role of adenosinergic pathway in autoimmune disease development. 
Rheumatoid arthritis (RA) for instance is a chronic autoimmune disease associated with joint 
destruction and characterized by synovial infiltration of inflammatory cells secreting 
proinflammatory cytokines. A protective role of CD73 in RA pathogenesis has been pointed out 
(Chrobak et al. 2015). Specifically by using collagen-induced arthritis (CIA) mouse models, 
which is a commonly used mouse model for RA study, Chrobak et al. found that CD73-deficient 
mice were significantly more susceptible to CIA than wild-type (WT) mice. CD73 deficiency 
resulted in an increased production of proinflammatory cytokines in joint and increased joint 
destruction (Chrobak et al. 2015). Furthermore increasing evidence has suggested that 
adenosinergic system may be an important factor in multiple sclerosis (MS) pathophysiology. 
MS is a chronic inflammatory autoimmune disease of the central nervous system (CNS), due to 
an immune reaction against myelin proteins. The etiology of MS is still unclear (Loma and 
Heyman 2011). Mills et al. demonstrated that CD73-deficient mice were more resistant to 
experiment autoimmune encephalomyelitis (EAE), which is the classical animal model of MS. 
In addition, it was observed that the infiltration of lymphocytes into CNS in CD73-deficient mice 
was fewer than that in WT mice (Mills et al. 2008). CD73 has also been found to be involved in 
autoimmune type 1 diabetes development. Tai et al. have showed that TLR9 deficiency in non-
obese diabetic mice could significantly protect from disease development via upregulating CD73 
expression (Tai et al. 2013). Additionally, lower expression of CD73 has been found on synovial 
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fluid mononuclear cells (SFMCs) extracted from juvenile idiopathic arthritis (JIA) patients, 
compared to peripheral cells extracted from both JIA patients and healthy controls (Botta 
Gordon-Smith et al. 2015). JIA is a chronic autoimmune rheumatic disease of childhood with 
unknown etiology, characterized by swelling of the joints and thickening of synovial lining (Woo 
and Wedderburn 1998). Moreover, low expression of CD73 on T and B cells in inflamed site is 
correlated with the clinical severity of JIA patients. This finding suggested that the decreased 
CD73 expression in SFMCs would lead to a decreased potential for anti-inflammatory activity 
and then, the deterioration of disease (Botta GordonSmith et al. 2015). Like CD39, also CD73 
is found overexpressed in several type of cancer, including bladder cancer, leukemia, glioma, 
glioblastoma, melanoma, ovarian cancer, colon cancer and breast cancer (Allard et al. 2012, 
Beavis et al. 2012). CD73 transcripts are induced by hypoxia-inducible factor (HIF)-1 
(Synnestvedt et al. 2002) and the overexpression observed in tumor is at least in part a 
consequence of the hypoxic nature of the tumor microenvironment. Lately, CD73 has been 
widely used as a marker for mouse B cell memory. In T-dependent model of immunization, 
CD80 combined with CD73 and PD-L2 resulted in the identification of at least five different 
subsets of memory B cells. These data indicate that the diversity of memory B cells is 
considerable and the authors suggested the presence of a spectrum of memory B cells, where the 
high and concomitant expression of CD80, PD-L2 and CD73 define a “more memory like” 
phenotype (Tomayko et al. 2010).  
  
                   
Figure 15. Dependence of Immunoglobulin CSR in B Cells on vesicular release of ATP and CD73 
ectonucleotidase activity. In human B cells, ATP is stored in secretory vesicles that are released in a 
Ca2+-sensitive fashion upon BCR stimulation. CD73-dependent adenosine generation favors CSR, 
endowing the B cell with an intrinsic control of differentiation toward Ig class-switched plasma cells 
(Schena et al. 2013).  
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Effect of adenosine on the immune system  
  
Under physiological conditions, adenosine is constantly present at low level in the interstitial 
fluids of unstressed tissues. However the concentration of this nucleoside can rapidly increase in 
response to pathophysiological conditions, such as hypoxia, ischaemia, inflammation or trauma. 
In these conditions, after being released in the extracellular space, adenosine behaves like a 
danger signal and activates specific receptors on target cells aiming to restore tissue homeostasis 
and promote healing processes (Hasko et al. 2008). Four distinct G-protein- coupled P1 receptors 
have been cloned: A1, A2A, A2B and A3. A1, A2A and A2B receptors are conserved throughout 
evolution and are highly homologous (80-95%), whereas A3 receptors vary substantially among 
species (Antonioli et al. 2008). Unlike A1, A2A and A3 receptors that can be stimulated by 
levels of adenosine ranging between 30 and 300 nM, the low-affinity A2B receptor requires 
higher concentrations of adenosine to be activated, such as those encountered for example in 
hypoxic microenvironments (Fredholm et al. 2001). The A1 and A3 receptors are coupled to G 
proteins from the Go and Gi family and their activation is linked to the inhibition of adenylyl 
cyclase, decreasing intracellular cyclic AMP (cAMP) levels. The stimulation of A1 and A3 
receptors can also elicit the release of calcium ions from intracellular stores (Hoskin et al. 2008). 
On the other hand signaling mechanism of A2A and A2B receptors relies on the stimulation of 
adenylyl cyclase by Gs proteins, increasing cAMP synthesis (Ralevic and Burnstock 1998, 
Klinger et al. 2002). As a consequence, activation of A2A and A2B receptors on immune cells 
induce strong immunosuppressive effects through the cAMP/PKA-mediated inhibition of NF-
kB, TCR and JAK-STAT signaling pathways (Palmer and Trevethick 2008). Moreover, all 
adenosine receptors couple to mitogen-activated protein kinase (MAPK) pathways, which 
include extracellular signal-regulated kinase 1 (ERK1), ERK2, JUN N-terminal kinase and p38 
MAPK (Hoskin et al. 2008). Adenosine receptors signaling depend on the level of extracellular 
adenosine, which is determined by a complex ecto-enzyme machinery and uptake system. 
Adenosine biological activity is further regulated by an ecto-adenosine deaminase (ADA) which 
degrades it into inosine, or via the reuptake of adenosine by equilibrative and/or concentrative 
transporters (Baldwin et al. 2004, Gray et al. 2004, Antonioli et al. 2012).  
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Figure 16. The adenosinergic system. Extracellular adenosine production results from the concerted 
action of CD39 and CD73. CD39 catalyses the degradation of ATP into AMP, whereas CD73 hydrolyses 
AMP into adenosine. ATP breakdown into AMP is reversible through the action of membrane-bound 
regenerating enzymes, namely, adenylate kinase and NDPK. In contrast, AMP hydrolysis into adenosine 
by CD73 is irreversible. Nevertheless, CD73-generated adenosine can regenerate AMP after reuptake in 
the intracellular medium through NT and subsequent phosphorylation by AK. Of note, adenosine can also 
be produced intracellularly through the dephosphorylation of AMP by cytosolic 5′-nucleotidase (cNT). 
Biologically active adenosine can be catabolized into inosine by intracellular or membrane-bound ADA. 
Importantly, CD26 or dipeptidyl peptidase 4 can form a complex with ADA and allows its expression at 
the cell surface. Extracellular adenosine exerts its biological effects through the engagement of four 
distinct subtypes of adenosine receptors, namely, A1, A2A, A2B and A3 receptors. Those receptors are 
differently coupled to intracellular G proteins, which can then trigger various signaling pathways. In 
general, A1 and A3 receptors are coupled to Gi/o and inhibit the production of cAMP by AC. On the 
contrary, A2A and A2B receptors are commonly coupled to Gs, which activates the cAMP/PKA pathway. 
Furthermore, activation of the PLC/IP3/calcium pathway has also been documented for A1 and A3 
receptors. In addition to the activation of the canonical G-protein-associated pathways, adenosine 
receptors have been shown to trigger the MAPK and PI3K/Akt/mTOR pathways. In the case extracellular 
ATP is not degraded by the ectoenzymatic machinery, ATP can activate purinergic P2X and P2Y 
receptors. Signaling through the P2X7 receptor has been shown to trigger the NLRP3-dependent 
production of inflammatory cytokines such as IL-1β and IL-18 (Allard et al. 2014).  
  
Adenosine receptors are abundant on the surface of many innate immune cell types, including 
neutrophils which express all four P1 receptors. Low concentration of adenosine enhances 
adhesion property of this cell subset, whereas higher levels of adenosine, mainly acting through 
A2A receptors, inhibit neutrophils recruitment to the endothelium probably by decreasing 
neutrophil integrin expression (Sullivan et al. 2004). Furthermore, the involvement of A2B 
receptors in regulating neutrophil transmigration is as well documented. Thus activation of A2B 
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on neutrophils diminishes the ability of these cells to transmigrate through endothelial 
membranes (Wakai et al. 2001).  
The pattern of adenosine receptor expression on DCs changes during their development. Indeed 
immature human myeloid DCs (mDC)s express dominantly A1 and A3 receptors, while mature 
mDCs predominantly express A2A receptors (Panther et al. 2001, Fossetta et al. 2003). 
Similarly, functional A1 receptors have been found expressed in human immature plasmacytoid 
DCs (pDCs). Upon pDCs maturation, the level of A1 receptor decreases and the expression of 
A2A receptor is instead robustly increased (Schnurr et al. 2004). Stimulation of A1 and A3 
adenosine receptors on immature DC cells promotes their migration to the site of infection or 
tissue injury. On the other hand, activation of A2A receptors on mature human DCs changes 
their cytokine expression profile, shifting toward an anti-inflammatory type, with reduced IL-
12, IL-6, IFN-α, and TNF-α release and enhanced IL-10 production (Panther et al. 2001, Panther 
et al. 2003, Schnurr et al. 2004). Furthermore adenosine receptors regulate many functions of 
adaptive immune cells. T cells for instance mainly express A2A receptor and studies in a knock 
out mouse model have shown a major inhibitory effect of A2A activation on IL-2 production 
and proliferation of CD4+ cells after TCR engagement (Naganuma et al. 2006, Sevigny et al. 
2007). A2A receptor activation also suppresses the synthesis of both Th1 and Th2 cytokines by 
naïve CD4+ (Lappas et al. 2005, Naganuma et al. 2006), as well as polarized Th1 and Th2 
lymphocytes (Csoka et al. 2008). As already mentioned Treg cells can produce adenosine and 
thereby regulate immune cell function. The first evidence that adenosine might be involved in 
Treg functions was derived from an in vivo experimental colitis study, where Tregs failed to 
control colitis by effector T cells that lacked the A2A receptor, suggesting that adenosine 
contributed to the anti-inflammatory effect conferred by Tregs (Naganuma et al. 2006). Tregs 
express A2A receptors and A2A receptor activation augments the level of FOXP3 transcription 
factor, which is a key Treginducing factor (Zarek et al. 2008). Additionally, FOXP3 upregulates 
CD39 expression thereby creating a positive feedback circle for amplifying adenosine signaling 
by Tregs (Borsellino et al. 2007). Altogether, these data strongly support the concept that 
adenosine is a crucial mediator of Treg responses.  
As already mentioned, human B cells store ATP in secretory vesicles which are released in the 
extracellular space upon BCR stimulation. ATP is further metabolized in a CD73-dependent 
mechanism generating adenosine, which in turn promotes class switch recombination (Schena et 
al. 2013). Schena et al pointed out for the first time a role of adenosine in activating instead of 
inhibiting the immune system.  
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Worthy of note, alternative pathways for extracellular adenosine generation have been described. 
This includes the production of adenosine from nicotinamide dinucleotide (NAD) instead of 
ATP, by the concerted action of CD38, CD203a and CD73 (Horenstein et al. 2013), and the 
CD73-independent production of adenosine by other phosphates such alkaline phosphatase or 
prostate-specific phosphatase (Street et al. 2013).   
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SUMMARY  
  
Microbial  colonization  of the gut induces the devel- 
opment of gut-associated lymphoid tissue (GALT). The 
molecular mechanisms that regulate GALT func- tion 
and result in gut-commensal  homeostasis are poorly 
defined. T follicular helper (Tfh) cells in Peyer’s patches 
(PPs) promote  high-affinity  IgA responses. Here we 
found that the ATP-gated ionotropic  P2X7 receptor  
controls  Tfh cell numbers in PPs. Lack of P2X7 in Tfh 
cells enhanced germinal center reactions and high-
affinity  IgA secretion and binding to com- mensals. The 
ensuing depletion of mucosal bacteria resulted in 
reduced systemic translocation of micro- bial 
components, lowering B1 cell stimulation and serum 
IgM concentrations.  Mice lacking  P2X7 had increased 
susceptibility to polymicrobial  sepsis, which was 
rescued by Tfh cell depletion or adminis- tration of 
purified IgM. Thus, regulation of Tfh cells by P2X7 
activity is important  for mucosal colonization, which in 
turn results in IgM serum concentrations necessary to 
protect the host from bacteremia.  
  
INTRODUCTION  
  
Host physiology and diet influence the development of the gut 
ecosystem (Muegge et al., 2011). Reciprocally, through interac- 
tions with the host, the gut microbiota influences physiology and 
disease susceptibility (Lozupone et al., 2012), a beneficial 
homeostatic relationship that is ensured by several layers of 
control, including mucus, antimicrobial factors, and innate and 
adaptive immunity (Henao-Mejia et al., 2012; Littman and Pamer, 
2011; Sun et al., 2007; Vaishnava et al., 2011).  
  
The gut microbiota promote the development of the gut- 
associated  lymphoid  tissue (GALT) (Macpherson  and Harris, 
2004), which is responsible for intestinal IgA production in 
response  to   microbial   stimulation   (Cerutti   and  Rescigno, 
2008; Craig and Cebra, 1971). In the Peyer’s patches (PPs) of 
the small intestine, T follicular helper (Tfh) cells support affinity 
maturation of B cells in germinal centers (GCs) (Crotty, 2011) and 
differentiation of B cells to IgA-secreting plasma cells, a process  
that  is critical  in maintaining intestinal homeostasis and efficient  
mucosal  defense (Wei  et al., 2011). Moreover, some evidence 
suggests that  affinity  maturation of  IgA can also affect systemic 
immunity. For example, it has been shown that recognition of 
luminal bacteria by secretory IgA prevents their access to the 
lamina propria and systemic proinflamma- tory stimulation by 
bacterial products (Johansen  et al., 1999; Macpherson and Uhr, 
2004; Sait et al., 2007), a result in agree- ment with the 
observation that IgA with reduced bacterial bind- ing capacity 
results in systemic hyperactivation of the immune system 
(Kawamoto et al., 2012).  
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Purinergic receptors in the plasma membranes of eukaryotic 
cells comprise ATP-gated ionotropic P2Xs (P2X1-7) and guanine 
nucleotide-binding protein (G protein)-coupled P2Ys (P2Y1, 2, 4, 
6, 11–14, which bind also ADP, UDP, UTP, or UDP-glucose) 
(Burnstock, 2007). ATP released during tissue damage acts as a 
danger-associated molecular pattern (DAMP) for cells of the 
innate immune system through stimulation of P2 receptors. 
P2rx7, which encodes the ATP-gated P2X7 receptor, is a signa- 
ture gene of effector T cell subsets (Choi et al., 2013; Gavin et 
al., 2007; Hale et al., 2013; Hill et al., 2008). We have previously 
shown that P2X7 activity regulates the immunosuppressive 
function of regulatory T (Treg) cells (Schenk et al., 2011), and 
persistent P2X7 stimulation by ATP results in pyroptosis-like cell 
death of Treg cells (Taylor et al., 2008). In fact, sustained P2X7 
activation leads to the formation of a pore permeable to 
molecules up to 900 Da.  
  
We found that P2rx7 is selectively and highly expressed in 
Tfh cells. Deletion of P2rx7 in Tfh cells resulted in resistance to 
cell death, enhanced GC reaction in PPs, increased IgA binding 
to commensals, and reduction of mucosal bacteria. Our results 
unravel P2X7 as a regulator of the adaptive IgA response in the 
small intestine to allow commensalism and systemic stimulation 
of the immune system.  
  
RESULTS  
  
Tfh Cell Numbers Are Increased in the PPs of 
P2rx7–/– Mice  
Histochemical  analysis of  the  intestine  from  P2rx7-/-   mice 
revealed enlarged PPs with increased cellularity as compared 
to wild-type (WT) mice (Figure 1A); ileal and colonic epithelium 
were otherwise histologically normal (Figure S1A available 
online). Flow cytometry  of cells from P2rx7-/-   PPs revealed an 
increase of Tfh cells identified by expression of the C-X-C 
chemokine  receptor  type  5  (CXCR5) (Fo¨ rster  et  al.,  1996), 
CD28 family member inducible T cell costimulator (ICOS) (Choi 
et al., 2011), the transcription factor B cell lymphoma 6 (Bcl6) 
(Nurieva et al., 2009; Yu et al., 2009), programmed cell death-
1 (PD1) (Haynes et al., 2007), and CD40L (Figure 1B). In 
addition to the increase in Tfh cell numbers, mean fluorescence 
intensities (MFIs) of ICOS and CD40L were increased in Tfh 
cells from P2rx7-/- mice (Figure 1C). Quantitative real-time PCR 
on various cell subsets purified from PPs of WT mice, namely 
CD19+ B cells, Fas+PNA+  GC B cells, CD3+CD4+  T cells, Treg 
cells, and Tfh cells, revealed highest expression of P2rx7 
transcripts in Tfh cells (Figure 1D). P2X7 was the only P2X 
receptor subtype expressed in PPs Tfh cells (Figure  1E). In 
fact, these cells showed the strongest response to stimulation 
with the P2X7 agonist 30 -O- (4-Benzoyl)benzoyl ATP (BzATP) 
(see below). In Tfh cells isolated from P2rx7-/- PPs, we observed 
higher expression of Bcl6 transcripts and concomitant reduction 
in transcripts encoding the Bcl6 antagonist Blimp1 (Figure 1F; 
Johnston et al., 2009). Expression of Bcl6 inhibits CD4 T cell 
polarization toward T help- er 1 (Th1) and Th17 phenotypes 
(Nurieva et al., 2009; Yu et al., 2009). Accordingly, the Th17-
cell-specific transcripts Rorc and Il17a and Th1-cell-specific 
transcripts Tbx21 and Ifng were all reduced in Tfh cells from 
P2rx7-/-  PPs (Figure 1F).  
The activity of the P2X7 receptor is influenced by a strain 
poly- morphism (P451L) in the cytoplasmic domain. Proline-
bearing BALB/c mice are more sensitive to P2X7 stimulation by 
ATP than leucine-bearing C57BL/6 mice (Adriouch et al., 2002). 
We observed a progressive increase in Tfh cells across 
BALB/c, C57BL/6, and finally P2rx7-/- mice, indicating that P2X7 
respon- siveness inversely correlates with Tfh cell number 
(Figure S1B). These observations suggest that P2X7 activity 
limits the abun- dance of Tfh cells in PPs.  
  
Expansion of Tfh Cells in PPs of P2rx7–/– Mice  Is Cell  
Intrinsic  
To rule out that other cell subsets contributed to the increase of 
Tfh cell numbers in PPs from P2rx7-/-  mice, we adoptively 
transferred either WT or P2rx7-/-  CD4 Foxp3EGFP   T cells into 
Cd3e-/-  mice. This model of transfer into lymphopenic mice has 
previously demonstrated selective conversion of FoxP3- 
expressing  cells  into  Tfh  cells  in  PPs  (Tsuji et  al.,  2009).  
    
Foxp3EGFP  cells from P2rx7-/-  mice did not differ from the WT 
counterpart in the expression of gut-homing receptors (CD103 and 
CCR9) (Annacker  et al., 2005; Zabel et al., 1999)  (data not 
shown). PPs from Cd3e-/-  mice adoptively transferred with Foxp3-
expressing P2rx7-/-  cells showed a prominent increase of Tfh cells 
(Figure  2A). To more directly address the role of P2X7 in Tfh cells, 
we competitively transferred Cd3e-/-  mice with Tfh cells purified 
from PPs of WT (CD45.1+) and P2rx7-/- (CD45.2+) mice at a 1:1 
ratio. After 1 month, more than 90% of the Tfh cells recovered from 
PPs of reconstituted mice originated from P2rx7-/-   mice, indicating 
that P2rx7 deletion conferred greatly enhanced reconstitution 
potential to Tfh cells (Figure 2B).  
To exclude the possibility that the expansion of Tfh cells in  
P2rx7-/-  mice was driven by inheritable differences in intestinal 
microbiota we analyzed Tfh cells in PPs from cohoused WT and 
P2rx7-/-  mice, which were either delivered through caesarian and 
cofostered (CoF) with CD1 adoptive mothers (Figure  2C) or cross-
fostered (CrF) with reciprocal WT and P2rx7-/- mothers  
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(Figure  2D) or cobred  (CoB) with WT and P2rx7-/-   mothers  
(Figure  2E). In all these breeding conditions,  P2rx7-/-   mice 
sacrificed at 8 weeks of age showed an increase in Tfh cell 
numbers.  Finally, reconstitution  of  cohoused  Cd3e-/-   mice with 
WT or P2rx7-/-  Foxp3-expressing T cells also showed the selective 
expansion of Tfh cell numbers in mice transferred with P2rx7-/-  
cells (Figure  2A). Taken together, these results demonstrate that 
expansion of Tfh cell numbers is T cell intrinsic  
and not secondary to inheritable dysbiosis in P2rx7-/-  mice.  
  
P2X7 Mediates Tfh Cell Death  
We analyzed PPs from WT and P2rx7-/- mice by terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL).  
This assay revealed the reduction of positive cells in P2rx7-/- mice 
(Figure 3A). Because P2X7-mediated cell death is charac- terized 
by phosphatidylserine (PS) exposure, we analyzed PP cells for 
Annexin V staining by flow cytometry; more than 20% of ex vivo 
Tfh cells were labeled by Annexin V in WT but not P2rx7-/- mice, 
whereas Annexin V staining in other PP cell subsets was 
consistently lower and indistinguishable between the two strains 
(Figure  3B). These results indicate that P2X7 expression 
correlates with selective Tfh cell death in PPs.  
In peripheral lymph nodes and spleen of nonimmunized animals, 
Tfh cells are virtually absent, and P2rx7-/-  mice did not show 
differences with respect to WT animals (Figure S2A). In contrast, 
Tfh cells could be detected in mesenteric lymph nodes (mLNs) 
because of constant antigenic challenge. As observed in PPs, 
significant increases in Annexin V+  Tfh cells were detected in 
mLNs from WT mice, suggesting that P2X7 also regulates Tfh cell 
representation in LNs (Figure S2B; Wilhelm et al., 2010). The 
increase in cell death of PP Tfh cells in WT mice was confirmed 
with VAD-FMK staining detecting acti- vated caspases and by 
increased expression of proapoptotic bik (Boyd et al., 1995) and 
bax (Oltvai et al., 1993) transcripts (Fig- ure S2C). An analogous 
result together with selective increase in Annexin V+ Tfh cells was 
obtained with converted WT but not P2rx7-/-  Tfh cells in adoptively 
transferred Cd3e-/-  mice (Fig- ure S2D), indicating the cell-
autonomous nature of P2X7-medi- ated Tfh cell death. This 
conclusion was further supported by the significant increase of 
Annexin V+ cells in Cd3e-/- mice recon- stituted with Tfh cells 
purified from PPs of WT mice (Figure S2E). 
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Figure 1. P2rx7–/–  Mice Have Increased Tfh Cell Numbers in the PP  
(A) Ileal PPs from 8-week-old mice (scale bars represent 100 mm); histograms show the number of total cells (mean ± SD, n = 5) recovered from PPs 
harvested from the entire small intestine.  
(B) Dot plot and statistical analyses of WT and P2rx7-/-  CD3+CD4+ PPs cells stained with ICOS, Bcl6, PD1, CD40L, and CXCR5 antibodies. 
Percentages are shown in each gate, histograms show mean percentages ± SD (n = 5).  
(C) Mean fluorescence intensity (MFI) of ICOS and CD40L on Tfh cells from WT or P2rx7-/-  quantified by flow cytometry.  
(D) Quantitative real-time PCR of P2rx7 transcripts in purified CD19+B220+, Fas+PNA+ GC B cells, CD19+ B cells, CD3+CD4+ T cells, CD3+CD4+CD25hi 
Treg cells, and CD3+CD4+CXCR5+ICOS+ Tfh cells from WT mice.  
(E) Quantitative real-time PCR of P2rx gene transcripts in purified CD3+CD4+CXCR5+ICOS+ Tfh cells from WT mice.  
(F) Quantitative real-time PCR of Bcl6, Prdm1, Tbx21, Ifng, Rorc, and Il17a transcripts in purified CD3+CD4+CXCR5+ICOS+ Tfh cells from WT or P2rx7-/- 
mice. Data are representative results of three independent experiments with at least five mice per experiment. *p < 0.05, **p < 0.01, and ***p < 0.001; ns, not 
significant. Error bars represent SD.  
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Analysis of permeability to DAPI upon stimulation with the 
P2X7 agonist BzATP showed that Tfh cells were the most sensi- 
tive subset to P2X7-mediated pore formation in PPs (Figure 3C).  
Time monitoring of PS exposure and DAPI uptake upon P2X7 
stimulation using the natural ligand ATP confirmed the lack of PS 
exposure and DAPI uptake in P2rx7-/-  Tfh cells (Figure 3D).  
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Figure 2. Expansion  of Tfh Cell Numbers  in  
  
 -/-
 the PPs of P2rx7–/–  Mice Is Cell Autonomous  
(A) Dot  plot  and  statistical   analyses  of  PPs cells 
from Cd3e-/-   mice reconstituted  with WT  
-/- or P2rx7-/-  Foxp3EGFP   cells. In two  independent 
experiments,   cohoused   Cd3e- /- mice   were analyzed 
4 weeks after the reconstitution and are
 
shown as 
superimposed blue and red results for mice 
reconstituted with WT or P2rx7-/- Foxp3EGFP cells, 
respectively.  
(B) Dot plot and statistical analyses of PPs cells 
from Cd3e-/- mice reconstituted with purified WT 
(CD45.1) and P2rx7-/-  (CD45.2) Tfh cells at 1:1 ratio. 
Cells were gated for surface CD4 and CD3, and 
ICOS+CXCR5+ cells were analyzed for CD45.1 and  
CD45.2  to  score  WT  and  P2rx7- /- cells (left dot plot). 
Middle panels show staining with  
CXCR5 and ICOS antibodies on gated WT and P2rx7-
/-  CD4 cells. Histograms on the right show statistics for 
percentage and absolute cell number of WT and P2rx7-
/-  Tfh cells recovered from PPs of reconstituted Cd3e-/-  
mice (n = 3).  
(C–E) Flow cytometry of PPs CD3+CD4+ T cells
 
stained 
with CXCR5 and ICOS antibodies; cells were 
recovered from cohoused WT and P2rx7-/- mice. Before 
cohousing, mice were delivered through caesarean 
and cofostered with CD1 adoptive mothers (C), cross-
fostered  with recip- rocal WT and P2rx7-/- mothers and 
cohoused for 4 weeks (D), or cobred  with  WT and 
P2rx7-/- mothers and cohoused for 4 weeks (E).  
Data are representative results of six (A), two (B), and  
three  (C–E) independent  experiments  with three to 
five mice per experiment. ***p < 0.001. Error bars 
represent SD.  
P2X7 in Tfh Cells Limits GC  
Reaction in PPs  
The increase of Tfh cells in P2rx7-/- mice 
correlated with an enhanced GC reaction in the PPs (Figure  4A); the increase in  
Analogous sensitivity to ATP stimulation was observed in Tfh 
cells from WT but not P2rx7-/-  mLNs (Figure S2F), indicating that 
Tfh cells are exquisitely sensitive to P2X7-mediated cell death 
by extracellular ATP.  
Importantly, extracellular ATP-mediated Tfh cell death via 
P2X7 does not affect Tfh cells actively responding to cognate 
antigen stimulation. Indeed, p2rx7 transcription in Tfh cells was 
robustly downregulated by CD3 and CD28 stimulation and Tfh 
cells became resistant to P2X7-mediated DAPI permeability 
(Figure 3E). Further, we generated antigen-specific Tfh cells by 
feeding TCR transgenic OT-II mice (recognizing OVA peptide 
323-339) with  OVA. After  7  days  we  analyzed the  amount of 
P2rx7 transcripts in ex vivo sorted OT-II Tfh cells from PPs as 
well as in OT-II Tfh cells sorted after in vitro stimulation for 16 hr 
with dendritic cells pulsed with OVA peptide. This analysis 
revealed the robust P2rx7 downregulation in antigen-stimulated 
cells (Figure 3F), thereby supporting the notion that acute TCR 
stimulation spares Tfh cells from death via P2X7. 
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Fas+PNA+   GC B  cells  was  associated with   increased   
expression   of   Aicda  
mRNA encoding activation-induced  cytidine deaminase (AID), 
which controls Ig somatic hypermutation (SHM) and class switch 
recombination (CSR) (Figure 4B; Muramatsu et al., 2000). In vitro 
stimulation of both T and B cells results in extracellular ATP 
release (Schena et al., 2013; Schenk et al., 2008). To see whether 
P2X7 activation affected Tfh cell activity in vitro, WT IgM+ B cells 
were cocultured with either WT or P2rx7-/-  Tfh cells isolated from 
PPs; when P2rx7-/-  Tfh cells were present in the culture, there was 
increased Ig CSR to IgA with more abundant IgA secretion, 
suggesting that lack of P2X7 results in enhanced B cell helper 
function (Figure 4H). The number of IgA-secreting B cells 
measured by ELISPOT was significantly increased in the small 
but  not large intestine lamina propria  of P2rx7-/- mice, consistent 
with increased Tfh cell activity in vivo (Fig- ure 4C). Accordingly, 
fecal IgA concentrations in P2rx7-/-  mice were elevated, whereas 
IgM were reduced  (Figure  4D). The same phenotype was 
observed in Cd3e-/-  mice reconstituted with  P2rx7-/-   Foxp3+   T 
cells, indicating  the dependence  of 
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(A) Representative TUNEL assay on ileal PPs from WT and P2rx7-/-  mice (scale bars represent 100 mm); white numbers represent TUNEL-positive cells.  
(B) Annexin V staining and corresponding statistical analysis of freshly isolated WT and P2rx7-/-  PP cell subsets gated as indicated (n = 5).  
(C) Time monitoring of electronically gated PPs cell subsets for DAPI uptake after stimulation with Bz-ATP (75 mM).  
(D) Time monitoring of electronically gated PPs WT or P2rx7-/-  Tfh cells for DAPI uptake and PS exposure after stimulation with the indicated doses of ATP. (E) 
Real-time PCR of P2rx7 transcripts in Tfh cells either unstimulated or stimulated for 16 hr with anti-CD3 and CD28 mAbs; Bz-ATP responsiveness measured 
by time-monitoring of DAPI staining in the same cells.  
(F) Real-time PCR of P2rx7 transcripts in OT-II Tfh cells either unstimulated or stimulated for 16 hr with OVA peptide-pulsed dendritic cells. Data 
are representative results of three to six independent experiments. ***p < 0.001; ns, not significant. Error bars represent SD.  
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 Figure   4. P2X7  Deficiency  in   Tfh   Cells  
Leads   to   Enhanced   GC  Reactions    and  
IgA Response  
  
( A) Representative dot plots and statistical analysis of 
Fas+PNA+ GC B cells.  
(B) Real-time PCR of Aicda in purified CD19+ cells 
(n = 5).  
(C) IgA-secreting plasma cells in lamina propria of 
small (SI) or large (LI)  intestine quantified by ELISPOT 
(n = 3).  
(D) Fecal IgA (n = 10) and IgM (n = 5) 
concentrations  
 in WT and P2rx7-/-  mice.  
 (E–G) Representative  dot  plots  and  statistical 
analysis of Fas+PNA+ GC B cells (E), real-time PCR  
  of Aicda in purified 
CD19 + cells (n = 5) (F), and fecal  
 IgA concentrations (n = 6) (G) in Cd3e-/-   mice  
either nonreconstituted or reconstituted with WT  
 or P2rx7-/-  Foxp3EGFP  cells.  
 (H) Absorbance values in ELISA-detecting IgA in  
the supernatants of B cells cocultured with WT or  
 P2rx7-/-  Tfh cells purified from PPs.  
 Data are representative results of at least two  
independent experiments. *p < 0.05, **p < 0.01, and 
***p < 0.001; ns, not significant. Error bars represent 
SD.  
  
  
  
Wild-type  Tfr cells were more resistant to cell death than Tfh cells, as determined  
by  cell  labeling  with  Annexin  V  (Fig-  
 ure S3C). Interestingly, in Tfr cells we  
Immunity  
P2X7 as Regulator of Tfh Cells  
  
  
  
 Immunity 41, 789–801, November 20, 2014 ª2014 Elsevier Inc.   799  
 
observed  increased surface expression of  the plasma membrane ectonucleoti- dase CD39 (that degrades ATP to ADP/ AMP) with 
respect to Tfh cells, likely reducing P2X7 sensitivity to extracellular ATP (Figure S3D). These observations suggest that P2xr7 
deletion does not influence Tfr cells. In mice reconstituted with  Foxp3+   cells,  we  observed  more  
-/- than 90%  conversion of P2rx7-/-   Treg to Tfh cells in PPs. P2rx7-/-   Treg cells  
converted to Tfh cells more efficiently  
 
than  WT Treg cells  (Figure  S3E), sug- gesting that lack of P2X7 results in  
 
skewing and/or expansion of Tfh but not  
Tfr cells.  Finally, transfer  into  Cd3e-/- mice of CD4 +CXCR5  +ICOS  + cells, com-  
1/1 1/2 1/4 prising both Tfh and Tfr cells, resulted in  
the observed phenotype on P2rx7 deletion in Tfh cells (Figures 
4E–4G).  
Follicular regulatory (CD4+CXCR5+ICOS+Foxp3+) T (Tfr) 
cells play a crucial role in GC responses by limiting Tfh and GC 
B cell numbers as well as plasma cells differentiation (Chung et 
al., 2011; Linterman et al., 2011; Wollenberg et al., 2011). 
Because P2rx7 is expressed in Tfr cells (Figure S3A), P2rx7 
dele- tion might result in increasing Tfr cells in PPs. However, 
similar Tfr cell numbers were found in WT and P2rx7-/-  mice, 
while the percentage was reduced in p2rx7-/-   mice (Figure  
S3B). the  recovery  of  mostly  CD4+CXCR5+ ICOS+Foxp3- Tfh 
cells after 4 weeks (Fig-  
ure S3F), indicating that lack of P2X7 does not result in Tfr cell 
expansion.  
  
P2X7 Signaling Regulates Human Tfh Cells  
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TUNEL-positive cells were observed in the T cell area of human 
PPs (Figure 5A) as well as selective PS exposure by FACS in Tfh 
cells from PPs of three healthy subjects (Figure  5B). On-line 
monitoring of Annexin V staining and DAPI permeability of PP cells  
exposed  to  ATP revealed an increase in  Tfh but  not other PP 
cells (Figure 5C). Indeed, naive B cells do not express detectable 
amounts of P2rx7 (Figure 5E), and P2rx7 transcripts were not 
detected  in plasma blasts (PBs), GC, and memory (ME) B cells 
by real-time PCR (Figure 5D). These observations suggest that 
luminal ATP can also modulate Tfh cell function in the human small 
intestine. To address the role of P2X7 in regu- lating B cell help by 
Tfh cells, an in vitro assay of Ig CSR was per- formed in the 
presence of a selective P2X7 pharmacological antagonist 
(A438079). Naive B cells isolated from peripheral blood as 
CD19+Lin-CD27-IgG-IgA- cells predominantly ex- press P2rx5 and 
to a lesser extent P2rx1 and P2rx4 (Figure 5E), and therefore they 
were not directly influenced by the drug. Coculturing of naive B 
cells with Tfh cells isolated from peripheral blood as 
CD4+CXCR5+CD45RA-  cells (Morita et al., 2011) re- sulted in 
substantial Ig CSR to IgG. Notably, inhibition of P2X7 by A438079 
resulted in an increase of IgG concentration in the culture medium 
  
 - 
 Figure 5. Purinergic Regulation  of Tfh Cells  
 + Is Conserved  in Humans  
(A) Representative TUNEL assay on ileal PPs 
from a healthy subject.  
(B) Cell suspensions from human PPs were 
stained with  CD3, CD4, CXCR5, and ICOS antibodies. A 
representative staining with Annexin V of  
CD3+CD4+ICOS-CXCR5- (X5-ICOS-) and Tfh  
(X5+ICOS+) cells is shown. Bars on the right show 
statistical analysis of Annexin V staining for three  
    subjects.  
(C) Fold increase of Annexin V+ cells and DAPI MFI  
in the indicated cell subsets recovered from PPs of 
healthy subject upon stimulation with 3 mM ATP.  
  
cell subsets and real-time PCR of P2rx7 transcripts in 
germinal center B cells (GC), plasmablasts (PB), 
memory B (ME), and Tfh cells purified in flow cy- 
tometry from ileal PPs of healthy subjects. (E) Real-
time PCR of P2rx7 transcripts  in naive B  cells  sorted  
as  CD19+IgM+IgD+CD27-    from
 
blood of three healthy 
donors.  
(F) Quantification of IgG by ELISA in the superna- 
tants of blood naive B cells cultured with purified 
memory CXCR5+CD45RA-CD4+  T cells in pres- ence 
of P2X7 antagonist (A438079).  
Results  are  means  ±  SD  of  five  independent 
experiments with cells from five different healthy 
donors. *p < 0.05. Error bars represent SD.  
  
  
2004; Peterson et al., 2007). Low-affinity 
T-cell-independent IgA is sufficient for 
controlling benign commensal bacteria. 
Conversely, T-cell-dependent affinity- 
matured IgA responses are critical for 
efficient mucosal defense and contain-  
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(Figure  5F), suggesting that P2X7 activity  is also important for 
regulating human Tfh cells.  
  
P2rx7–/– Mice  Have Enhanced High-Affinity IgA  
Responses and Reduced Mucosal Colonization  
Mucosal IgA inhibits intestinal bacteria from penetrating the 
epithelial cell layer (Burns  et al., 1996; Macpherson and Uhr, 
bacteria  (SFB), which  tightly  adhere to  
epithelial cells in the terminal ileum (Ivanov et al., 2009; Suzuki 
et al., 2004). High-throughput sequencing of Ig VH regions in B 
cells isolated  from  PPs revealed minor differences between WT 
and P2rx7-/-  mice in the distribution of the VH  repertoire of IgA 
(Figure  6A). However, an increase in the frequency of 
replacement  (R) mutations  (i.e., encoding  a  different  amino 
acid) in VH1   family’s  CDR2 was detected  in P2rx7-/-   mice, 
suggesting  enhanced  affinity  maturation  of  IgA  responses 
(Figure 6B). Analysis in flow cytometry of IgA-coated bacteria 
from the small intestine revealed the increase of IgA-coated cells 
in P2rx7-/-  mice. Conversely, bacteria coated by IgG3, a T-cell-
independent  Ig subclass present in the small intestine and 
specific for bacterial polysaccharides (McLay et al., 2002), were 
the same for both strains (Figure  6C). Inspection of the ileum 
from WT and P2rx7-/-  mice by scanning electron micro- scopy 
(SEM) revealed the striking reduction of mucosal coloniza- tion  
by  SFB in P2rx7-/-   mice  (Figure  6D). To demonstrate enhanced 
high-affinity IgA responses in P2rx7-/- mice, we gav- aged mice 
with E. coli and analyzed the specific IgA response. In fact, the 
E. coli-specific IgA response is fully dependent on PPs (Le´ 
cuyer et al., 2014). Total IgA concentration in intestinal washes 
was quantified  by  ELISA. Undiluted  aliquots  of  the  
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Figure 6. P2X7 Deficiency Leads to Enhanced IgA Affinity  and Depletion  of Mucosal  Commensals  
(A and B) VH family distribution in five mice per genotype (A) and frequency of R mutations in IgVH1 family CDR2 (B) in IgA-expressing CD19+ B cells isolated 
from PPs of WT and P2rx7-/-  mice.  
(C) Representative dot plots and percentages of IgA (n = 6)- and IgG3 (n = 6)-coated bacteria from the small intestine of WT and P2rx7-/-  mice as determined 
by flow cytometry.  
(D) SEM of the terminal ileum from WT and P2rx7-/-  mice. Inset in WT image shows SFBs in more detail.  
(E) Quantification by flow cytometry of E. coli-specific IgA in intestinal lavages from WT and P2rx7-/-  mice gavaged with E. coli.  
(F) Statistical analysis of colony forming units (CFU) of aerobic and anaerobic bacteria recovered from the SI of WT and P2rx7-/-  mice (n = 10).  
(G) Quantitative real-time PCR of ileal adherent bacteria in WT and P2rx7-/-  mice expressed as prokaryotic/eukaryotic DNA ratio (n = 5). Data are from one 
experiment (A and B) or at least two independent experiments. *p < 0.05, **p < 0.01. Error bars represent SD.  
  
  
  
  
same samples were used to stain E. coli for FACS analysis. Mean 
fluorescence intensities of E. coli-specific  IgA plotted against IgA 
concentrations revealed an increase of E. coli-specific IgA in 
P2rx7-/- mice, thereby indicating that PP-dependent IgA response 
was enhanced (Figure 6E). Taxonomic analysis of total gut 
microbiota in WT and P2rx7-/-  mice did not reveal differ- ences in 
the representation of bacterial families (Figure  S4A).  
However, bacterial cultures from small intestine of P2rx7-/- mice 
showed a decrease of both aerobic and anaerobic species 
(Figure  6F). Finally, after removal of fecal pellet, we isolated 
whole  ileal mucosa  comprising  epithelium  and  mucus  (Fig- 
ure S4B) to  quantify  adherent bacteria  per  tissue  mass by real-
time PCR. In P2rx7-/-  mice we could detect a decreased 
prokaryotic to eukaryotic DNA ratio (Figure 6G), indicating that 
P2X7 in Tfh cells is important in dampening high-affinity IgA 
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responses in the small intestine and that P2rx7 deletion results in 
an enhanced clearance of mucosal commensals in the small 
intestine.  
  
P2rx7–/– Mice  Have Reduced Serum  IgM and 
Are Susceptible to Sepsis  
Sensing of commensals profoundly shapes host immune system  
(Hand et al., 2012; Hooper et al., 2012). In P2rx7-/-  mice, reduced 
IgM serum concentrations were observed in compari- son with 
WT animals (Figure 7A). In WT mice, long-term dosing of 
antibiotics  resulted in reduction  of serum IgM, consistent with a 
requirement for mucosal colonization in maintaining serum IgM at 
physiological concentrations (Figure 7A). It was recently found 
that lack of IgA negatively correlates with serum lipopoly- 
saccharide (LPS) concentrations (Shulzhenko et al., 2011). 
Hyper-IgA in P2rx7-/-  mice was associated with reduced con- 
centrations of serum LPS (Figure 7B). In addition, a single low- 
dose (20 mg) intraperitoneal injection of LPS induced a significant 
increase in serological IgM in P2rx7-/-  mice (Figure 7C), sug- 
gesting that reduced mucosal colonization and consequently less 
translocation of bacterial components results in reduced B cell 
stimulation and IgM secretion.  
Because deletion of  Icos results in a lack of  Tfh cells in both  
P2X7-proficient  and  P2X7-deficient  mice  (Figure  S5A), we 
used Icos-/-  and double mutant Icos-/-P2rx7-/-  mice to address the 
role of P2X7 in Tfh cells for conditioning  serum IgM 
concentrations through the regulation of mucosal IgA. By 
comparing the ratio of P2rx7-/- to P2rx7+/+  fecal IgA and serum 
IgM in ICOS-proficient and ICOS-deficient mice, we found that 
Icos deletion restored the balance between fecal IgA and serum  
IgM in P2rx7-/-  mice (Figure  7D). These results suggest that Tfh 
cells are responsible for the elevated fecal IgA and reduced 
serum IgM characteristic of P2rx7-/-  mice.  
Evaluation of  IgM-secreting  cells  (ISCs) in  the  spleen by  
ELISPOT assay revealed the  decrease  of  ISCs in P2rx7-/- mice 
with respect to their WT counterpart. ISCs reduction in  
P2rx7-/-  mice was Tfh cell dependent since it was restored by Icos 
deletion (Figure S5B). Further investigation of the spleens of  
P2rx7-/-   mice  revealed that  follicular and marginal zone B cells 
were not able to spontaneously secrete IgM (data not shown) 
whereas B1 cells did and were responsive to stimulation by 
commensals components. In fact, IgM secretion by these cells  
was  reduced  in  germ-free  mice  and  was  restored  in P2rx7-/-  
mice by LPS injection (Figures 7E and 7F).  
Serum from P2rx7-/- mice (1:4 dilution) showed reduced IgM 
binding to antigens from cecal commensals compared to serum 
from WT mice (Figure 7G) as well as impaired ability to inhibit 
cecal bacteria growth in vitro (Figure 7H). Notably, this serolog- 
ical defect of P2rx7-/- mice was restored by addition of purified IgM 
from the sera of WT mice (Figure 7H), suggesting that 
translocation of bacterial antigens from the small intestine results 
in the priming of B cells to secrete IgM able to inhibit bacterial 
growth and that this priming is significantly defective in P2rx7-/-  
mice.  
It is known that IgM constitutes a first line of defense against 
blood-borne microbial infection (Boes et al., 1998), and thus the 
reduced concentrations of IgM in P2rx7-/-  mice should make them 
more susceptible to polymicrobial sepsis. To test this hy- 
pothesis, a sublethal terminal cecal ligation and puncture (CLP) 
was performed. This model has been shown to closely resemble 
human sepsis (Hubbard et al., 2005; Rittirsch et al., 2009). 
Strikingly, P2rx7-/- mice displayed severe symptoms in the first 
hours after surgery and most succumbed within 48 hr (Figures 7I 
and 7L). Although blood from WT mice was always sterile, both 
aerobic and anaerobic bacteria could be easily cultured from 
blood of P2rx7-/-  mice (Figure S5C). The same morbidity was 
observed by CLP in cohoused WT and P2rx7-/-  mice, suggest- ing 
that lack of P2X7 results in the depletion of ‘‘protective’’ com- 
mensals (Figure  S5D). Notably, P2rx7-/-   mice surviving CLP 
showed an increase of serological IgM concentrations relative to 
WT mice, indicating that P2rx7-/- B cells were not intrinsically 
defective in differentiating to ISCs upon stimulation by bacterial 
antigens (Figure  7M). Prophylactic intravenous affinity-purified  
IgM from WT mice was administered to P2rx7-/-  mice before CLP. 
IgM-treated  mice were indistinguishable from WT mice and 
showed comparable survival rates (Figures 7I and 7L), impli- 
cating reduced IgM as cause of mortality by polymicrobial sepsis 
in P2rx7-/- mice. Of note, infection with Listeria monocytogenes, in 
which adaptive immunity is dispensable for containing infection at 
early time points (Pamer, 2004), did not result in differences for 
morbidity and bacterial recovery between WT and P2rx7-/- mice 
(Figures  S5E and S5F). To show the causative role of P2rx7-/-  
Tfh cells in bacterial sepsis after sublethal CLP, the same 
experiment was repeated in P2rx7-/-Icos-/-  mice. Strik- ingly, these 
mice were fully resistant to sublethal CLP, analo- gously to Icos-/-  
animals (Figure S7N). These results indicate that enhanced 
adaptive mucosal response in P2rx7-/- mice attenuates systemic 
sensing and basal IgM response to com- mensals, thus exposing 
the organism to possible fatal sepsis.  
  
DISCUSSION  
  
The regulated release of ATP influences eukaryotic cell function 
through ubiquitously expressed purinergic P2 receptors (Burn- 
stock, 2007). The high concentration of ATP inside cells and its 
virtual absence extracellularly in healthy tissues renders ATP also 
an ideal harbinger of cell death; in fact, ATP is sensed as a DAMP 
by cells of the innate immune system. P2rx7 has been recently 
shown to be a signature gene of Tfh cells (Choi et al., 2013; Iyer 
et al., 2013), but its function in this cell subset has not been 
addressed so far. Interestingly, extracellular ATP con- centrations 
active on P2X7 are present during an alloreactive response and 
at site of immunization with complete Freund’s  
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Figure 7. P2X7 Deficiency Is Associated with Reduced IgM-Secreting B1 Cells and Susceptibility to Polymicrobial Sepsis  
(A) ELISA quantification of serum IgM in WT and P2rx7-/-  mice treated either with PBS (-) or VAM (+) (n = 3).  
(B) Serum LPS concentrations in WT and P2rx7-/-  mice as determined by Limulus amebocyte lysate (LAL) assay.  
(C) ELISA quantification of serum IgM concentrations in WT and P2rx7-/-  mice treated either with PBS or LPS.  
(D) Ratio of P2rx7-/-  to P2rx7+/+  fecal IgA (n = 10) and serum IgM (n = 6) in Icos+/+  (left) and Icos-/-  (right) backgrounds.  
(E) Representative picture and mean percentages of IgM-secreting cells by ELISPOT in purified splenic B1 cells from WT, germ-free (GF), and P2rx7-/-  
mice (WT, 20 mice pooled in group of 5; GF, 10 mice pooled in group of 5; P2rx7-/-, 15 mice pooled in group of 5).  
(F) Representative picture and mean percentages of IgM-secreting cells by ELISPOT in purified splenic B1 cells from WT, P2rx7-/-, and P2rx7-/- mice 
treated with intraperitoneal injection of LPS (WT, 10 mice pooled in group of 5; p2rx7-/-, 10 mice pooled in group of 5; p2rx7-/- treated with LPS, 10 mice pooled 
in group of 5).  
(G) Absorbance in ELISA of antimicrobiota serum IgM in WT and P2rx7-/-  mice (n = 5).  
(H) CFUs in cecal cultures from WT and P2rx7-/-  mice with addition of PBS or autologous serum and IgM from WT mice (serum + IgM) (n = 5). (I and J) 
Clinical score (I) and survival rate (J) of WT, P2rx7-/-, and P2rx7-/-  mice treated with IgM purified from WT mice, upon sublethal CLP.  
(K) Seru  IgM concentrations by ELISA in surviving WT and P2rx7-/-  mice before and 1 week after CLP.  
(L) Survival rates of Icos-/-  and P2rx7-/-Icos-/-  mice upon sublethal CLP.  
Data are representative results of two to five independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars represent SD.  
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adjuvant (Wilhelm et al., 2010), suggesting that signaling 
through the ATP-P2X7 axis can regulate Tfh cell response in 
secondary lymphoid organs.  
Tfh-cell-dependent high-affinity IgA is critical in maintaining 
intestinal  homeostasis  and  efficient   mucosal   defense  by 
limiting translocation of potentially invasive bacteria from the gut 
lumen into the organism (Wei  et al., 2011; Shroff et al., 1995).  
Conversely,  microbiota-independent   (‘‘natural’’)   and T-cell-
independent (‘‘primitive’’) IgA are sufficient for controlling 
benign commensal bacteria by promoting their exclusion from 
the mucus layer (Slack et al., 2012). In an elegant study, Hapfel- 
meier et al. (2010) have shown that mucosal IgA response in 
the gut is adapted to actual commensals. In Tfh cells, P2rx7 is 
robustly downregulated by acute TCR stimulation, thereby 
sparing actively responding cells from death via P2X7. The 
sensi- tivity of non-actively stimulated Tfh cells to ATP as a 
metabolite associated with mucosal colonization might underlie 
IgA attrition in the gut and allow adapting IgA response to 
predominant taxa at any given time. Probably this mechanism 
contributes also to the complexity of developing vaccines that 
effectively protect the  host  against  intestinal  mucosal  
infections  (Slack  et  al., 2012). Notably, oral immunization of 
P2rx7-/-  mice with E. coli resulted in dramatically enhanced IgA 
response with respect to WT mice. Because Tfh cell death by 
extracellular ATP was observed also in human PPs, 
pharmacological ATP antagonism might constitute a strategy to 
limit Tfh cells death and promote long-lasting mucosal IgA 
responses.  
Lack of the inhibitory coreceptor PD1 was recently shown to 
result in expanded Tfh cells in PPs. However, the increased help 
by PD1-deficient cells interfered with selection of the IgA 
repertoire and IgA responses were not specific for commensals 
(Kawamoto  et al., 2012). In contrast,  Tfh cells expansion by 
P2rx7 deletion resulted in enhanced IgA responses to commen- 
sals and to gavaged E. coli. Further, P2rx7-/-   mice showed 
increased IgA SHMs and reduced mucosal colonization, indi- 
cating enhanced antigen-specific Tfh cell help and the fact that 
P2X7 activity contributes to mucosal commensalism by limiting 
follicular T cell help.  
Commensal-derived signals shape a number of systemic 
immune responses (Clarke et al., 2010; Hill et al., 2012; Macpher- 
son and Harris, 2004; Noverr and Huffnagle, 2004). Secretory IgA 
limit access of antigens from the microbiota to the organism 
(Johansen et al., 1999; Macpherson and Uhr, 2004; Sait et al., 
2007; Shulzhenko et al., 2011) and increased IgA are likely 
responsible of reduced stimulation of B1 cells as well as serum 
IgM concentrations in P2rx7-/-  mice. IgM plays a crucial role in 
protecting the organism against blood microbial infection (Boes 
et al., 1998) and contrast lethal dissemination of commen- sals 
(Kirkland  et al., 2012). Sepsis is a major health problem 
(Hotchkiss and Karl, 2003); in hospitalized patients, antibiotic- 
induced changes in the intestinal microbiota can enable bacteria 
to invade the bloodstream (Ubeda  et al., 2010). Hypo-IgM in 
P2rx7-/-  mice increases the risk of polymicrobial sepsis and death 
by otherwise sublethal CLP, an experimental model that closely 
resembles the human disease (Hubbard et al., 2005; Rittirsch et 
al., 2009). These results point to P2rx7 in Tfh cells as a master 
regulator of host-microbiota mutualism. Finally, elevated ATP in 
the intestine, as may occur  during invasion of the microbiota by 
intestinal pathogens or damage to the epithelium by pathogens, 
toxins, or injected chemicals, might modify the balance of immune 
responses toward a more potent innate response. Production of 
metabolically ‘‘expensive’’ and risky adaptive immunity can then 
be limited to persistent micro- organisms that cannot be cleared 
by innate immunity alone.  
  
EXPERIMENTAL PROCEDURES  
Mice  and In Vivo Experiments  
All animal experiments were performed in accordance with the Swiss Federal 
Veterinary Office guidelines and authorized by the Animal Studies Committee 
of Cantonal Veterinary. Mice were on a C57BL/6 genetic background. C57BL/ 
6J, P2rx7-/-  (B6.129P2-P2rx7tm1Gab/J),  ‘‘Foxp3EGFP’’ (B6.Cg-Foxp3tm2Tch/J),  
Icos-/-, and Cd3e-/-  mice were bred in specific-pathogen-free (spf) facility at 
Institute for Research in Biomedicine Switzerland. C57BL/6J germ-free mice 
were maintained in flexible film isolators at the Clean Animal Facility, University 
of Bern, Switzerland. For sublethal CLP, the cecum was ligated at 10 mm from 
the distal pole. Cecal puncture (‘‘through-and-through’’) in a mesenteric to 
antimesenteric direction was carried out after ligation with a 20G needle. Body 
temperature and clinical score were measured every 3 hr.  
Cohousing experiments were performed as follows.  
For caesarean delivery and fostering by CD1 adoptive mothers (CoF), WT 
and P2rx7-/-  mice were delivered by caesarean section on gestation day 18.5, 
fed by CD1 adoptive mother, weaned at 4 weeks, cohoused, and sacri- ficed at 
8 weeks of age. For cross-fostering with reciprocal WT and P2rx7-/- mothers 
(CrF), WT mice were fed by P2rx7-/- mother and P2rx7-/- newborns were fed by 
WT mother. Cubs were weaned at 4 weeks, cohoused, and sacri- ficed at 8 
weeks of age. For cobreeding with WT and P2rx7-/- mothers (CoB), WT and 
P2rx7-/-  newborns were bred together and fed by both WT and P2rx7-/-  mothers 
in the same cage (up to ten cubs with two mothers). Mice were weaned at 4 
weeks of age, cohoused, and sacrificed at 8 weeks of age.  
  
Isolation of Human PPs and In Vitro  Tfh-Cell-Dependent B Cell Help Peyer’s 
patches were obtained during endoscopy from the terminal ileum of young 
adults presenting with chronic abdominal pain and in which subsequent 
examinations excluded the presence of organic diseases of the bowel. All 
patients were otherwise healthy and not taking medications. Peyer’s patches 
were identified at endoscopy as small nodules covered by normal mucosa. For 
CD4 T-B cell coculture, naive B cells were cocultured with sorted CD4+  
T cells in the presence of endotoxin-reduced SEB. P2X7 selective antagonist 
A 438079 hydrochloride (Tocris) was added at a final concentration of 10 nM 
in the coculture. After 9 days of culture, supernatants were collected and IgG 
content was measured by ELISA.  
  
Statistical Analyses  
Student’s paired t test was used to determine the significance of differences 
between mean values. In flow cytometry analyses, mean values ± SD of at least 
five mice from the same experiment are shown and are representative of at 
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least three independent experiments. Values of p < 0.05 were considered 
significant.  
  
ACCESSION NUMBERS  
  
The Sequence Read Archive (SRA) accession number for the Ig VH  region 
sequences reported in this paper is SRP049293.  
  
SUPPLEMENTAL INFORMATION  
  
Supplemental Information includes five figures and Supplemental Experi- mental 
Procedures and can be found with this article online at http://dx.doi.  
org/10.1016/j.immuni.2014.10.010.  
  
AUTHOR CONTRIBUTIONS  
  
F.G., M.P., and E.T. designed experiments. M.P. and V.C. performed most ex- 
periments. T.R.J., A.R., C.E.F., L.P., R.R., S.P., and E.T. performed experi- 
ments. E.R. contributed  histolochemical analysis. F.C. contributed  human 
samples. B.B. contributed bioinformatic analysis of IgA sequencing data. M.T., 
K.D.M., E.S., and E.T. contributed reagents and intellectual input. F.G.  
and M.P. analyzed data and wrote the paper.  
  
ACKNOWLEDGMENTS  
  
We thank D. Jarrossay and E. Montani (Institute for Research in Biomedicine) 
for cell sorting and help with confocal microscopy, M. Francolini (Fondazione 
Filarete, Milan, Italy) for SEM, and J. Hastewell (Novartis Institute for Biomed- 
ical Research, Cambridge, MA) for comments on the manuscript. The work was 
supported by grant 310030-140963 and Sinergia CRSII2-127547 of the Swiss 
National Science Foundation, grant 2012-0519 of Fondazione Cariplo, Nano-
Tera project 20NA21-128841, Fondazione Ticinese per la Ricerca sul Cancro, 
Fondazione per la Ricerca sulla Trasfusione e sui Trapianti, and Converge 
Biotech.  
  
Received: June 20, 2014  
Accepted: October 3, 2014  
Published: November 13, 2014  
  
  
REFERENCES  
  
Adriouch, S., Dox, C., Welge, V., Seman, M., Koch-Nolte, F., and Haag, F. 
(2002). Cutting edge: a natural P451L mutation in the cytoplasmic domain im- 
pairs the function of the mouse P2X7 receptor. J. Immunol. 169, 4108–4112.  
Annacker, O., Coombes, J.L., Malmstrom, V., Uhlig, H.H., Bourne, T., 
Johansson-Lindbom, B., Agace, W.W., Parker, C.M., and Powrie, F. (2005). 
Essential role for CD103 in the T cell-mediated regulation of experimental 
colitis. J. Exp. Med. 202, 1051–1061.  
Boes, M., Prodeus, A.P., Schmidt, T., Carroll, M.C., and Chen, J. (1998). A 
critical role of natural immunoglobulin M in immediate defense against sys- 
temic bacterial infection. J. Exp. Med. 188, 2381–2386.  
Boyd, J.M., Gallo, G.J., Elangovan, B., Houghton, A.B., Malstrom, S., Avery, 
B.J., Ebb, R.G., Subramanian, T., Chittenden, T., Lutz, R.J., et al. (1995). Bik, 
a novel death-inducing  protein shares a distinct sequence motif with Bcl-2 
family proteins and interacts with viral and cellular survival-promoting 
proteins. Oncogene 11, 1921–1928.  
Burns, J.W., Siadat-Pajouh, M., Krishnaney, A.A., and Greenberg, H.B. 
(1996). Protective effect of rotavirus VP6-specific IgA monoclonal antibodies 
that lack neutralizing activity. Science 272, 104–107.  
Burnstock, G. (2007). Purine and pyrimidine receptors. Cell. Mol. Life Sci. 64, 
1471–1483.  
Cerutti, A., and Rescigno, M. (2008). The biology of intestinal immunoglobulin 
A responses. Immunity 28, 740–750.  
Choi, Y.S., Kageyama, R., Eto, D., Escobar, T.C., Johnston, R.J., Monticelli, 
L., Lao, C., and Crotty, S. (2011). ICOS receptor instructs T follicular helper 
cell versus effector cell differentiation via induction of the transcriptional 
repressor Bcl6. Immunity 34, 932–946.  
Choi, Y.S., Yang, J.A., Yusuf, I., Johnston, R.J., Greenbaum, J., Peters, B., 
and Crotty,  S. (2013). Bcl6  expressing  follicular  helper CD4 T cells  are fate 
committed early and have the capacity to form memory. J. Immunol. 190, 
4014–4026.  
Chung, Y., Tanaka, S., Chu, F., Nurieva, R.I., Martinez, G.J., Rawal, S., 
Wang, Y.H., Lim, H., Reynolds, J.M., Zhou, X.H., et al. (2011). Follicular 
regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center 
reactions. Nat. Med. 17, 983–988.  
Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y., and Weiser, J.N. 
(2010). Recognition of peptidoglycan from the microbiota by Nod1 enhances 
systemic innate immunity. Nat. Med. 16, 228–231.  
Craig, S.W., and Cebra, J.J. (1971). Peyer’s patches: an enriched source of 
precursors for IgA-producing immunocytes in the rabbit. J. Exp. Med. 134, 
188–200.  
Crotty, S. (2011). Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 
29, 621–663.  
Fo¨ rster, R., Mattis, A.E., Kremmer, E., Wolf, E., Brem, G., and Lipp, M. 
(1996). A putative chemokine receptor, BLR1, directs B cell migration to 
defined lymphoid organs and specific anatomic compartments of the spleen. 
Cell 87, 1037–1047.  
Gavin, M.A., Rasmussen, J.P., Fontenot, J.D., Vasta, V., Manganiello, V.C., 
Beavo, J.A., and Rudensky, A.Y. (2007). Foxp3-dependent programme of 
reg- ulatory T-cell differentiation. Nature 445, 771–775.  
Hale, J.S., Youngblood, B., Latner, D.R., Mohammed, A.U., Ye, L., Akondy, 
R.S., Wu, T., Iyer, S.S., and Ahmed, R. (2013). Distinct memory CD4+ T cells 
with commitment to T follicular helper- and T helper 1-cell lineages are gener- 
ated after acute viral infection. Immunity 38, 805–817.  
  
Hand, T.W., Dos Santos, L.M., Bouladoux, N., Molloy, M.J., Paga´ n, A.J., Pepper, 
M., Maynard, C.L., Elson, C.O., 3rd, and Belkaid, Y. (2012). Acute gastrointestinal 
infection induces long-lived microbiota-specific  T cell re- sponses. Science 337, 
1553–1556.  
Hapfelmeier, S., Lawson, M.A., Slack, E., Kirundi, J.K., Stoel, M., Heikenwalder, 
M.,  Cahenzli, J.,  Velykoredko, Y., Balmer, M.L.,  Endt, K., et al. (2010). 
Reversible microbial colonization of germ-free mice reveals the dynamics of IgA 
immune responses. Science 328, 1705–1709.  
Haynes, N.M., Allen, C.D., Lesley, R., Ansel, K.M., Killeen, N., and Cyster, J.G. 
(2007). Role of CXCR5 and CCR7 in follicular Th cell positioning and appear- 
ance of a programmed cell death gene-1high germinal center-associated 
subpopulation. J. Immunol. 179, 5099–5108.  
Immunity  
P2X7 as Regulator of Tfh Cells  
  
  
  
 Immunity 41, 789–801, November 20, 2014 ª2014 Elsevier Inc.   807  
 
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss, C.A., 
Kau, A.L., Eisenbarth, S.C., Jurczak, M.J., et al. (2012). Inflammasome- mediated 
dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179–185.  
Hill, J.A., Hall, J.A., Sun, C.M., Cai, Q., Ghyselinck, N., Chambon, P., Belkaid, Y., 
Mathis, D., and Benoist, C. (2008). Retinoic acid enhances Foxp3 induction 
indirectly  by  relieving  inhibition  from  CD4+CD44hi  Cells.  Immunity  29, 758–
770.  
Hill, D.A., Siracusa, M.C., Abt, M.C., Kim, B.S., Kobuley, D., Kubo, M., 
Kambayashi, T., Larosa, D.F., Renner, E.D., Orange, J.S., et al. (2012). 
Commensal bacteria-derived signals regulate basophil hematopoiesis and 
allergic inflammation. Nat. Med. 18, 538–546.  
Hooper, L.V., Littman, D.R., and Macpherson, A.J. (2012). Interactions be- tween 
the microbiota and the immune system. Science 336, 1268–1273.  
Hotchkiss, R.S., and Karl, I.E. (2003). The pathophysiology and treatment of 
sepsis. N. Engl. J. Med. 348, 138–150.  
Hubbard, W.J., Choudhry, M., Schwacha, M.G., Kerby, J.D., Rue, L.W., 3rd, 
Bland, K.I., and Chaudry, I.H. (2005). Cecal ligation and puncture. Shock 24 (1), 
52–57.  
Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., 
Goldfarb, K.C., Santee, C.A., Lynch, S.V., et al. (2009). Induction of intestinal 
Th17 cells by segmented filamentous bacteria. Cell 139, 485–498.  
Iyer, S.S., Latner, D.R., Zilliox, M.J., McCausland, M., Akondy, R.S., Penaloza- 
Macmaster, P., Hale, J.S., Ye, L., Mohammed, A.U., Yamaguchi, T., et al. (2013). 
Identification of novel markers for mouse CD4(+) T follicular helper cells. Eur. J. 
Immunol. 43, 3219–3232.  
Johansen, F.E., Pekna, M., Norderhaug, I.N., Haneberg, B., Hietala, M.A., Krajci, 
P., Betsholtz, C., and Brandtzaeg, P. (1999). Absence of epithelial 
immunoglobulin A transport, with increased mucosal leakiness, in polymeric 
immunoglobulin receptor/secretory component-deficient  mice. J. Exp. Med. 190, 
915–922.  
Johnston, R.J., Poholek, A.C., DiToro, D., Yusuf, I., Eto, D., Barnett, B., Dent, A.L., 
Craft, J., and Crotty, S. (2009). Bcl6 and Blimp-1 are reciprocal and antagonistic 
regulators of T follicular helper cell differentiation. Science 325, 1006–1010.  
Kawamoto, S., Tran, T.H., Maruya, M., Suzuki, K., Doi, Y., Tsutsui, Y., Kato, L.M., 
and Fagarasan, S. (2012). The inhibitory receptor PD-1 regulates IgA selection 
and bacterial composition in the gut. Science 336, 485–489.  
Kirkland, D., Benson, A., Mirpuri, J., Pifer, R., Hou, B., DeFranco, A.L., and 
Yarovinsky, F. (2012). B cell-intrinsic  MyD88 signaling prevents the lethal 
dissemination of commensal bacteria during colonic damage. Immunity 36, 228–
238.  
Le´ cuyer, E., Rakotobe, S., Lengline´ -Garnier, H., Lebreton, C., Picard, M., Juste,  
C.,  Fritzen, R., Eberl, G., McCoy,  K.D., Macpherson,  A.J.,  et  al. (2014). 
Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues 
to induce gut IgA and specific T helper 17 cell responses. Immunity 40, 608–620.  
Linterman, M.A., Pierson, W., Lee, S.K., Kallies, A., Kawamoto, S., Rayner, T.F., 
Srivastava, M., Divekar, D.P., Beaton, L., Hogan, J.J., et al. (2011). Foxp3+ 
follicular regulatory T cells control  the germinal center response. Nat. Med. 17, 
975–982.  
  
Littman, D.R., and Pamer, E.G. (2011). Role of the commensal microbiota in 
normal  and  pathogenic  host  immune  responses.  Cell Host  Microbe  10, 
311–323.  
Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., and Knight, R. 
(2012). Diversity, stability and resilience of the human gut microbiota. Nature 
489, 220–230.  
Macpherson, A.J., and Harris, N.L. (2004). Interactions between commensal 
intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478–485.  
Macpherson, A.J., and Uhr, T. (2004). Induction of protective IgA by intestinal 
dendritic cells carrying commensal bacteria. Science 303, 1662–1665.  
McLay, J., Leonard, E., Petersen, S., Shapiro, D., Greenspan, N.S., and 
Schreiber, J.R. (2002). Gamma 3 gene-disrupted mice selectively deficient in 
the dominant IgG subclass made to bacterial polysaccharides. II. Increased 
susceptibility to fatal pneumococcal sepsis due to absence of anti-polysac- 
charide  IgG3  is  corrected   by   induction   of  anti-polysaccharide   IgG1. J. 
Immunol. 168, 3437–3443.  
Morita,  R., Schmitt,  N., Bentebibel,  S.E., Ranganathan, R., Bourdery, L., 
Zurawski, G., Foucat, E., Dullaers, M., Oh, S., Sabzghabaei, N., et al. (2011). 
Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and 
contain specific subsets that differentially support antibody secretion. Immunity 
34, 108–121.  
Muegge,  B.D., Kuczynski, J.,  Knights, D., Clemente, J.C., Gonza´ lez, A., 
Fontana, L., Henrissat, B., Knight, R., and Gordon, J.I. (2011). Diet drives 
convergence in gut microbiome functions across mammalian phylogeny and 
within humans. Science 332, 970–974.  
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., and 
Honjo,  T. (2000). Class switch  recombination  and hypermutation  require 
activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. 
Cell 102, 553–563.  
Noverr, M.C., and Huffnagle, G.B. (2004). Does the microbiota regulate immune 
responses outside the gut? Trends Microbiol. 12, 562–568.  
Nurieva, R.I., Chung, Y., Martinez, G.J., Yang, X.O., Tanaka, S., Matskevitch, 
T.D., Wang, Y.H., and Dong, C. (2009). Bcl6 mediates the development of T 
follicular helper cells. Science 325, 1001–1005.  
Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes 
in vivo with a conserved homolog, Bax, that accelerates programmed cell death. 
Cell 74, 609–619.  
Pamer, E.G. (2004). Immune responses to Listeria monocytogenes. Nat. Rev. 
Immunol. 4, 812–823.  
Peterson, D.A., McNulty, N.P., Guruge, J.L., and Gordon, J.I. (2007). IgA 
response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host 
Microbe 2, 328–339.  
Rittirsch, D., Huber-Lang, M.S., Flierl, M.A., and Ward, P.A. (2009). 
Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. 
Protoc. 4, 31–36.  
Sait, L.C., Galic, M., Price, J.D., Simpfendorfer, K.R., Diavatopoulos, D.A., Uren, 
T.K., Janssen, P.H., Wijburg, O.L., and Strugnell, R.A. (2007). Secretory 
antibodies reduce systemic antibody responses against the gastro- intestinal 
commensal flora. Int. Immunol. 19, 257–265.  
Schena, F., Volpi, S., Faliti, C.E., Penco, F., Santi, S., Proietti, M., Schenk, U., 
Damonte, G., Salis, A., Bellotti, M., et al. (2013). Dependence of immunoglob- 
ulin class switch recombination in B cells on vesicular release of ATP and CD73 
ectonucleotidase activity. Cell Rep. 3, 1824–1831.  
Schenk, U., Westendorf, A.M., Radaelli, E., Casati, A., Ferro, M., Fumagalli, M., 
Verderio, C., Buer, J., Scanziani, E., and Grassi, F. (2008). Purinergic control of 
T cell activation by ATP released through pannexin-1 hemichannels. Sci. Signal. 
1, ra6.  
  
  
  
  
  
  
  
Immunity  
P2X7 as Regulator of Tfh Cells  
  
    
808 Immunity 41, 789–801, November 20, 2014 ª2014 Elsevier Inc.  
 
  
  
  
Schenk, U., Frascoli, M., Proietti, M., Geffers, R., Traggiai, E., Buer, J., Ricordi, 
C., Westendorf, A.M., and Grassi, F. (2011). ATP inhibits the generation and 
function of regulatory T cells through the activation of purinergic P2X recep- 
tors. Sci. Signal. 4, ra12.  
Shroff, K.E., Meslin, K., and Cebra, J.J. (1995). Commensal enteric bacteria 
engender a self-limiting humoral mucosal immune response while perma- 
nently colonizing the gut. Infect. Immun. 63, 3904–3913.  
Shulzhenko, N., Morgun, A., Hsiao, W., Battle, M., Yao, M., Gavrilova, O., 
Orandle, M., Mayer, L., Macpherson, A.J., McCoy, K.D., et al. (2011). Crosstalk 
between B lymphocytes, microbiota and the intestinal epithelium governs 
immunity versus metabolism in the gut. Nat. Med. 17, 1585–1593.  
Slack, E., Balmer, M.L., Fritz, J.H., and Hapfelmeier, S. (2012). Functional flex- 
ibility of intestinal IgA - broadening the fine line. Front. Immunol. 3, 100.  
Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., and 
Belkaid, Y. (2007). Small intestine lamina propria dendritic cells promote de 
novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775–
1785.  
Suzuki, K., Meek, B., Doi, Y., Muramatsu, M., Chiba, T., Honjo, T., and 
Fagarasan, S. (2004). Aberrant expansion of segmented filamentous bacteria 
in IgA-deficient gut. Proc. Natl. Acad. Sci. USA 101, 1981–1986.  
Taylor, S.R., Gonzalez-Begne, M., Dewhurst, S., Chimini, G., Higgins, C.F., 
Melvin, J.E., and Elliott, J.I. (2008). Sequential shrinkage and swelling underlie 
P2X7-stimulated   lymphocyte   phosphatidylserine   exposure   and   death. J. 
Immunol. 180, 300–308.  
Tsuji, M., Komatsu, N., Kawamoto, S., Suzuki, K., Kanagawa, O., Honjo, T., 
Hori, S., and Fagarasan, S. (2009). Preferential generation of follicular B helper 
T cells from Foxp3+ T cells in gut Peyer’s patches. Science 323, 1488–1492.  
Ubeda, C., Taur, Y., Jenq, R.R., Equinda, M.J., Son, T., Samstein, M., Viale, A., 
Socci, N.D., van den Brink, M.R., Kamboj, M., and Pamer, E.G. (2010). 
Vancomycin-resistant Enterococcus domination of intestinal microbiota is 
enabled by antibiotic treatment in mice and precedes bloodstream invasion in 
humans. J. Clin. Invest. 120, 4332–4341.  
Vaishnava, S., Yamamoto, M., Severson, K.M., Ruhn, K.A., Yu, X., Koren, O., 
Ley, R., Wakeland, E.K., and Hooper, L.V. (2011). The antibacterial lectin 
RegIIIgamma promotes the spatial segregation of microbiota and host in the 
intestine. Science 334, 255–258.  
Wei, M., Shinkura, R., Doi, Y., Maruya, M., Fagarasan, S., and Honjo, T. (2011). 
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic 
hypermutation have impaired gut homeostasis and compromised mucosal 
defense. Nat. Immunol. 12, 264–270.  
Wilhelm, K., Ganesan, J., Mu¨ ller, T., Du¨ rr, C., Grimm, M., Beilhack, A., 
Krempl, C.D., Sorichter, S., Gerlach, U.V., Ju¨ ttner, E., et al. (2010). Graft-
versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat. 
Med. 16, 1434–1438.  
Wollenberg, I., Agua-Doce, A., Herna´ ndez, A., Almeida, C., Oliveira, V.G., 
Faro, J., and Graca, L. (2011). Regulation of the germinal center reaction by 
Foxp3+ follicular regulatory T cells. J. Immunol. 187, 4553–4560.  
Yu, D., Rao, S., Tsai, L.M., Lee, S.K., He, Y., Sutcliffe, E.L., Srivastava, M., 
Linterman, M.,  Zheng, L., Simpson, N., et al. (2009). The transcriptional 
repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 
457–468.  
Zabel, B.A., Agace, W.W., Campbell, J.J., Heath, H.M., Parent, D., Roberts, 
A.I., Ebert, E.C., Kassam, N., Qin, S., Zovko, M., et al. (1999). Human G pro- 
tein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively 
expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and 
thymocytes and is required for thymus-expressed chemokine-mediated 
chemotaxis. J. Exp. Med. 190, 1241–1256.  
  
Immunity, Volume 41  
 Supplemental Information  
 ATP-Gated Ionotropic P2X7 Receptor Controls 
Follicular T Helper Cell Numbers in Peyer’s Patches 
to Promote Host-Microbiota Mutualism  
Michele Proietti, Vanessa Cornacchione, Tanja Rezzonico Jost, Andrea Romagnani,  
Caterina Elisa Faliti, Lisa Perruzza, Rosita Rigoni, Enrico Radaelli, Flavio Caprioli, 
Silvia  
Preziuso, Barbara Brannetti, Marcus Thelen, Kathy D. McCoy, Emma Slack, Elisabetta 
Traggiai, and Fabio Grassi  
  
 
  
  
  
  
  
  
  
  
Figure S1. Histochemical analysis of ileum and colon from WT and P2rx7-/- mice.  
Tfh cells representation in different mouse strains, Related to Figure 1 (A) 
Representative ileum and colon sections from C57BL/6 (WT) and P2rx7-/- mice stained 
with hematoxylin and eosin (H&E) (bar=100μm). (B) Percentages of  
CD3+CD4+CXCR5+ICOS+ Tfh cells in PPs of Balb/c, C57BL/6 and P2rx7-/-. Histograms 
show mean percentages ± s.d. (n=5). *p<0.05; **p<0.01.  
  
 
  
  
  
  
  
Figure S2. Tfh cells representation in secondary lymphoid organs and PS exposure 
in mLNs. Tfh cells death in normal and reconstituted mice, Related to  
Figure 3 (A) Flow cytometry of peripheral LNs (superficial, cervical, axillary, brachial and 
inguinal) and spleens from WT and P2rx7-/- mice for CXCR5, Bcl6 and ICOS on 
electronically gated CD3+CD4+ cells. (B) Statistical analysis of Annexin V+ cells in 
CXCR5+ICOS+ Tfh cells gated as shown from mLNs of WT and P2rx7-/- mice (n=3). (C) 
Statistics of VAD-FMK staining (n=5) and quantitative real-time PCR of Bik and Bax 
transcripts on Tfh cells from PPs of WT and P2rx7-/- mice. (D) Statistical analysis of 
Annexin V staining (n=5) and real-time PCR of Bik and Bax transcripts on Tfh cells from 
PPs of Cd3e-/- mice reconstituted with WT or P2rx7-/- Foxp3EGFP cells; error bars for 
technical replicates are shown for bik and bax real-time PCR values; the results are from 
a single experiment representative of three with analogous results. (E) Statistical 
analysis of Annexin V staining on Tfh cells from Cd3e-/- mice reconstituted with purified 
  
Tfh cells from PPs of WT or P2rx7-/- mice (n=3). (F) Time monitoring of electronically 
gated Tfh cells from mLNs for PS exposure and DAPI uptake following stimulation with 
ATP [1.25 mM]. Error bars in all histograms represent s.d.  
 
  
  
  
  
  
  
Figure S3. Analysis of P2rx7 in Tfr cells, Related to figure 4 (A) Real-time PCR of 
P2rx7 transcripts in Tfh, Tfr, Treg and CD4+ cells sorted as shown. (B) Statistical 
analyses of WT and P2rx7-/- Tfr cells in PPs; histograms show mean percentages and 
absolute numbers ± s.d. (n=5). (C) Annexin V staining and corresponding statistical 
  
analysis of WT Tfh and Tfr cells (n=5). (D) Histograms overlay of CD39 staining by flow 
cytometry in the indicated cell subsets and statistical analysis of MFI. (E-F) Dot plot for 
CD4 and Foxp3, and statistical analyses of Tfr cells from Cd3e-/- mice reconstituted with 
WT or P2rx7-/- Foxp3EGFP cells (E) or with CD4+CXCR5+ICOS+ cells (F). Error bars 
represent s.d.  
 
  
  
  
  
  
  
Figure S4. Bacterial phyla distribution in whole intestine of WT and P2rx7-/- mice 
and method used for quantification of mucosal commensals, Related to Figure 6 
(A) Bacterial phyla distribution and family richness across individual samples of total gut 
  
content from WT and P2rx7-/- (KO) mice. (B) Diagram showing the tissue specimen used 
for quantification of prokaryotic to eukaryotic DNA ratio in ileal mucosa.  
  
  
  
  
  
  
  
Figure S5. Analysis of Tfh cells and GC B cells in Icos-/- mice. IgM secreting 
splenocytes in different mouse strains. Blood cultures from mice with CLP. CLP in 
Icos-/- and Icos-/- P2rx7-/- mice. Infection of WT and P2rx7-/- mice with Listeria 
monocytogenes, Related to Figure 7 (A) Representative dot plots of PPs from Icos-/- 
  
and Icos-/- P2rx7-/- mice stained as indicated to score Tfh and GC B cells. (B) Analysis of 
IgM secreting cells by ELISPOT in the spleen of the indicated mice. (C) Aerobic and 
anaerobic blood cultures from WT and P2rx7-/- mice 72 h after sublethal CLP. (D) 
Survival rates of co-housed WT and P2rx7-/- mice upon sublethal CLP. (E) Survival rates 
and (F) CFU measurement in the indicated compartments 3 days after i.v. injection of 3 
x 103 CFUs of Listeria monocytogenes. Error bars represent s.d.  
SUPPLEMENTAL EXPERIMENTAL PROCEDURES  
Mice and in vivo experiments  
C57BL/6J, P2rx7-/- (B6.129P2-P2rx7tm1Gab/J), “Foxp3EGFP” (B6.Cg-Foxp3tm2Tch/J ), Icos-/- and Cd3e-/-  
  
(Malissen et al., 1995) mice were bred in specific pathogen-free (spf) facility at Institute for Research 
in Biomedicine, Bellinzona, Switzerland. Foxp3EGFP P2rx7-/- mice were generated by crossing P2rx7-/- 
with Foxp3EGFP mice. Icos-/- P2rx7-/- mice were generated by crossing P2rx7-/- with Icos-/- mice. 
C57BL/6J germ free mice were maintained in flexible film isolators at the Clean  
  
Animal Facility, University of Bern, Switzerland. For adoptive transfer of Foxp3 expressing cells, EGFP+ 
CD4 cells were sorted at FACSAria (BD Biosciences) from pooled cell suspensions of spleen, inguinal, 
axillary, brachial, cervical and mesenteric LNs of Foxp3EGFP or Foxp3EGFP P2rx7-/- mice. Eight wk old 
Cd3e-/- mice were injected with 1x105 EGFP+CD4+  T cells. Recipient mice were sacrificed 4 wk after 
reconstitution. For adoptive transfer of Tfh cells, CD4+CD8-CXCR5+ICOS+ cells were sorted at FACSAria 
from pooled PPs of C57BL/6J or P2rx7-/- mice. Eight wk old Cd3e-/- mice were injected with 1x105 Tfh 
cells. Recipient mice were sacrificed 4 wk after reconstitution. For analysis of P2rx7 transcription upon 
antigen stimulation, CD45.2 OT-II TCR transgenic mice were fed with 2 % ovalbumin in the drinking 
water for 4 d. At day 7, CD4+CD8-CXCR5+ICOS+  cells were sorted from PPs and either processed for 
real-time PCR or co-cultured with OVA peptide pulsed splenic APCs (CD11c+B220-  cells) from CD45.1 
mice. After 16 h, CD45.2+CD4+CD11c- were sorted and processed for real-time PCR.  
Cecal puncture ('through-and-through') from mesenteric toward anti-mesenteric direction was carried 
out after ligation with a 20G needle. Body temperature and clinical score were measured every 3 h. 
The following clinical parameters were monitored: motility (0 to 4), fur (0 to 2), temperature (0 to 4), 
  
hunched posture (0 to 3). For IgM treatment, 0.5 mg/mouse of affinity purified IgM from the serum of 
WT mice were injected intravenously 2 h before CLP. Cohousing experiments were performed as 
follows. Caesarean delivery and fostering by CD1 adoptive mothers (CoF): WT and P2rx7-/- mice were 
delivered by caesarean section on gestation day 18.5, fed by CD1 adoptive mother, weaned at 4 wk, 
co-housed and sacrificed at 8 wk of age. Cross-fostering with reciprocal WT and P2rx7-/- mothers 
(CrF): WT mice were fed by P2rx7-/- mother and P2rx7-/- newborns were fed by WT mother. Cubs were 
weaned at 4 wk, co-housed and sacrificed at 8 wk of age. Co-Breeding with WT and P2rx7-/- mothers 
(CoB): WT and P2rx7-/- newborns were bred together and fed by both WT and P2rx7-/- mothers in the 
same cage (up to 10 cubs with 2 mothers). Mice were weaned at 4 wk of age, co-housed and 
sacrificed at 8 wk of age. In all of the above breeding conditions male mouse (father) was moved from 
the cage at the delivery. For experiments with one dose of LPS, 20 μg/mouse of LPS were injected 
i.p. The dose of LPS used was much lower than those used in studies to induce septic shock (Wang 
et al., 2003). We could not detect evidences of LPS toxicity such as weight loss, increased body 
temperature or behavioural change after injection.  Mice were sacrificed 1 wk after treatment. All 
animal experiments were performed in accordance with the Swiss Federal Veterinary Office 
guidelines and authorized by the Cantonal Veterinary.  
Antibodies and flow cytometry  
  
The following mAbs were purchased from BD Biosciences  
  
(http://www.bdbiosciences.com/eu/index.jsp): biotin conjugated anti-CXCR5 (clone: 2G8, Cat.#:  
  
551960, working dilution: 1:50), PE conjugated anti-Fas (clone: Jo2 Cat.#: 554258, working dilution: 
1:300), PE conjugated anti-bcl6 (clone:K112-91, Cat.#: 561522, working dilution: 1:50), PE 
conjugated anti-ICOS (clone: 7E.17G9, Cat.#: 552146, working dilution: 1:300).  The following mAbs 
were purchased from Biolegend (http://www.biolegend.com/): APC conjugated anti-PD-1 (Clone: 
RMPI-30, Cat.#: 109111, working dilution 1:200), APC conjugated anti-B220  
(clone: RA3-6B2, Cat.#: 103212, working dilution: 1:400), PE-Cy7 conjugated anti-CD4 (Clone:  
GK1.5, Cat.# 100422, working dilution: 1:300), APC-Cy7 conjugated anti-CD19 (clone: 6D5,  
  
Cat.#: 115530, working dilution: 1:300). The following mAbs were purchased from eBioscience  
(http://eu.ebioscience.com/): Percp-eFluor710 conjugated anti-CD3 (Clone: 17A2, Cat.#: 46- 0032-80 
, working dilution: 1:200), APC conjugated anti-CD11c (Clone: N418, Cat.# 17-0114, working dilution: 
1:200), APC-eFluor780 conjugated CD45.2 (Clone: 104, Cat.#: 47-0454-82, working dilution: 1:200), 
Pe-Cy7 conjugated anti-CD45.1 (Clone: A20, Cat.#: 25-0453-82, working dilution: 1:200). APC 
conjugated streptavidin was purchased from Biolegend (Cat.#:  
405207) and efluo405 conjugated streptavidin from eBioscience (Cat.#: 48-4317-82). 
Fluorescein labelled Peanut Agglutinin (PNA) (Cat.#: FL-10-71, working dilution: 1:500) was 
purchased from Vectorlabs (http://www.vectorlabs.com/). Samples were acquired on a 
FACSCanto II or LSRFortessa (BD Biosciences) flow cytometer. Data were analysed using  
FlowJo software (TreeStar, Ashland, OR) or FACS Diva software (BD Biosciences).  
Real-time PCR  
  
Total RNA from FACS sorted cells was precipitated in Trizol (Invitrogen) and reverse transcribed to 
cDNA using Random hexamers (Roche, Cat.#: R 15504) and M-MLV reverse-transcriptase (Invitrogen, 
Cat.#: 28025-013). For quantification of transcripts, mRNA samples were treated with 2 U/sample of 
DNase (Applied Biosystems). Transcripts were quantified by real-time PCR on an ABI PRISM 7700 
Sequence Detector with predesigned TaqMan Gene Expression Assays and reagents according to the 
manufacturerʼs instructions (https://www.lifetechnologies.com).  The following probes were used: Ifng 
(Mm00801778_m1), Il17a (Mm00439618_m1), Aicda (Mm00507774_m1), Bcl6 (Mn00477633_m1), 
Gapdh (Mm99999915_g1), Prdm1 (Mm00476128_m1), Rorc (Mm01261022_m1), Tbx21 
(Mm00450960_m1), Hprt1 (Mm00446968_m1), P2rx1 (Mm00435460_m1), P2rx2 (Mm01202368_g1) 
p2rx3(Mm00523699_m1), P2rx4 (Mm00501787_m1), P2rx5 (Mm00473677_m1) 
p2rx6(Mm00440591_m1), P2rx7 (Mm01199500_m1). The following probes for human purinergic 
receptors were used: P2rx1 (Hs00175686_m1), P2rx2 (Hs04176268_g1), P2rx3  
(Hs01125554_m1), P2rx4 (Hs00602442_m1), P2rx5 (Hs01112471_m1), P2rx6  
  
(Hs01003997_m1), P2rx7 (Hs00175721_m1). All reactions were performed in triplicate. The relative 
amounts of mRNAs were calculated by the ΔΔCT method. 18S, Hprt or Gapdh were used as internal 
housekeeping genes.  
TUNEL assay, Annexin V and VAD-FMK staining 
  
PPs were fixed in Neutral Buffered Formalin (16 h at 4°C). After fixation samples were dehydrated, 
embedded in paraffin and then cut at microtome to the desired thickness (6 µm). In situ DNA 
fragmentation was performed with terminal deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) method using the Trevigen TACS® 2 TdT-Fluor In Situ Apoptosis Detection Kit 
(http://www.trevigen.com/ Cat. #: 4812-30-K) according to the manufacturerʼs protocol. Counterstain 
with Alexa-Fluor 647 conjugated rat anti-mouse CD19 antibody (http://www.biolegend.com/ Clone: 
6D5, Cat.#: 115525, working dilution: 1:200) was performed after permeabilization with Cytonin IHC 
(Trevigen). Incubation was performed (16 h at 4°C) with antibody diluted 1:200 in Cytonin IHC.  For 
detection of PS exposure 1x106 cells were freshly  
  
harvested from PPs and stained with appropriate antibodies, labeled with fluorochrome conjugated 
Annexin V and analyzed on LSRFortessa flow cytometer.  Annexin V staining was performed in 
Biolegend Annexin V binding buffer (#422201) (1x106 cells/ml) following the manufacturerʼs protocol.  
For detection of activated caspases PPs cells were incubated for 30-45 min at 37 °C with FITC-
VAD-FMK (CaspGlow Fluorescein Active Caspase Staining Kit; BioVision) in RPMI medium 
according to the manufacturerʼs protocol and then stained with the appropriate antibodies.  
In vitro time monitoring of DAPI uptake and PS exposure  
  
Cellular suspensions were prepared from freshly isolated PPs, stained with the appropriate 
antibodies, washed, resuspended in Annexin V binding buffer for Annexin V staining (1x106/ml) and 
loaded with DAPI (1µg/ml). Phosphatidylserine exposure and DAPI uptake following cell stimulation 
with different doses of Bz-ATP or ATP were time monitored at LSRFortessa and their kinetics 
analyzed using FlowJo software.  
  
Oral immunization with E. coli and flow cytometry for detection of anti-E. coli IgA  
  
Single colonies of E. coli were aseptically inoculated into LB medium and incubated at 37°C for  
  
18 h. Bacteria were harvested by centrifugation, washed in sterile PBS and concentrated to a 
density of 2×1010 CFUs/ml in PBS. Bacterial suspensions (1010 CFUs in 300 μl) were gavaged into 
the stomach. The procedure was repeated every 3 day for 3 weeks and mice were sacrificed at day 
28. Intestinal contents were collected by lavages with 5 ml of intestinal wash buffer (PBS,  
0.5M EDTA, Soybean trypsin inhibitor, PMSF), spun at 14ʼ000 rpm in a sterile tube and filtered (0.22 
µm) to remove any bacteria-sized contaminants (Hapfelmeier et al., 2010). For flow cytometry 
analysis of anti-E. coli IgA, 3ml of LB broth were inoculated with single colonies and cultured 
overnight at 37°C. Cultures were subsequently centrifuged (3 min at 7ʼ000 rpm), washed 3 times 
with sterile-filtered PBS, 2% BSA, 0.005% NaN3 and resuspended at a density of approximately 107 
bacteria per ml. Intestinal contents and bacteria were then mixed and  
  
incubated at 4°C for 1h. Bacteria were washed twice, before being resuspended in monoclonal FITC-
anti-mouse IgA (Southern Biotech http://www.southernbiotech.com/  Cat.#: 1040-02, working dilution 
1:200). After 1 h incubation bacteria were washed twice and resuspended in 2% paraformaldehyde in 
PBS for acquisition on a FACSCanto using FSC and SSC parameters in logarithmic mode. For each 
animal analyzed, ELISA was used to determine the total IgA concentration in an undiluted aliquot of 
the same intestinal wash sample used for surface staining of E. coli. This value was used to calculate 
the total IgA concentration at each dilution of intestinal wash used for flow cytometry of E. coli and was 
plotted against the geometric mean fluorescence obtained in flow cytometry.  
Isolation of human PPs and in vitro Tfh dependent B cell help  
  
Peyerʼs patches were obtained during endoscopy from the terminal ileum of young adults presenting 
with chronic abdominal pain, and in which subsequent examinations excluded the presence of 
organic diseases of the bowel. All patients were otherwise healthy and not taking medications. 
Peyerʼs patches were identified at endoscopy as small nodules covered by normal mucosa.  
  
PBMCs purified from apheresis blood samples obtained from adult healthy volunteers were used in 
the experiments. Peripheral blood mononuclear cells were isolated by Ficoll-Hypaque gradient 
centrifugation. In order to isolate naïve B lymphocytes, CD19+ B cells were selected by CD19 
microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany, http://www.miltenyibiotec.com) according 
to the manufacturerʼs instructions. Following staining for lineage (lin) (CD3, clone  
UCHT1; CD14, clone M5E2, both from Biolegend; and CD56, clone b159, BD BIosciences),  
CD19 (clone HIB19BD, BD Biosciences), CD27 (clone O323, eBioscience), surface IgG and IgA 
(Jackson ImmunoResearch), naïve B cells were sorted as lin-CD19+CD27-IgG-IgA-. The CD19 
negative fraction was used to purify T cells. Briefly, CD4+ T cells enriched by negative selection with 
EasySep human CD4 negative isolation kit (STEMCELL Technologies) were stained with anti-CD4 
FITC (clone RPA T4, BD Biosciences), anti-CXCR5 PE (clone MU5UBEE) and anti- CD45RA PE-
Cy5 (clone HI100), both from eBioscience. The purity of the sorted B and T cell subsets was > 95%. 
For CD4 T-B cell co-culture naive B cells were co-cultured with sorted CD4+ T cells (5 x 104 
cells/well) in the presence of endotoxin-reduced SEB (1 mg/ml) in RPMI 1640  
  
complete medium supplemented with 10% heat-inactivated FBS in 96 well round bottom plates.  
P2X7 selective antagonist A 438079 hydrochloride (Tocris) was added at a final concentration of 10 
nM in the co-culture. After 9 days of culture supernatants were collected and IgG content was 
measured by ELISA. Briefly, 96-well flat-bottomed plates (Greiner Bio-One, Frickenhausen, 
Germany, http://www.gbo. com/en) were coated with isotype-specific goat anti-human IgG 
antibodies (SouthernBiotech, http://www.southernbiotech.com)  diluted in 0.2 M Na2HPO4 pH 9.6 
and incubated for 16 h at 4 °C. Plates were washed and blocked with PBS 10% FCS for 2 h at room 
temperature. After washing, serial dilutions of culture supernatants were added and incubated for 2 
h at room temperature. Plates were washed again, and alkaline phosphatase- conjugated goat anti-
human IgG was added and incubated for 1 h at room temperature. The reaction was developed with 
Sigma-Aldrich 104 substrate (Sigma-Aldrich).  
  
Next generation sequencing of IgA from PPs B cells  
  
CD19+ cells from PPs were sorted and total RNA extracted with E.Z.N.A. HP Total RNA kit  
  
(OMEGA Biotech, Cat.#: R6912-02) according to the manufacturerʼs instructions. The arm PCR 
Technology (amplicon rescued multiplex PCR), a patented multiplex amplification strategy  
(patent No. 7,999,092) developed by iRepertoire was used to amplify murine Ig Heavy chain 
(http://www.irepertoire.com/#!mbhim/c14vs). High throughput sequencing was performed by 
iRepertoire and sequences obtained downloaded in a fastq format and analysed with  
HMMER3.1.  
Quantification of IgA and IgM secreting plasma cells by ELISPOT  
  
Plasma cells secreting IgM, or IgA were detected using ELISPOT assay. Briefly, 96-well plates  
(Millipore) were coated with 10 µg/ml purified goat anti-mouse IgA or IgM (Southern  
Biotechnologies). After washing and blocking with 1% BSA in PBS for 30 min, serial dilutions of 
cultured B cells were added and incubated at 37 ºC for 16 h. The plates were washed and incubated 
with isotype-specific, biotin-conjugated secondary antibodies, followed by streptavidin- HRP (Sigma-
Aldrich). The assay was developed with AEC (Sigma-Aldrich). For quantification of gut IgA secreting 
plasma cells, lamina propria lymphocytes from all small intestine or colon, were isolated as 
described in “Current Protocols of Immunology”, Wiley (unit 3.19). For quantification of total splenic 
IgM secreting cells, spleens were collected and the obtained cellular suspension, after RBCs lysis in 
ACK solution, counted and then plated. Quantification of IgM secreting splenic  
B1 cells was performed on purified CD19+B220-CD23-IgD+CD43+  cells.  
Serum anti-commensals IgM quantification by ELISA  
Fresh caecal content was collected and carefully resuspended in PBS (0.01 g/ml). The obtained 
suspension was centrifuged at 400 x g  for 5 min to remove larger particle from bacteria. Bacterial 
suspensions were then lysed by physical disruption through sonication. The protein concentration of 
the lysate was quantified with Bradford protein assay. ELISA plates (CORNING  
half-area 96 well plate, Cat.#: 3690) were coated for 16 h at 4°C with 100 μl of protein  
  
  
suspension (5 μg/ml). Sera were diluted 1:4 and incubated on coated plates (16 h at 4°C). After  
  
4 washes in PBS 0.025 % Tween 20, 50 µl of alkaline-phosphatase conjugated goat anti-mouse  
  
  
IgM (Southern Biotech http://www.southernbiotech.com/  Cat.#: 1021-04) (1:500 in PBS 10  
%FCS) were incubated for 2 h at room temperature. The assay was developed with Sigma 104 
phosphatase substrate.  
In vitro inhibition of bacterial growth by sera and IgM  
  
Fresh caecal content was diluted to 0.01 g/ml in PBS and serial dilutions of the obtained suspension 
plated in 24 well plates containing 0.4 ml/well of BHI agar. Undiluted sera were added in some wells. 
200 µl of affinity purified IgM from sera of WT mice (0.5 mg/ml) were added to P2rx7-/- sera.  
  
Flow cytometry of IgA and IgG3 coated bacteria  
  
For analysis of IgA or IgG3 coated bacteria in flow cytometry, intestinal contents were collected by 
lavages with 5 ml of PBS. Lavages were centrifuged at 400 x g for 5 min to remove larger particle from 
bacteria. Supernatants were centrifuged at 8ʼ000 x g for 10 min to remove unbound Igs.  
Bacterial suspensions were resuspended at a bacterial density of approximately 108 bacteria per ml 
(OD = 0.125) and then diluted 1 to 10 for staining with APC conjugated rabbit anti-mouse IgA 
antibodies (http://www.brookwoodbiomedical.com/ Cat.#: SAB1186,  working dilution 1:400) or biotin 
conjugated goat anti-mouse IgG3 F(abʼ)2 (Southern Biotech http://www.southernbiotech.com/  Cat.#: 
1102-08, working dilution 1:200). After 1 h incubation bacteria were washed twice and resuspended 
in 2% paraformaldehyde in PBS for acquisition at FACSCanto using FSC and SSC parameters in 
logarithmic mode. SYBR Green was added to the bacterial suspension in order to identify bacteria-
sized particles containing nucleic acids.  
Scanning electron microscopy (SEM)  
  
The last 1 cm of the terminal ileum was cut, fixed by immersion in fixative containing 2.5% 
glutaraldehyde and 2% paraformaldehyde in 0.1M sodium cacodylate buffer (pH 7.2) for 6 hours and 
  
post-fixed with 1% osmium tetroxide for 1.5 hours at room temperature. Samples were then routinely 
processed and critical point dried for scanning electron microscopy (SEM).  
Quantification of mucosal adherent bacteria by RT-PCR.  
  
After removal of faecal pellet the last centimeter of ileum was recovered and directly transferred in 
500 µl of Lysis Buffer (10 mM Tris, 100 mM NaCl, 10 mM EDTA, 0.5 % SDS) containing 0.4 mg/ml 
of proteinase K. Samples were incubated 1 h at 60 °C, DNA precipitated in ethanol and 
resuspended in nuclease free water. 20 ng of DNA from each sample were used to perform RT- 
PCR. Microbial load was measured by RT-PCR using microbial 16S (small ribosomal subunit gene) 
broad-range (universal) primers: 5′-GTG STG CAY GGY TGT CGT CA-3′ (forward) and 5′-ACG TCR 
TCC MCA CCT TCC TC-3′ (reverse) with SYBR Green. 18S rDNA was quantified using a probe 
from Applied Biosystem (cat. # 4333760F).  
Quantification of serum IgM by ELISA  
  
ELISA plates were coated (16 h at 4°C) with 75 µl of unlabeled goat anti-murine IgM (Southern 
Biotech http://www.southernbiotech.com/  Cat.#: 1021-01) at 5 µg/ml in PBS, washed 4 times with 
PBS 0.025 % Tween 20, saturated with 200 µl of PBS 10% FCS for 2 h at room temperature. Fifty μl 
of serial dilutions of sera were incubated 16 h at 4°C. After 4 washes in PBS 0.025 % Tween 20, 50 
µl of alkaline-phosphatase conjugated goat anti-mouse IgM (Southern Biotech 
http://www.southernbiotech.com/  Cat.#: 1021-04) (1/500 in PBS 10 %FCS) were added and plates 
incubated for 2 h at room temperature. The assay was developed with  
Sigma 104 phosphatase substrate.  
Microbial profiling of intestinal microflora  
  
Fecal DNA was extracted from stool and mucus of 8 wk old mice using the QIAamp DNA Stool Mini 
Kit (Qiagen). To guarantee the withdrawal of adherent bacteria, mucus was removed by curettage. 
The entire 16S rRNA gene was amplified from DNA extracts. The entire procedure was performed 
by Second Genome through the Signature Discovery platform. Briefly, to calculate the summary 
intensity for each feature on each array, the central 9 pixels of individual features were ranked. 
  
Fluorescence intensity for sets of probes complementing an operational taxonomic unit (OTU) was 
averaged after discarding the highest and lowest value and the mean was log2 transformed then 
ranging from 0 to 16. The hybridization score (HybScore) for an OTU was calculated as the mean 
fluorescence intensity of the perfectly matching probes exclusive of the maximum and minimum. 
Statistical analyses  
  
Studentʼs paired t test was used to determine the significance of differences between mean values. 
In flow cytometry analyses, mean values ± s.d. of at least 5 mice from the same experiment are 
shown and are representative of at least three independent experiments. Values of P <0.05 were 
considered significant.  
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Abstract  
  
The cellular basis of lifetime antibody production rests on long lived plasma cells and memory 
B cells. The latter have been first described in mouse as cells carrying surface switched isotype, 
somatically hyper-mutated BCRs and able to respond faster upon antigenic stimulation compared 
to the naïve counterpart. In human, a common feature of the somatically mutated B cell subsets, 
both IgM and class switched, is the surface expression of the CD27 antigen which therefore has 
been used as a general marker of memory B cells. Nonetheless, over the last decades a population 
of switched memory B cells which do not express CD27 has been identified, implying the 
existence of antigen-experienced B cells not captured by the CD27 marker. The present study 
shows that in human ecto-5'-nucleotidase (5’-NT) CD73 is differentially expressed in peripheral 
naïve and memory B cells and it can be used as a marker to discriminate multiple layers of 
circulating memory B cells. Notably, we identified a novel B cell subset in the CD27 negative 
compartment, which lacks CD73 expression and carries somatically mutated IgM BCRs, 
resembling features and properties of IgM memory B cells. Additionally, we showed that CD73 
expression, in the CD27 positive IgG-switched memory compartment defines a subset of cells 
with higher ability to expand and differentiate to plasma cells in a germinal center fashion and 
characterized by higher frequency of poly-reactive BCRs. These data suggest the presence of 
distinct levels of selection within the humoral memory compartment, which could have potential 
implications in vaccines design as well as in the pathogenesis of autoimmune diseases.  
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Introduction  
  
Hallmark of adaptive immune responses is the generation of long-lived protection after primary 
exposure to a pathogen. This mechanism is defined as immunological memory and emerges from 
a range of changes that evolves over time, involving both T and B lymphocytes. Among T cells 
multiple types of long lived memory cells are generated, including those that circulate in 
secondary lymphoid organs, those that reside within tissues and those that are poised towards 
effector function (Sallusto and Lanzavecchia 1994, Hamann et al. 1997, Sallusto et al. 2004, 
Jaigirdar and MacLeod 2015). In humoral responses, this protection stems from a combination 
of sustained antibody titers, deriving from long-lived plasma cells (LLPCs) and memory B cells. 
Both types of cells are thought to primarily derive from the germinal center (GC) reaction 
(Shlomchik and Weisel 2012). LLPCs have been extensively investigated both in human and 
mouse and have been defined as the reservoir of persistent serum antibody production (Manz et 
al. 1997, Amanna et al. 2007, Halliley et al. 2015), whereas more controversial is the definition 
of memory B cells and of their role in sustained serum antibody production. Historically, the 
latter have been defined, both in mouse and human, as cells carrying isotype-switched BCRs and 
mutated Ig-V genes, implying a higher affinity for the antigen and higher ability to respond faster 
upon antigenic re- challenge (McHeyzer-Williams et al. 1991). Indeed, in a more general and 
agnostic terms memory B cells can be defined as a subset that has been primed by a specific 
antigen and has returned to a quiescent state, persisting for a life time, being able to respond 
faster and more prompt to a second challenge with that specific antigen. Initial studies, in mouse 
and human, were focused on IgG+ memory B cells, as these can be easily identified and isolated. 
However, the detection of somatically mutated IgM+ B cells has led to a new definition of 
memory which finally consider the existence of memory B cells carrying IgM BCRs. Klein et al 
described for the first time a member of tumor necrosis factor receptor superfamily, CD27, as a 
surface marker to discriminate naïve from somatically mutated B cells (Klein et al. 1998). Since 
then CD27 has been widely used to identify circulating human memory B cells. Nonetheless, in 
the last decades, several studies in the field have revealed distinct levels of complexity and 
heterogeneity. Indeed, within IgG+ and IgA+ circulating human B cells there is a fraction lacking 
CD27 expression, implying the presence of antigen-experienced isotype- switched B cells not 
captured by CD27 expression. These cells express an array of inhibitory receptors, homologous 
to Fc receptors, called Fc receptor like (FCRL) molecules which have been found expanded in 
some pathological conditions, such as systemic lupus erythematosus (SLE) and rheumatoid 
arthritis (Ehrhardt et al. 2005, Fecteau et al. 2006, Wei et al. 2007).   
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Recent advances in characterizing memory B cells have been achieved using transgenic- mouse 
model, in which relative numbers of antigen-specific memory B cells are elevated. This strategy 
enabled the identification of memory B cell surface markers, which were then confirmed in non-
transgenic mice. In this regard CD80, PDL-2 and CD73 have been defined as murine memory B 
cells markers (Anderson et al. 2007, Tomayko et al. 2010). If mouse study can be used to predict 
human B cell responses and whether there is a correlation between mouse and human B cell 
markers are still debating points. Nevertheless, it has been showed that ecto-5'-nucleotidase (5’-
NT) CD73 is highly expressed in circulating human B cells and its expression correlates with 
higher capacity to perform class switch recombination (CSR) and plasma cells differentiation 
(Schena et al. 2013). In the present study, we analyzed CD73 expression in circulating human B 
cells and investigated the functional properties, BCR mutations, and poly-reactivity against self- 
and pathogen-antigens of naïve and memory B cell subsets isolated according to CD73 
expression, aiming to detect potential novel layers of human memory B cells.  
  
Results CD73 positive cells are significantly decreased in circulating memory B cell 
subsets  
  
  
The expression and activity of CD73 undergo dynamic changes in accordance to the 
environmental context, contributing to the outcome of several cellular responses (Antonioli et 
al. 2013). In human B cells, CD73-dependent adenosine generation favors CSR, endowing cells 
with an intrinsic control of differentiation toward immunoglobulin isotypeswitched plasma cells 
(Schena et al. 2013). To gain insight into the role of CD73 in the B cell physiology, we sought 
to fully characterize its expression by flow cytometry on peripheral circulating B cells in adult 
healthy donors. Bone marrow emigrants transitional B cells represent the most immature 
circulating B cell subset, originally identified by surface expression of CD24 and CD38 and 
defined as CD19+CD27−CD24highCD38high (Carsetti et al. 1995, Carsetti 2004, Carsetti et al. 
2004). Additionally, bright co-expression of CD24 and CD38 have been previously associated 
with CD10 expression (Cuss et al. 2006). In fact, we observed higher expression level of CD10 
in transitional B cells compare to the naïve subset  
(Figure 1A). A detailed analysis of human CD27− compartment in 8 healthy donors revealed that 
among circulating B cells CD73 is expressed at the highest level on transitional and naïve B 
cells, which showed respectively 88% and 82% of CD73+CD39+ cells (Figure 1A). In healthy 
adults ~ 40% of peripheral B cells are CD27+ and defined as memory B cells. Within this 
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compartment, the percentages of different circulating memory B cell subsets showed comparable 
frequency in all the analyzed healthy donors: ~ 25% IgM+D+, ~ 10% IgM only, ~  
10% IgD only, ~ 30% IgG. The observed IgM−IgD−IgG− population can be reasonably assumed 
as the circulating IgA-isotype-switched memory B cells (~ 25%) (Figure 1B). A dynamic 
regulation of CD73 in the CD27+ compartment was observed. Specifically, higher expression in 
the IgG and IgA class-switched B cells memory (60% and 64% respectively) and a moderate 
reduction in the IgM+IgD+ memory cells (45%) (Figure 1A). Collectively, our results suggest 
that CD73 is highly expressed on antigen inexperienced B cells, namely naïve and transitional 
subsets, whereas it is bimodal-expressed in the CD27+ compartment, with isotype-switched 
memory B cells expressing higher level compared to IgM memory counterpart.  
  
CD73 expression in human naïve B cells correlates with more efficient cognate interaction 
with T follicular helper cells  
  
In mice, CD73 is expressed primarily on B cells that have undergone class-switch recombination 
(Yamashita et al. 1998), and is used as marker of memory (Anderson et al. 2007, Tomayko et 
al. 2010). Furthermore, recent evidences showed that mouse GC- independent memory is 
enriched in CD73− IgM B cells, while the GC-dependent counterpart is mainly generates isotype-
switched B cells characterized by surface expression of CD73 (Taylor et al. 2012). In the present 
study, we aimed to investigate whether CD73 could identify a population of circulating human 
B cells more prone to generate a GC reaction and therefore prone to interact with T follicular 
helper cells (Tfh). Human blood CD4+ CD45RA−CXCR5+ T cells have been defined as a 
circulating memory counterpart of Tfh able to support antibody secretion (Morita et al. 2011). 
CD4+CD45RA−CXCR5+ were sorted from peripheral blood of 3 healthy donors and co-cultured 
with autologous peripheral naïve B cells  
(CD19+CD27−IgM+IgD+) separated based on CD73 expression (Figure 2A). To mimic the 
antigen-specific interaction between T and B cells staphylococcus enterotoxin B (SEB) was 
added to the culture. Notably, it has been previously reported that the aforementioned culture 
condition ensures a T cell-dependent immunoglobulin secretion (Morita et al. 2011). After 7 
days of co-culture, the IgG-secreting plasma cells were measured by ELISPOT assay and a 
significant increase was observed when Tfh cells where co-cultured with naïve CD73+ B cells 
respect to the CD73− counterpart (Figure 2B). The number of viable cells was similar between 
the tested culture conditions (data not shown) indicating that the less ability of CD73− B cells to 
produce IgG was not due to an impaired survival. Collectively, these data provide evidence that 
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expression of CD73 in human naïve B cells correlates with more efficient cognate interaction 
with Tfh cells, which results in higher T cell-dependent immunoglobulin secretion.  
  
Single human B cell expansion confirmed the higher potential of naïve CD73+ to class 
switch to IgG  
  
To further understand the role of CD73 activity in shaping the outcome of B cell responses, we 
used a high-throughput strategy to screen a broader range of peripheral blood B cells and to 
analyze functional characteristics of their BCRs at the single cell level. Naïve and IgM memory 
B cells were sorted based on CD73 expression. Transitional B cells were included in the 
screening but due to their low peripheral blood representation, no further discrimination for 
CD73 expression was done. Cells were plated at a density of 1 cell per well, expanded in vitro 
with the addition of feeder cells and conditioned medium. After 12 days the B cell efficiency 
response and the IgG-CSR efficiency were evaluated (Suppl. Figure 1). The culture supernatants 
were screened for IgM production and the analysis showed an overall comparable IgM 
differentiation efficiency between naïve and IgM memory subsets, either positive or negative for 
CD73 (Figure 3A). Instead, a significant difference was observed in the response efficiency of 
transitional B cells, which showed a decrease in the percentage of IgM expanding cells compare 
to naïve CD73+ B cells (Figure 3B). Notably, in line with the results collected in a bulk B cell 
stimulation system, we observed higher IgG CSR efficiency in the naïve  
CD73+ compartment compare to CD73− counterpart, which intriguingly showed a comparable 
efficiency to IgM memory subsets. Collectively, the results obtained at the single cell level 
provided additional evidence that CD73 expression endows naïve B cells with intrinsic plasticity 
to perform CSR. Analogous CSR efficiency was observed in transitional and naïve  
CD73+ B cells, indicating that the high CD73 expression of the former could already be crucial 
in favoring in vitro CSR and plasma cells differentiation. Furthermore, the diminished potential 
of naïve CD73− B cells to differentiate into antibody-secreting cells was like what observed in 
the IgM memory B cell compartment.  
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Predominant poly-reactivity in naïve CD73+ B cells  
  
The development of a proper adaptive immune response is based on the random generation of 
antigen receptors. A stringent selection process, aiming to remove the undesired BCRs 
specificities, is necessary in the bone marrow as well as in the periphery. Indeed, peripheral 
human B cell selection has been proposed to be regulated by two different check points, which 
allow the decrease of poly-reactive BCRs frequency (Wardemann et al. 2003). We reasoned that 
CD73 expression could identify B cell subsets with different degree of poly-reactivity. 
Circulating naïve and IgM memory B cells were isolated from 6 healthy donors, according to 
CD73 expression and clonal expanded for 12 days in a 384 well plate (Suppl. Figure 1). The 
culture supernatants were screened by ELISA assay for binding to a defined set of antigens, 
which included self-antigens (insulin, IL-2 and IL-17AF) and pathogen-antigens (influenza, 
tetanus toxoid). The frequency of B cells expressing poly-reactive BCRs was determined 
considering as poly-reactive a clone which bound to at least two different antigens in the 
screening. Overall, the analysis demonstrated a significantly reduced poly-reactive BCRs 
fraction in the naïve CD73− B cell subset, which showed Igs-reactivity profile similar to IgM 
memory B cells (Suppl. Figure 2). Notably, the poly-reactivity was significantly decreased in the 
naïve CD73−and IgM memory CD73− B cells (Figure 4). Taken together, these results 
demonstrate that low expression of CD73 in naïve and IgM memory compartments defines an 
advanced differentiation step, characterized by a restricted BCR repertoire compare to the CD73+ 
counterparts.  
  
IgM+CD27−CD73− B cells are enriched in mutated sequences  
  
Given the different functional properties observed in the IgM compartment (either CD27+ or  
CD27−) according to CD73 expression, we set out to assess whether the expression of the marker 
correlates with different BCR-genetic properties. The presence of mutations in the Ig heavy chain 
V gene segments is generally considered as an indication of previous antigenic exposure and 
thus is generally considered as a hallmark of memory B cells. Ig heavy chain V gene sequences 
were amplified from cDNA extracted from a single B cell clone expanded in vitro for 12 days. 
Clones containing unique VH sequences were analyzed for gene segment usage, germline 
identity, and CDR3 composition, using the IgBlast algorithm. From 3 healthy donors, a total of 
301 sequences were analyzed and the germline identity was evaluated. In the IgM+CD27−CD73+ 
a total of 183 sequences showed a 4.3% of sequences with < 95% of germline identity. Notably, 
in the IgM+CD27−CD73− a total of 136 sequences were analyzed and 30.1% was found mutated, 
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with < 95% of germline identity (Figure 5A). The difference in the mutation status between the 
IgM+CD27− subsets was surprisingly remarkable, as the  
CD73− cells were enriched in mutated sequences. Furthermore the mutations showed the 
tendency to accumulate in the CDR1 and CDR2 gene fragments. These results demonstrate for 
the first time that the IgM+CD27−CD73− subset represent a population of IgM-bearing B cells 
that express somatically mutated V genes. Importantly, usage of CD73 as a surface marker 
allows the identification of antigen-experienced B cells within the IgM+CD27− population, which 
until now has been referred as a naïve population.  
We next compared the percentage of mutated VH sequences in the IgM+CD27− and IgM+CD27+ 
compartments. A total of 71 sequences of IgM+CD27+ B cells from 1 healthy donor were 
included in the analysis. Remarkably, IgM+CD27−CD73− showed comparable mutations 
frequency to the one observed in the IgM+CD27+ memory B cells and distant from the highly 
germlined IgM+CD27−CD73+ naïve B cells (Figure 5B). Taken together, these results 
demonstrate for the first time that low expression level of CD73 in the IgM+CD27− compartment 
defines an antigen-experienced subset enriched in mutated sequences and detached from the 
highly germlined CD73+ counterpart.  
  
CD73 defines a subset of human reactive memory B cell  
  
The bimodal expression of CD73 observed in the IgG+CD27+ memory compartment (Figure 1), 
suggest that this marker might define a novel subset of switch memory B cells. To test this 
hypothesis, peripheral IgG+CD27+ B cells from 7 healthy donors were sorted according to CD73 
expression and expanded in vitro at the density of 1 cell/well (Suppl. Figure 1). After 12, days 
the culture supernatants were screened by ELISA assay for IgG secretion and the analysis 
showed a significantly increased B cell response efficiency in the CD73+ subset compare to the 
CD73− counterpart (Figure 6A). These data suggest that CD73 expression defines a subset of 
isotype class-switched memory B cells more prone to secrete IgG antibodies upon in vitro 
stimulation. We therefore aimed to evaluate the kinetic of IgG secretion in the IgG CD27+ CD73+ 
and CD73− memory compartment at 6 different time points (Figure 6B). This was done by 
quantifying in the culture supernatants the IgG secretion using an ELISA assay, at different ime 
points: 2-4-6-8-10 and 12 days. Our results showed that over the time, the immunoglobulin 
concentration was delayed and reduced in CD73− memorycompartment. Indeed, at 4 days CD73+ 
cells showed ~ 40% of response efficiency compare to the ~ 10% showed by CD73−, which 
correlates with a concentration of IgG in the culture supernatants of roughly 1 ng/ml. In the latest 
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time points, CD73+ B cells showed higher fraction of IgG secreting cells reaching higher 
immunoglobulin concentration in the supernatants (Figure 6B). Collectively, these data suggest 
that CD73 can be used as a marker to define a subset of reactive IgG CD27+ memory B cells, 
which are faster and more efficient in immunoglobulin secretion upon in vitro stimulation.  
  
Predominant poly-reactivity in the CD73+ IgG class switched memory B cells  
  
Poly-reactivity was evaluated in the IgG isotype-switched memory B cell compartment. After 
clonal expansion, culture supernatants were screened for binding to a defined set of antigens 
which included self-antigens (insulin, IL-2 and IL-17AF) and pathogen-antigens (influenza, 
tetanus toxoid). As previously described, the poly-reactive BCRs fraction was defined 
considering the clones which bound to at least two different antigens in the ELISA screening. 
The analysis of 5 healthy donors showed that class-switched memory CD73+ B cells are enriched 
in poly-reactivity compare to the CD73− counterpart (Figure 7A). To determine whether this 
finding correlates with specific Ig sequence features, heavy chain VH sequences were amplified 
from cDNA extracted from single clones of B cell expanded in vitro for 12 days. A total of 431 
clones from 2 healthy donors were analyzed for germline identity and CDR3 composition using 
the IgBlast algorithm. The CDR3 amino acid length comparison showed significant longer 
sequences in the CD73+ memory B cells compare to the CD73− counterpart and no differences in 
the amount of mutated sequences were observed (Figure 7B-  
C). Thus, these data show that the enrichment of poly-reactive BCRs in the CD73+ IgG memory 
compartment is associated to longer CDR3s sequences.  
  
Discussion  
  
Immunological humoral memory is the result of a successful immune response, which leads to 
generation of long-lived protection after a primary exposure to a pathogen. This protection stems 
from long-lived plasma cells (PCs) and long-lived memory B cells. Both types of cells are 
thought to primarily derive from a germinal center (GC) reaction (Shlomchik and Weisel 2012). 
Understanding how these cells are generated from naïve compartment has important implication 
not only in vaccine design, but also for our understanding of human memory B cells development 
and their contribution in the pathogenesis and progression of autoimmune diseases. A major 
challenge for the detection of memory B cells is the lack of a unique phenotype that distinguishes 
them from naïve B cells. Despite the importance of studying human B cell memory response, 
much information in the field is coming from mouse experiments. Indeed, using a transgenic 
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mouse model the co-stimulatory molecule CD80 has been identified as a memory B cell marker 
(Anderson et al. 2007). In later studies this molecule has been combined with CD73 and PD- L2 
to identify at least five different populations arising in response to immunization (Tomayko et 
al. 2010). In the present study we focused on the analysis of peripheral human B cells, aiming to 
characterize the expression and the role of CD73 in cell differentiation and memory generation. 
We observed that CD73 is highly expressed on circulating antigen-inexperienced B cells, namely 
transitional and naïve cells and significantly decreased in circulating memory subsets defined 
according to the expression of CD27. We observed enrichment in CD73− B cells in the 
IgM+IgD+CD27+ subset. This finding is in line also with recent evidence in mice showing that 
memory B cells can differentiate through two independent pathways: a GC-independent which 
generates memory B cells mainly IgM+CD73−, and GC-dependent which leads to the formation 
of classswitched memory B cells and are characterized by CD73 surface expression (Takemori 
et al. 2014). Interestingly, we observed that CD73 expression endowed human naïve B cells with 
higher capacity to cognate interaction with T follicular helper cells (Tfh). Our finding suggests 
that the higher class-switch recombination (CSR) efficiency observed in naïve CD73+ B cells 
(Schena et al. 2013) is linked to their intrinsic capacity to respond to a T-cell dependent 
stimulation. Indeed, these functional properties are linked to the enzymatic function of CD73, 
since treatment of naïve and memory B cells CD73− with adenosine significantly increased the 
differentiation of the latter to class switched B cells (Schena et al. 2013). We confirmed this data 
using an enzymatic antagonistic antibody which dampens significantly both CSR and plasma 
cell differentiation (data not shown). Notably therapeutic interventions targeting the 
adenosinergic pathway have recently gained much attention (Young et al. 2016) and open up the 
possibility to interfere with GC-dependent B cell responses by targeting CD73.  
  
The adenosine receptor expressed by human B cells is the A2A, which is a Gs-protein coupled 
receptor linked to activation of adenylyl cyclase enzyme. This results in the conversion of ATP 
into c-AMP, which in turn acts as a second-messenger activating c-AMP dependentkinase, PKA, 
responsible for the phosphorylation of specific target proteins (Yang et al. 2015). It has been 
shown that AID physically interacts with PKA in the cytoplasm and is phosphorylated by PKA 
catalytic subunit at specific residues (Pasqualucci et al. 2006). We speculate that the higher CSR 
efficiency observed in the CD73+ compartment, in both naïve and IgG memory B cells, is linked 
to the PKA activation A2A-dependent, with the consequent phosphorylation of AID, which is 
required for CSR. Whether naïve B cells are intrinsically programed for recruitment into the GC-
independent or GC-dependent pathway, or can enter either pathway depending on signals 
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received upon activation, remains to be explored. In this study we showed that CD73 expression 
might represent an early decision check point in the development of human B cell memory, 
which drives towards a GC-dependent response. Unravelling the signal driving B cells towards 
T-dependent response may also improve our understanding of the transforming mechanisms 
driving the development of GC-derived B cell malignancies.  
  
To better understand the origin and function of B cell populations expressing CD73, we 
investigated the composition of the functional BCR repertoire in naïve and memory B cell 
subsets isolated according to CD73 expression. Recently, the need to develop an efficient method 
to solve the complexity of BCRs repertoire in normal as well pathological situation, such as 
autoimmune disorders, immunodeficiencies and infection diseases has emerged (DiLillo et al. 
2011). One limitation in studying B cell physiology has been the unlikelihood to generate long-
term B cell lines from mature B cells. Indeed, stimulation of naïve and memory B cells causes 
their terminal differentiation to PCs along with cell cycle arrest. Traggiai et al described the first 
published improved method for the Epstein Barr Virus-mediated transformation of memory B 
cells, which increased the efficiency of B cell immortalization to a level that has allowed the 
isolation of naturally generated monoclonal antibodies in many diseases (Traggiai et al. 2004). 
The drawback of this approach is that, due to the low clonal efficiency, it involves the screening 
of large numbers of B cells to obtain monoclonal antibodies of the desired specificity. Recent 
advances in the isolation, culture and expansion of human B cells are enabling the isolation of 
the cognate immunoglobulin heavy and light chain variable genes from a single B cell. These 
genes can then be cloned and expressed in eukaryotic cell lines. Wardemann et al were the first 
to apply this approach to examine the development and silencing of autoreactive B cells 
(Wardemann et al. 2003) and subsequently it has been used to understand the human B cell 
selection process in healthy and diseased individuals (Wardemann and Nussenzweig 2007, 
Meffre and Wardemann 2008, Isnardi et al. 2010, Meffre 2011). Despite the possibility to clone 
and express antibodies from single human B cells, this method does not provide the functional 
analysis of the B cell clone of interest. To overcome this issue, we optimized a published method 
(Huang et al. 2013), with the aim to functionally screen at a single cell level distinct subset of 
peripheral B cells and thereafter investigate their genetic Ig sequence information. In this study, 
we used CD73 as a surface marker to further discriminate naïve and memory B cells. Cells were 
seeded at a density of 1 cell/well and expanded in vitro for 12 days in the presence of feeder cells 
and conditioned medium. We observed that adding a TLR9 agonist, transferrin, BAFF at the 
cocktail stimulation and using an anti-CD40 antibody instead of the CD40-ligand determined a 
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significant improvement of the single cell expansion efficiency compare to the published method 
(Lindner J.M et al, manuscript in preparation). The culture supernatants were screened for IgM 
and IgG secretion to evaluate respectively IgM response and CSR efficiency. Importantly, our 
results confirmed the intrinsic role of CD73 in shaping the outcome of the B cell response, 
endowing naïve B cells with higher intrinsic plasticity to perform CSR. Indeed, we showed that 
low expression of CD73 resulted in a significant decrease in the IgG-CSR efficiency compared 
to the positive counterpart, but a comparable IgM response efficiency. The decision between 
extrafollicular response and GC migration represents the main branching point during a T-
dependent B cell response and the mechanisms which direct B cells down one pathway versus 
the other are so far unknown (MacLennan et al. 2003). Remarkably, our results point to CD73 
in naïve compartment as a master regulator of B cell response, which drives towards a GC B cell 
differentiation.  
  
Transitional B cells represent newly bone marrow (BM) emigrants and the most immature 
peripheral B cell subset. Here we observed for the first time that high expression of CD73 in 
human transitional B cells is associated to high IgG CSR efficiency. We speculate that the high 
CD73 expression could already be crucial in promoting CSR of the immature transitional 
compartment. Notably CD73 expression is regulated by Hypoxia Inducible Factor 1 (HIF-1), 
which is likely involved in CD73 modulation in the BM niche. In this context, it is important to 
consider that CD73 has been shown to be highly expressed by BM stromal cells, also termed 
mesenchymal stem cells (MSCs) (Boxall and Jones 2012) and to be involved in BM stromal 
interactions (Barry et al. 2001) MSC migration (Ode et al. 2011), and, potentially MSC 
modulation of adaptive immunity (Eckle et al. 2007).  
  
A historic definition of B cell memory has been generally focused on class switched IgG+ B 
cells, whereas IgM+IgD+ were assumed to represent antigen-inexperienced expressing variable 
region genes without somatic mutations. However, it’s now well established that two distinct 
populations in human IgM memory can be identified: IgM only, with a GC derivation (Weill et 
al. 2009) and IgM+IgD+ memory B cells with a doubtful origin. The latter has been defined as 
human marginal zone (MZ) B cells. Nevertheless, although they share many properties with their 
mouse counterpart, they also display striking differences (Spencer et al. 1998, Dammers et al. 
2000). Indeed, the presence of somatic mutations in the IgM receptor of human MZ B cells has 
caused confusion about their definition, leading these cells to be called IgM memory by most 
authors. Splenic IgM+IgD+CD27+ B cells share with mouse MZ B cells localization at the 
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periphery of B cell follicles. However in contrast to mouse MZ B cells previously described as 
a splenic-resident subset with un-mutated B-cell receptors, human IgM+IgD+CD27+ harbor 
mutated Ig variable genes and recirculate (Weller et al. 2004). Mutations are an indication of 
prior activation, from which most of memory B cells are assumed to originate. In our study, we 
showed for the first time that low expression of CD73 in the naïve IgM+IgD+CD27− compartment 
defines an antigen-experienced subset enriched in mutated sequences, distant from the highly 
germlined CD73+ counterpart. Furthermore, the level of mutation in the  
IgM+IgD+CD27−CD73− was similar to the one observed in IgM+IgD+CD27+ memory B cells.  
Overall our study pointed out that CD27 is not an appropriate un-equivocal marker of memory  
B cells, as already reported after the discovery of IgG+CD27− population (Fecteau et al. 2006, 
Wu et al. 2011). Remarkably, from our data it emerges that human memory B cells progressively 
acquire phenotypes and properties that distinguish them from not experienced naïve B cells, with 
CD73 playing an important role in the early differentiation steps. We speculate that 
IgM+IgD+CD27−CD73− B cells might represent early precursors of IgM+IgD+CD27+ B cells, 
which have already encountered the antigen and consequently mutated Ig variable genes. Further 
experiments are necessary to confirm this hypothesis and to gain insights into biological 
pathways and molecular mechanisms that regulate cell fate and development.  
  
The healthy immune system constantly produces B cells able to recognize specifically only one 
antigen and a significant fraction of poly-reactive B cell clones. The latter are defined as BCRs 
able to bind multiple structurally unrelated antigens (Casali and Notkins 1989, Zhou and Notkins 
2004). Besides the possible role of antibody poly-reactivity in magnifying the antigen detection 
power and in regulating immune system own functions, is still questionable whether these 
“promiscuous” interactions bear any physiological meaning. Indeed, definition of poly-reactivity 
would be certainly strengthened if correlated to a functional consequence (Dimitrov et al. 2013). 
Wardemann et al suggested that in healthy individuals the negative selection during B cell 
ontogeny is responsible for the significant reduction of poly-reactivity. In their model nearly 
90% of the poly-reactive antibodies are counterselected in the immature  
B cell stage and only ~ 4% of circulating naïve B cells express poly-reactive BCRs 
(Wardemann et al. 2003). The set of antigens used in the aforementioned study to define 
polyreactive antibodies includes: double-strand DNA (dsDNA), single-strand DNA (ssDNA) 
insulin and LPS. In our study we aimed to amplify the panel of antigens and to specifically 
introduce self-molecule, like insulin, IL-2 and IL-17 and non-self-(pathogen)-antigens like 
influenza and tetanus toxoid. In line with the hypothesis that CD73 represent a B cell 
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differentiation marker, we observed that reduced CD73 expression in naïve and IgM+IgD+ 
memory compartment defines a subset characterized by a restricted BCR repertoire compare to 
the CD73+ counterpart. Thus we identified a novel B cell subset in the CD27 naïve 
compartment which lacks CD73 expression and carry somatically mutated IgM BCRs 
resembling features and properties of IgM memory B cells.  
  
CD73 indeed is not confined only in the IgM compartment but we could also detect in the  
IgG+ memory cell subsets. Our results clearly show that CD73 can be used as a marker to define 
a subset of GC-reactive IgG memory B cells, which is faster and more efficient in Igs secretion 
upon in vitro stimulation. The higher IgG secretion efficiency observed in CD73+ memory B 
cells might reflect their need to further recirculate the GC and receive more cognate T cell help. 
In fact, upon reactivation memory B cells proliferate and eventually reenter the GC reaction, to 
improve immunity versus modified pathogen or infection conditions by downstream CSR and 
new rounds of affinity maturation (Dogan et al. 2009). The CD73− cells might instead represent 
the result of a successful GC reaction, which shutdown CD73 expression to escape further rounds 
of affinity maturation and to instead contribute to the long-lived PCs pool. In line with our 
hypothesis, in a mouse study it has been shown that CD73 is expressed on GC B cells upon 
immunization, but is absent among PCs and plasma blasts (Conter et al. 2014). In addition, it 
has been observed that CD73 expression is crucial for the adhesive interaction between follicular 
dendritic cells and GC B cells (Airas 1998). It is intriguing to consider that hypoxia-inducible 
factor 1 (HIF-1alpha) is a master regulator in promoting CD73 expression (Synnestvedt et al. 
2002), impling a dinamic regulation in the GC microenvironment, due to the hypoxia condition 
and the high rate of cell proliferation and cell death.  
  
In conclusion, taken together our data suggest a novel role for CD73 and adenosine signaling in 
regulating human B cell response and memory generation. Adenosine is generally referred as an 
inhibitory molecule, able to counter balance the activation effect of the ATP on innate immune 
system, from which adenosine is generated. Our findings provide new insights in the activation 
effect of adenosine on human B cells and in the CD73-depentent immunomodulation. Lastly, 
our data showed a novel subset of antigen-experienced CD27− characterized by low expression 
of CD73 and carrying somatically mutated IgM BCRs.  
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Experimental procedures Human blood samples  
  
  
Buffy coat samples were collected from healthy adult donors with approved informed consent 
(Local Swiss Ethics Committee) in the University Hospital Insespital Bern, Switzerland.  
Peripheral blood mononuclear cells (PBMCs) were freshly isolated by Ficoll-Paque Plus (GE 
Healthcare) density gradient centrifugation. For cryopreservation of human cells, freshly isolated 
PBMCs were aliquoted at a concentration of 107 cells per aliquot in 1 ml of fetal bovine serum 
(FBS) 10% dimethyl sulfoxide (DMSO). Cryovial tubes were placed in a prechilled freezing 
container (Nalgene Mr. Frosty, Sigma), stored at −80°C for 24 h and then stored at −150°C until 
thawing.  
  
mAbs and flow cytometry  
  
The following monoclonal antibodies were used in this study for flow cytometry and cell sorting: 
PC5.5 labeled anti-human CD3 (clone # UCHT1), PC5.5 labeled anti-human CD14 (clone # 
RMO52), PC5.5 labeled anti-human CD16 (clone # 3G8)  and PC5.5 labeled anti- human CD56 
(clone # N901) (all purchased from Beckman Coulter), BV785 labeled anti- human CD19 (clone 
# HIB19), BV650 labeled anti-human CD27 (clone # O323), BV510 labeled anti-human CD24 
(clone # ML5), Alexa Fluor 700 labeled anti-human IgM (clone # MHM-88), PC7 labeled anti-
human IgD (# clone IA6), PerCP-eFluor 710 labeled anti-human CD73 (clone # AD2), PE 
labeled anti-human CD10 (clone # HI10a), FITC labeled anti-human CD39 (clone # A1), PC5.5 
labeled anti-human CD38 (clone # LS198-4-3) and APC labeled anti-human IgG ( polyclonal).  
For flow cytometer analysis, cells were incubated with fluorochrome-conjugated mAbs specific 
for human surface antigens described above and diluted in PBS 2% FBS prior to analysis. 
Labeled cells were analyzed on an LSRFortessa (BD Biosciences) flow cytometer or sorted on 
a BD FACSAria using Diva software (BD Biosciences). Data were analyzed using FlowJo 
software.  
  
Human B cell enrichment  
  
To perform functional assay human peripheral B cells were isolated from PBMCs by negative 
selection with the EasySep Human B Cell Enrichment Kit, according to the manufacturer’s 
instructions (STEMCELL Technologies).  
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Media and reagents for cell culture  
  
The medium used for B cell culture was RPMI 1640 (GIBCO) supplemented with 10% fetal 
bovine serum (HyClone, Thermo Scientific), 2 mM GlutaMAX (GIBCO), 10 mg/ml 
nonessential amino acids (GIBCO), 1mM sodium pyruvate (GIBCO), 50 U/ml penicillin  
(Sigma), 50 U/ml streptomycin (Sigma), 50 U/ml kanamycin (GIBCO), and 5 × 10-5 M 2- 
mercaptoethanol (Sigma-Aldrich).  
  
In vitro Tfh-dependent B cell help  
  
To isolate peripheral naïve B lymphocytes, CD19+ B cells were selected by CD19 microbeads 
(Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s instructions. 
Total B cells were stained with the following mAbs: anti-human CD3, anti-human CD14, anti- 
human CD16, anti-human CD56, anti-human CD19, anti-human CD27, anti-human IgG/A and 
anti-human CD73. Naïve B cells (lin-CD19+CD27-IgG-IgA-) were sorted according to CD73 
expression by the cell sorter FACSAria (BD Biosciences). From the CD19 negative fraction, 
CD4+ T cells were purified by negative selection with EasySep isolation kit (STEMCELL 
Technologies) and stained with following monoclonal antibodies: anti-human CD4 (clone # RPA 
T4), anti-human CD8 (clone # RPA-T8) anti-human CXCR5 (clone #  
MU5UBEE) and anti-human CD45RA (clone # JS-83). Tfh cells were sorted as CD4+CD8- 
CD45RA-CXCR5+. Equal number (5×104 cells/well) of Tfh and naïve B cells were cocultured in 
96-well U-bottom plates in the presence of 1 μg/ml endotoxin-reduced SEB (Toxin Technology).  
  
Quantification of IgG secreting plasma cells by ELISPOT assay  
  
For IgG secreting plasma cells quantification, 96-well ELISPOT plates (Millipore MSIPS4510 
Sterile, hydrophobic high protein binding immobilon-P membrane) were coated with 10 μg/ml 
purified goat anti-human IgG (Southern Biotechnologies) for 2 h at room temperature. After 
washing with PBS solution the plates were blocked with 1% BSA in PBS and incubated for 30 
min at 37°C. Serial dilution of cultured B cells were added in a final volume of 200 μl of B cell 
medium (RPMI 10% Hyclone, complete medium) and incubated overnight at 37°C. Next the 
plates were washed 3 times with PBS 0.25% Tween20, 4 times with PBS and incubated 2 h at 
room temperature with isotype-specific, biotin-conjugated secondary antibody (Southern 
Biotechnologies). After washing, avidin-peroxidase (horseradish peroxidase, HRP, Sigma- 
Aldrich) was added and left 1 h at room temperature. The assay was developed with AEC 
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(Sigma-Aldrich). For quantification of antibody secreting cells, plates were acquired, counted 
and quality controlled using an ELISPOT reader and ImmunoSpot 5.1 software (CTL, Europe 
GmbH).  
  
Human single-cell expansion  
  
Transitional, naïve, IgM memory and IgG memory were sorted according to CD73 expression 
and seeded into 384-well plates at a density of 4 cells per well in a final volume of 50 μl of Bcell 
medium containing: 2.5 µg/ml CpG oligodeoxynucleotide 2006 (50-tcgtcgttttgtcgttttgtcgtt30; 
TIB Molbiol), 1 μg/ml anti-CD40 (Novartis clone 626.1), 30 μg/ml transferrin (CalBioChem), 4 
μg/ml IL-2 (Boehringer Mannheim), 10 ng/ml IL-21 (Novartis internal production human 
recombinant protein), 0.1 µg/ml BAFF (R&D Systems) and 2.5 × 105 freshly irradiated (50 Gy) 
PBMCs/ml. After 12 days of incubation at 37°C, culture supernatants were harvested, diluted in 
PBS+1% BSA and used for ELISA screening. B cells in each well were lysed with 20 μl lysis 
buffer containing: 100 mM Tris-HCl, pH 7.5 (Sigma- Aldrich #T2944) 500 mM LiCl (lithium 
chloride, Sigma-Aldrich #62476) 10 mM EDTA, pH 8.0 (ethylenediaminetetraacetic acid, 
Sigma-Aldrich #03690) 1% LiDS (lithium dodecyl sulfate, e.g. Sigma-Aldrich #L9781) 5 mM 
DTT (dithiothreitol, e.g. Sigma-Aldrich #43815). The plates were stored at −80°C for future use 
in Ig genes amplification and cloning.  
  
Quantification of culture supernatant IgM or IgG by ELISA assay  
  
384-well ELISA plates were coated with unlabeled goat anti-human IgM or IgG (Southern  
Biotech) at 1 μg/ml in PBS and incubated 16 h at 4°C. After washing 4 times with PBS 0.025 % 
Tween 20 the plates were blocked with PBS 0.5% BSA and incubated for 2 h at room 
temperature. Serial dilutions of culture supernatants, or undiluted supernatants were incubated 
16 h at 4°C. After 4 washes in PBS 0.025 % Tween 20, isotype specific HRP conjugated 
secondary antibodies (Southern Biotech) were added and plates incubated for 2 h at room 
temperature. After final washing with PBS 0.025 % Tween 20 the assay was developed with 
TMB (3,3',5,5'-tetramethylbenzidine) soluble substrates and the reaction stopped with sulfuric 
acid. Absorbance (OD405) was measured using Gen5 2.01 software (BioTek). For all the donors 
the expansion efficiency was defined using with the following formula:  
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For the IgM B cell populations, namely transitional, naïve and IgM memory the class switch 
recombination efficiency was calculated as the fraction of IgG-positive ELISA wells of the total 
IgM responders.  
  
Detection of antigen-specific immunoglobulin antibodies by ELISA assay  
  
After in vitro expansion of human B cell subsets, culture supernatants were screened to detect 
antigen-specific immunoglobulin secretion. 384-well ELISA plates were coated and incubated 
16 h at 4°C with self and pathogen antigens, namely: insulin (SIGMA-ALDRICH), IL-2 
(Boehringer Mannheim), IL-17AF (Novartis internal human recombinant protein production), 
influenza (Thermofisher) and tetanus toxoid recombinant protein. As a control, plates coated 
with PBS were included in the screening. After washing with PBS 0.025 % Tween 20 the plates 
were blocked with PBS 0.5% BSA and incubated for 16 h at 4°C. Culture supernatants harvested 
at day 12 were diluted in PBS+1% BSA and screened for the reactivity against selected antigens. 
After incubation of 16 h at 4°C, the plates were washed with PBS 0.025 % Tween 20 and 
incubated 16 h at 4°C with isotype specific HRP conjugated secondary antibodies (Southern 
Biotech). A final washing with PBS 0.025 % Tween 20 was performed then the assay was 
developed with 3,3',5,5'-tetramethylbenzidine TMB soluble substrates (Seramun, Diagnostica 
GmbH) and the reaction stopped with sulfuric acid 1M (Sigma-  
Aldrich). Absorbance (OD405) was measured using Gen5 2.01 software (BioTek). The cut-off 
OD at which a signal was considered positive was determined for each antigen based on the 
overall OD405 values distribution. The poly-reactivity was defined as a positive OD405 in at least 
two antigens.  
  
RT-PCR and Ig gene amplification/ BCR cloning  
  
Heavy chain VH sequences were amplified from cDNA using PCR reactions with either or both 
of the following approaches: 1) a two-round PCR using nested primer sequences in the VH leader 
peptide and, subsequently, framework 1 regions with their respective nested reverse primers in 
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the IgG or IgM CH1 domain, or 2) a single-round PCR reaction using primer sequences spanning 
the VH ATG start codon and a respective CH1 domain reverse primer. All forward primers 
consisted of a mix of oligonucleotide sequences designed to amplify any possible human VH 
sequence from the IMGT database. In either strategy, the primers used in the final PCR round 
contained flanking sequences homologous to expression vectors containing a CMV promoter, 
(in the case of the two-round PCR, a Kozak sequence, start codon, and canonical VH leader 
peptide), and the remaining CH domain open reading frame. In this way, the PCR product could 
be annealed to the plasmid and extended using polymerase (a so-called “overlap extension” 
reaction) to directly generate an expression vector for the given heavy chain, which could also 
be Sanger sequenced to cover the VH ORF and recover the amplified VH sequences.  
Clones containing unique VH sequences were analyzed for gene segment usage, germline 
identity, and CDR3 composition using the IgBlast algorithm  
(https://www.ncbi.nlm.nih.gov/igblast/). IgBlast output was parsed using an internally generated 
Perl script and statistically analyzed with the GraphPad Prism software package.  
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Figure 1. CD73 positive cells are significantly decreased in circulating memory B cell subsets.  
  
PBMCs were isolated from 8 healthy donors and analyzed by flow cytometry with a combination of 
specific monoclonal antibodies. CD73 expression was evaluated in circulating human B cells at different 
stage of maturation. (A) Representative flow cytometry plots showing peripheral cell suspension analyzed 
for the expression of CD19, CD24, CD38, IgM, IgD, CD10, CD27, IgG, CD39 and CD73. Briefly, 
transitional B cells were defined as CD19+CD10+CD27−CD24highCD38high and naïve B cells as 
CD19+CD27−CD10−IgM+IgD+. In the CD19+CD27+ compartment memory B cell subsets were defined, 
namely as IgD+, IgM+, IgD+IgM+, IgG+ and IgA+ (IgM−D−G−). CD73 expression was analysed in all subsets 
and it is showed in combination with the pan-B cells marker CD39. Numbers reported in dot plots indicate 
the percentage of cells within the quadrant. (B) CD73 expression in all indicated peripheral B cell subsets 
(left panel). Bars graph (right panel) shows percentages of CD73 positive cells within the indicated B cell 
populations. Data are represented as mean ± SD (n=8). Statistic was performed using unpaired t-test. **p 
< 0.01, ***p < 0.001, ****p < 0.0001.  
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Figure 2. T follicular helper cells stimulation of naïve CD73+ B cells induces higher class switch 
recombination.  
  
(A) Circulating T follicular helper cells were isolated according to the expression of CD45RA and CXCR5 
as CD4+CD8−CD45RA−CXCR5+. Representative dot plots of sorting strategy are shown (left panel). 
Naïve B cells were isolated as CD19+CD27−IgM+IgD+ from healthy donors PBMCs and sorted according 
to CD73 expression (right panel). (B) Circulating Tfh cells were co-cultured with autologous naïve B cells, 
either CD73+ or CD73− in the presence of SEB. IgG secreting cells were measured at day 7 by ELISPOT 
assay. Data are representative results of three independent experiments (n=3). Statistic was performed 
using ratio paired t-test. *p = 0.02.  
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Figure 3. Single human B cell expansion confirmed higher potential of naïve CD73+ to class switch 
recombine to IgG.  
  
Transitional, naïve CD73+, naïve CD73−, IgM memory CD73+ and IgM memory CD73− B cells were 
seeded 1 cell/well in 384 well plates and stimulated in vitro with CpG 2006, anti-CD40, IL-2, IL-21, BAFF 
and tranferrin for 12 days. (A) IgM secretion in the culture supernatants was measured by ELISA assay 
and the B cell response efficiency was calculated according to a formula which takes into account the 
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average of cells seeded per well, the total number of seeded wells and the number of IgM positive wells 
(Supplementary figure 1). Statistic was performed using unpaired t-test. *p = 0.03. (B) IgG secretion in 
culture supernatants was measured by ELISA assay and the class switch recombination efficiency 
expressed as a fraction of the OD450 IgG+ wells of the total OD450 IgM+ wells and expressed as percentage. 
Statistic was performed using unpaired t-test. *p = 0.01  
Figure 4  
  
  
  
  
  
  
  
  
  
Figure 4. Decreased frequency of poly-reactive B cell clones in CD73− B cell subsets.  
  
Culture supernatants from sorted and in vitro expanded naïve and IgM memory B cell subsets were 
analysed by ELISA assays for the presence of IgM antibodies reactive against: IL-2, IL-17AF, insulin, 
influenza and tetanus toxoid (Supplementary Figure 1). Poly-reactivity was defined by the recognition of 
at least two different antigens in the screening and expressed as the fraction of poly-reactive wells of the 
total IgM binders. Statistic was performed using unpaired t-test. **p = 0.001; *p = 0.02.  
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Figure 5. Enrichment of mutated sequences in IgM+IgD+CD27−CD73− B cells.  
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Heavy chain VH sequences were amplified from cDNA extracted from monoclonal naïve B cell expanded 
in vitro for 12 days. Clones containing unique VH sequences were analyzed for gene segment usage, 
germline identity, and CDR3 composition using the IgBlast algorithm. Analysis was performed on 301 
sequences extracted from 3 different healthy donors. (A) The percentage of germline identity of FR1, FR2 
and FR3 as well as of CDR1 and CDR2 gene segments is expressed for naïve CD73+ (black line, n=184) 
and CD73− (red line, n=117). Sequences showing a germline identity > 95% were defined not mutated; 
whereas sequences with a germline identity < 95% were defined mutated. The table shows the number of 
mutated versus not mutated sequences in CD73+ and CD73− naïve B cells. Statistic was performed using 
Fisher exact test. p = 2.5e-10. (B) 71 heavy chain VH sequences were amplified from cDNA extracted 
from IgM memory B cell clones isolated from one healthy donor and expanded for 12 days in culture. The 
percentage of germline identity of FR1, FR2 and FR3 as well as of CDR1 and CDR2 gene segments is 
expressed for naïve CD73+ (black dots, n = 184) and CD73− (red dots, n = 117) and IgM memory B cells 
(blue dots, n = 71).  
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Figure 6. CD73 defines a subset of human germinal center reactive memory B cell.  
  
IgG+CD27+ memory B cells were sorted according to CD73 expression, seeded at the density of 1cell/well 
in 384 well plates and stimulated in vitro with CpG 2006, anti-CD40, IL-2, IL-21, BAFF and tranferrin 
for 12 days. (A) IgG secretion in the culture supernatant was measured by ELISA assay and the response 
efficiency was calculated according to a formula which considers the average of cells seeded per well, the 
total number of wells seeded and the number of IgG positive wells (Supplementary figure 1). Statistic was 
performed using unpaired t-test. **p = 0.002. (B) The IgG secretion kinetic analysis in the 
IgG+CD27+CD73+ and IgG+CD27+CD73− was performed calculating the amount of IgG produced by 
single-B cell cultures in the indicated time points. The expansion efficiency of IgG differentiation was 
calculated with the formula mentioned above.  
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Figure 7. Decreased BCR poly-reactivity in CD73− IgG class switched memory B cells.  
Figure   
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(A) After clonal expansion of IgG memory B cell CD73+ and CD73− subsets, culture supernatants were 
screened by ELISA assays for the presence of IgG antibodies reactive against: IL-2, IL-17AF, insulin, 
influenza and tetanus toxoid (Supplementary Figure 1). Poly-reactivity was defined by the recognition of 
at least two diverse antigens and expressed as a fraction of the total number of IgG secreting wells (total 
binders). Statistic was performed using unpaired t-test. *p = 0.03. (B-C) 431 clones from 2 healthy donors 
containing unique VH sequences were analyzed for CDR3 amino acid length (B) and germline identity 
(C) using the IgBlast algorithm. (B) Statistic was performed using ratio paired t-test with Welch’s 
correction. **p = 0.008. (C) No differences in the mutated sequences were observed between the switch 
CD73+ and CD73− compartment.  
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Suppl. Figure 1. Functional BCRs repertoire by human B cell single-cell expansion  
  
(A) Workflow for the single-cell expansion. After flow cytometry-based sorting, cells are plated in a  
384 well plate at the density of 1 cell/well and stimulated with conditioned medium. On day 12, 
supernatants are collected and screened by ELISA assay to test the reactivity against a defined set of 
antigens. Other functional assays are compatible, for instance neutralization assay. Meanwhile, the cell 
pellet is lysed and can be stored at -80° for future Ig genes amplification and cloning. (B) Human B cell 
clonal expansion efficiency’s calculation.  
Supplementary Figure 2  
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Suppl. Figure 2. ELISA screening on single B cell culture supernatants  
  
After in vitro single B cell-expansion, culture supernatants were screened to detect antigen- 
specific immunoglobulin secretion. Self-antigens (insulin, IL-2, IL-17AF), pathogen-antigens 
(influenza and tetanus toxoid) and control plates coated with PBS were included in the screening.  
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3. Discussion  
  
The concept of ‘instructive immunology’ stems from the functional interconnection between 
innate and adaptive immune systems. Following the historical model predicted by Janeway, 
germline-encoded pattern-recognition receptors (PPRs) expressed by cells of the innate immune 
system, like dendritic cells (DCs) and macrophages, recognize conserved microbial molecular 
signatures and therefore instruct cells of the adaptive immune system to mount protective 
responses (Janeway 1989). Recently, our understanding of the interplay between the two systems 
has improved, most essential being the evidence that PPRs are expressed also by B and T 
lymphocytes (Bernasconi et al. 2003, Imanishi et al. 2007). The main targets recognized by PPRs 
include the invariant molecular structures shared by large groups of pathogen, called pathogen-
associated molecular patterns (PAMPs) and molecules released by stressed cells undergoing 
necrosis that act as endogenous danger signals and so called damageassociated molecular 
patterns (DAMPs).  
ATP released during inflammatory processes acts as a DAMP for cells of the innate immune 
system through stimulation of purinergic P2 receptors, which results in the activation of the 
NLRP3 inflammasome, with consequent release of the pro-inflammatory cytokines IL-1 and IL-
18 (Di Virgilio and Vuerich 2015). Purinergic receptors are widely expressed also by adaptive 
immune cells, where extracellular ATP has been shown to regulate many cell responses. Among 
P2 receptors, P2X7 is the most investigated receptor in regulating immune cell physiology. 
Grassi and colleagues have shown that extracellular ATP delivers a costimulatory signal to 
mouse T cells through stimulation of P2X7 receptor (Schenk et al. 2008); moreover few years 
later they have shown that P2X7 activity regulates the immunosuppressive function of regulatory 
T cells (Schenk et al. 2011). In our study we focused on the role of P2X7 receptor in regulating 
the adaptive IgA response in the small intestine. IgA is the dominant immunoglobulin isotype at 
the mucosal surface of the intestine and has a central role in holding homeostatic relationship 
between host and resident microbiota. Tfh-cell-dependent IgA responses occur in GCs of Peyer’s 
patches (PPs) and are responsible for the production of high-affinity antibodies, critical in 
limiting the translocation of potentially invasive bacteria from the gut lumen to the organism 
(Proietti et al. 2014). We identified a novel role of P2X7 receptor as regulator of the adaptive 
IgA response in the small intestine. Deletion of P2rx7 resulted in the expansion of Tfh located 
in the PPs with consequent enhanced production of high affinity IgA GC-derived. P2rx7−/− mice 
showed increased SHM of IgA repertoire and a reduced mucosal colonization, indicating 
enhanced antigen specific Tfh cell help. Serum IgM plays a crucial role in protecting the 
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organism against blood microbial infection and its production has been proposed to be driven by 
PRRs agonists which support the differentiation of marginal zone as well as innate B cells into 
IgM secreting cells (Cerutti et al. 2013). The increased high-affinity anti-bacterial IgA antibodies 
and the reduced translocation of microbial components observed in P2rx7−/− mice, resulted in 
lower IgM serum levels and an increased susceptibility to polymicrobial sepsis. These results 
point to P2rx7 as a master regulator of host-microbiota mutualism. P2X7 receptor activity is 
conserved in human, gaining more attention considering sepsis as one of the major health 
problems (Hotchkiss and Karl 2003). Furthermore, a general antibiotic treatment in human 
patients might induce changes in the intestinal microbiota eventually enabling bacteria to invade 
the bloodstream (Ubeda et al. 2010).  
The gut-microbiota can affect many aspects of host-metabolism, including energy harvesting 
from nutrients, hepatic lipogenesis and adipose tissue development (Backhed et al. 2004, 
Turnbaugh et al. 2006, Cox and Blaser 2013). Interestingly, it has been shown that Tfh cell 
activity is important for generating a diverse bacterial community in the gut and that sensing of 
microbiota-derived ATP via P2X7 promotes the generation of proficient ecosystem (Perruzza et 
al. 2017). Taken together these data suggest a central role for the purinergic signaling pathway 
in the reciprocal regulation of the adaptive immune system and microbiota, ensuring the 
maintenance of a healthy microbial community. In comparison to many other exocrine signaling 
systems, the purinergic network has many layers of complexity and displays a great deal of 
plasticity. Increase in the extracellular ATP is a key danger signal in innate inflammatory 
processes. Here we showed for the first time that extracellular ATP is able to counterbalance the 
activation of the innate harm by down-regulating effector functions of Tfh cells to promote host-
microbiota mutualism.  
Most messengers based signaling systems function only in an on/off mode, marked by the 
presence or absence of the ligand. By contrast, in the purinergic network, hydrolysis of the ligand 
does not necessarily terminate the signal, but generates a new metabolite with the capacity to 
signal on its own at a different receptor, initiating a distinct signaling cascade. Indeed, an 
additional layer in the regulation of extracellular ATP is due to its hydrolysis to adenosine. After 
the release in the extracellular space, ATP is hydrolyzed by ectonucleotidases in a two-step 
enzymatic process, which is important for calibrating the duration, magnitude and composition 
of the purinergic halo surrounding the immune cells. The first step consists in conversion of 
ATP to ADP and AMP and is orchestrated by CD39, while the second step brings to the 
generation of adenosine from extracellular AMP and is mediated by ecto-5'nucleotidase (5’-NT) 
CD73. The expression and activity of both CD39 and CD73 is dynamically regulated in 
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accordance with the environment context, contributing to the outcome of many adenosine-
mediated cellular responses. Under physiologic conditions, adenosine, similarly to ATP, is 
present at low level in the extra cellular space. The role of adenosine in favoring CSR has been 
already observed (Schena et al. 2013) and in our study we linked this phenomenon to higher 
capacity of CD73+ naive B cells to cognate interact with circulating Tfh cells compared to the 
CD73 negative counterpart. The first step in the GC reaction is the activation of naive B cells by 
the exogenous antigen followed by interactions with the antigenspecific T cells, in order to 
become fully active. The intrinsic role of CD73 in shaping the outcome of the B cell response 
was confirmed at a single cell level, where the clonal expansion of CD73+ naive B cells resulted 
in higher plasticity to perform IgG CSR.  
The extracellular adenosine concentration can rapidly increase in response to hypoxia, ischaemia, 
inflammation or trauma. In GCs, antigen-activated B cells proliferate, express high affinity 
antibodies, promote antibody class switching, and yield B cell memory and long-lived plasma 
cells (LLPCs). Significant rounds of apoptosis and cell proliferation occur within the GC niche, 
rendering this microenvironment highly hypoxic. Interestingly, hypoxia–inducible factor 1 (HIF-
1alpha) is a master regulator in promoting CD73 expression (Synnestvedt et al. 2002). Consistent 
with this notion, CD73 expression might be dynamically regulated in the GC microenvironment.  
The adenosine receptor expressed by human B cells is a Gs-protein coupled receptor linked to 
activation of adenylyl cyclase enzyme, namely the A2A receptor. Activation of A2A receptor 
induce an increase in cytosolic c-AMP which then acts as a second-messenger activating c- AMP 
dependent-kinase, such as PKA, which phosphorylate specific target proteins (). Intriguingly, it 
has been shown that AID physically interacts with PKA in the cytoplasm and is phosphorylated 
by PKA catalytic subunit at specific residues (Pasqualucci et al. 2006). We speculate that the 
higher CSR efficiency observed in the CD73+ compartment, in both naive and IgG memory B 
cells, is linked to the PKA activation A2A-dependent, with the consequent phosphorylation of 
AID, which is required for CSR.  
Analysis of CSR in naïve and memory human B cells separated on CD73 expression, showed a 
comparable level of CSR efficiency in IgM+IgD+CD27+ memory cells, both CD73 positive and 
negative, and IgM+IgD+CD27−CD73− B cells defined as naive B cells. This prompted us to 
investigate on eventual relation between the aforementioned compartments. Human  
IgM+IgD+CD27+ memory B cells are generally defined as marginal zone like B cells (MZ).   
Nevertheless, in contrast to the mouse counterpart, human MZ B cells recirculate and harbor 
mutated Ig variable genes (Weller et al. 2004, Weill et al. 2009). The involvement of this 
population in a T-dependent or -independent response is still under debate. In our study we 
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identified a novel subset of antigen-experienced B cell in the classical defined naïve 
IgM+IgD+CD27− compartment, which is characterized by lower expression of CD73. Analysis 
of the mutations in the Ig variable genes in the CD27− compartment showed an enrichment in the 
CD73 negative population, which appears distant to the fully germlined CD73 positive 
counterpart. Interestingly, the level of mutations observed in the IgM+IgD+CD27−CD73− cells 
was comparable to the IgM+IgD+CD27+ memory compartment, with a preferential accumulation 
in the CDR1 and CDR2 segments. Remarkably, from our data it is emerging that human memory 
B cells progressively acquire markers and properties that distinguish them from naive B cells, 
with CD73 playing an important role in the early differentiation steps. Indeed we speculate that 
IgM+IgD+CD27−CD73− B cells might represent early precursors of  
IgM+IgD+CD27+ B cells, which have already encountered the antigen and consequently mutated 
Ig variable genes. Further experiments are necessary to confirm this hypothesis and to gain 
insights into biological pathways and molecular mechanisms that regulate cell fate and 
development.  
The GC reaction has the unique potential to harmoniously generate plasma cells, which confer 
immediate protection by the secretion of specific antibodies, and memory B cells which confer 
rapid and enhanced response to secondary challenge. The overall concept of humoral 
immunological memory stems from the possibility to generate the long-lived cell populations. 
In this study, we identified CD73 as a marker in the main developmental check point existing 
between LLPCs and memory B cells generation in the course of a GC response. Our results 
clearly show that CD73 defines a subset of GC-reactive memory B cells, which is faster and 
more efficient in Igs secretion upon in vitro stimulation. The higher IgG secretion efficiency 
observed in the IgG+CD27+CD73+ memory B cells might reflect their need to further recirculate 
the GC and receive more cognate T cell help. The CD73− cells might instead represent the result 
of a successful GC reaction, which shutdown CD73 expression to escape further rounds of 
affinity maturation and to instead contribute to the long-lived PCs pool.  
  
In conclusion, our studies suggest a new checkpoint role for the purinergic halo surrounding 
immune cells which can either enhance or inhibit adaptive immune cell activation. Several 
questions remain to be answered before we can fully understand the several roles of autocrine 
and paracrine purinergic signaling in immune cell regulation. Nevertheless, our studies have 
contributed in the field raising better appreciation on the role of innate signals, like extracellular 
ATP and adenosine, in tightly shaping the adaptive immune responses in both T and B cell 
compartment. Our findings could be important for developing new immunomodulatory therapies 
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that target purinergic receptors, enabling a modulation of germinal center responses, which has 
been never been proposed before.  
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